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ABSTRACT

Mechanisms adopted by Dengue-2 viruses to induce
autophagy in mammalian cells
by
Sounak Ghosh Roy
Advisor: Zahra Zakeri

Rationale

Dengue, the most rapidly spreading flavivirus, threatens to affect almost half of

the human global population. We previously showed that dengue-2 protects canine kidney cells
(MDCK) from cytotoxic chemicals. We showed, independently, that cell protection as well as
viral replication and maturation are positively regulated by PI3K-dependent autophagy.
However, we had not identified the specific pathway that induces autophagy in infected cells.
The current study explores the role of a specific branch of endoplasmic reticulum (ER) stressmediated Unfolded Protein Response (UPR), the PERK/eIF2α/ATF4 pathway in induction of
autophagy by Dengue. We studied the relation between PERK pathway and induction of
autophagy in infected MDCK and MEF cells. We extended this study to determine whether
PERK activity correlates with protection of infected cells. Finally, we identified Ataxia
Telangiectasia Mutated (ATM), a DNA damage response (DDR) protein as an upstream
regulator of PERK, autophagy and cell protection.
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Methods

We measured the expression of markers and regulators of ER stress and

autophagy in infected mammalian cells (MDCK and MEF) using qPCR, immunoblotting and
immunohistochemistry. When applicable, infected cells were pretreated with chemical regulators
of ER stress, PERK, ATM and autophagy, with a goal to trace the relationship between these
pathways and the life cycle of virus. To quantify cell protection, we measured cell viability using
trypan blue exclusion assay.

Results

We first recorded the induction of global ER stress in infected cells, and much of

this activation diminished when cells were treated with inhibitors of PERK pathway. We
observed a rise in the expression level of different markers of PERK pathway in infected cells.
We used chemical inhibitors and genetic knockouts to establish that an active PERK pathway is
essential for increased autophagy flux and cell protection, as well as viral replication and
maturation. ATM kinase was separately identified as an upstream regulator of three distinct
processes: PERK activation, autophagosome formation and cell protection. However, we still
need to investigate whether ATM executes these functions through a single pathway or multiple
pathways.

Interpretation Our data show that, when dengue infects cells, ATM is an early regulator that
activates PERK, autophagy and cell protection. Since PERK and autophagy have been
implicated in viral production, the current study identifies several putative targets for antiviral
therapy, although these targets also serve multiple housekeeping functions (stress response,
protein folding, and homeostasis) in the cell. Future studies should focus on the links between
these pathways and identify an antiviral target that is redundant or non-essential for the host cell.
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6. INTRODUCTION
6.1. DIFFERENT PATHWAYS OF CELL DEATH The demise of a cell can be broadly
classified into Accidental Cell Death (ACD) and Regulated Cell Death (RCD) [1]. As the names
suggest, ACD is used to denote an acute form of cell death that takes place in response to
physical or mechanical assaults to the cell. In sharp contrast, RCD is the consequence of a
coordinated activation of signals that acts as an adaptive stress response to intracellular or
extracellular disturbances, or due to physiological reasons like cell division, development or
differentiation; the latter, physiological, form is also known as Programmed Cell Death (PCD)
[1]. Though identified as early as mid-19th century, when Carl Vogt observed loss of notochord
in amphibian metamorphosis, the idea of cells dying through a regulated pathway was not greatly
appreciated for almost a century [2, 3].

The negligence of regulated cell death during the first decades of its recognition, at least
until the 1960s, can be attributed to the shortage of tools to document or visualize dying cells,
since an apoptotic cell is often visible only up to 20 min after death. In spite of this shortcoming,
scientists were gathering evidence of RCD in diverse model organisms as Dictyostelium, insects,
and chicken [4-6]. The identification, naming, and further characterization of apoptosis (RCD
type 1) as a morphological process common to most types of RCD in the period between 1972
and 90s made it impossible to ignore, anymore, the importance of RCD in AIDS, Huntington's,
Parkinson's, Alzheimer’s and viral infection [7-9]. With identification of even more types and
pathways of RCD, classification became essential, and the most common parameters used were
morphological. Based on the associated morphological features, RCD was classified into type I
(apoptosis), type II (autophagy) and type III (necrosis). Type I cell death is usually characterized
1

by plasma membrane blebbing, chromatin condensation (pyknosis), nuclear fragmentation
(karyorrhexis) and type II involves the lysosomal degradation of certain double membraned
vesicles containing a “cargo” to be recycled. Type III death exhibits none of these features. As
more pathways were identified, so did studies linking these processes to the pathogenesis of
various diseases, including tumorigenesis, diabetes, and viral infection [10-17].

Besides, dying cells release certain molecules called DAMP (Danger Associated Molecular
Pattern) that can help other threatened cells, hence the organism, by acting as an alarm to which
the threatened cells respond by augmenting whatever defenses they can muster [18-21].

Testimony to the expanding horizon of cell death studies can simply be judged by the fact
that The Nomenclature Committee on Cell Death (NCCD) recognized over the last decade several
novel pathways of programmed death. The NCCD now lists the following as accepted forms of
cell death (Table 1): extrinsic apoptosis, intrinsic apoptosis, mitochondrial permeability
transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell
death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death,
immunogenic cell death, and non-lethal processes as cellular senescence and mitotic catastrophe.
Since the approach of classification based solely upon the morphology needs extensive revision,
NCCD is stressing the importance of molecular, genetic and pharmacological parameters [1].
Moreover, since traditional markers of RCD were associated with non-lethal conditions as well,
the same committee has also suggested a re-evaluation of the defining hallmarks for a dead cell:
complete disintegration of the cell membrane and engulfment by phagocytosis [22].
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Table 1: Different forms of cell death, as recognized by NCCD
TYPES OF CELL DEATH

MAJOR CHARACTERISTICS
LETHAL
Extrinsic Apoptosis
Associated with extracellular perturbations that
leads to caspase 8 activation and optional
mitochondrial outer membrane permeabilization
(MOMP)
Intrinsic Apoptosis
Associated with mitochondrial outer membrane
permeabilization (MOMP) and activation of
executioner caspases (CASP-3) brought about by
changes in the internal and external environment.
MPT-Driven Necrosis
Associated with cyclophilin D (CYPD) that is
activated due to intracellular modifications
Necroptosis
Associated with increased activity of Mixed
Lineage Kinase Domain-Like Pseudo Kinase
(MLKL) and Receptor Interacting Serine
Threonine Protein Kinase 3 (RIPK3) in response
to changes in intracellular or extracellular
homeostasis
Ferroptosis
A form of cell death linked to the oxidation status
of the cell, that can be blocked by iron chelators
and lipophilic antioxidants
Pyroptosis
Characterized by the formation of cell membrane
pores by gasdermin family proteins
Parthanatos
Associated with increased Poly [ADP-Ribose]
Polymerase (PARP)-1 activity in response to
DNA damage induced by Apoptosis Inducing
Factor (AIF) and Macrophage Migration
Inhibitory Factor (MIF)
Entotic Cell Death
A lysosomal process that leads to cell-in-cell
internalization
NETotic Cell Death
A ROS-dependent mechanism associated with the
release of Neutrophil Extrusion Traps (NET)
Lysosome-Dependent Cell Death Associated
with
Lysosomal
Membrane
Permeabilization (LMP) and requires the
involvement of Cathepsins (CTS)
Immunogenic Cell Death
Responsible for mounting an adaptive immune
response in immunocompetent host cells
Autophagy-Dependent
Cell A form of cell death that can be blocked by
Death
pharmacological and genetic inhibition of the
macroautophagy pathway
NON-LETHAL
Cellular Senescence, Mitotic Catastrophe, Terminal Differentiation

3

6.1.1.

APOPTOSIS The earliest recognized form of RCD, apoptosis (Greek: falling of leaves),

was first reported, albeit not identified, by Walter Fleming [3]. Kerr et al characterized apoptosis
and described it as a general process mistakenly previously identified as an arcane form of death
that Kerr had described as ‘shrinkage necrosis’ [7]. Apoptosis (RCD type I) involves
fragmentation of the nucleus, chromatin condensation, blebbing of the cell membrane, followed
by the engulfment of the apoptotic cell by phagocytic cells (efferocytosis). The recognition of
apoptotic cells by the phagocytes involves the externalization of an inner membrane lipid of the
cell membrane, phosphatidylserine (PS) - a process mediated by the regulation of scramblase
and flippase enzymes. This event precedes all the phenotypes described above, however
identification of non-apoptotic PS externalization casts a shadow of doubt on the status of PS
externalization as a defining hallmark of apoptosis [23-25].

Apoptosis follows either of two distinct pathways, the extrinsic (death receptor) and intrinsic
(mitochondrial) pathway [26]. Apoptosis is responsible for the elimination of presumptively
nonessential cells, sculpting of digits, and degradation of presumptively unnecessary tissues and
organs [27].

1. Extrinsic apoptosis According to the recent NCCD guidelines, extrinsic apoptosis is defined
as the ligand-mediated activation of plasma membrane receptors in response to external factors,
and the culmination of this process is the activation of executioner caspases and in some cases,
mitochondrial outer membrane permeabilization (MOMP). The receptors associated in this
branch of apoptosis are classified as 1) death receptors, and 2) dependent receptors [1, 28-34].

4

In case of death receptors, specific cognate ligands (TNF-α, FasL, TRAIL) are
responsible for the activation of their respective receptors (TNF RI, Fas/CD95, DR3, TRAIL
R1/DR4, or TRAIL R2/DR5) on the cell surface [26, 35-37]. This interaction results in the
homotrimerization and activation of the preformed receptors at the intracellular side. An
extensive assembly process ensues that culminates in the formation of a death inducing signaling
complex (DISC) that activates initiator caspase CASP8. The caspase proteins (Cysteinedependent Aspartate-directed Proteases = C-ASP-ASES) are central to the entire apoptotic
machinery within the cell. They are also integral to the dependence receptors as well as the
intrinsic pathway is discussed later [38-46].

The formation of the DISC and the subsequent initiation of the caspase-cascade follow
different courses in case of different death receptors. In case of the FAS and TRAIL receptors,
which are activated by FAS ligands (FASL) and Tumor Necrosis Factor apoptosis-inducing
ligands (TRAIL) respectively, the activation of homotrimer at the intracellular side involves the
interaction of an amino acid sequence common to the partners of the trimer called the FASassociated Death Domain (FADD) that is instrumental in the formation of FAS-specific DISC II
complex. The formation of this complex is followed by the c-FLIP mediated activation of
CASP8, which involves autoproteolytic cleavage as well as homodimerization. Apart from
cFLIP isomers, CASP8 can also be regulated by phosphorylation and deubiquitylation. The
downstream effects of CASP8 take different courses in “type I” cells (lymphocytes and
thymocytes) and “type II” cells (most cancer cells, pancreatic cells, hepatocytes).1 In case of the

1

Authors have defined the terms "type I" and “type II” differently.
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former, there is apparently no crosstalk between CASP8 activity, manifested as maturation of
CASP3/7, and the BCL-2 proteins that are involved in the mitochondrial intrinsic apoptosis
(discussed later). In contrast, in “type II” cells there is compelling evidence of extensive
crosstalk between CASP8 and the key players of the intrinsic pathway, especially XIAP and BID
[38-65].

In comparison to the FADD pathway, the downstream effects of the interaction between
Tumor Necrosis Factor-α (TNF-α) and Tumor Necrosis Factor-α Superfamily member 1A
receptor (TNFR1) are more diverse and subject to more layers of cellular regulation. Unlike
FADD, the TNF-associated death domain (TRADD) is responsible for the formation of DISC
complex I, which recruits and ultimately is composed of heterogeneous proteins like TNF
receptor associated factor 2 (TRAF2), RIPK1, cIAP1, TRAF5 and a linear ubiquitin chain
assembly complex (LUBAC1). RIPK1 is crucial for maintaining a balance between extrinsic and
intrinsic apoptosis in a cell, as well as the balance between pro-survival and pro-apoptotic
signals. Post-translational modifications of this protein determine the fate of both apoptosis and
the cell itself, e.g., phosphorylation, polyubiquitination (by LUBAC) or deubiquitylation, which
determine the nature of extrinsic apoptosis and the type of DISC involved [66-84].

Dependence receptors (DCC, PTCH1, NTRK3, UNC5A) are activated when their ligands
drop below a threshold concentration. This occurrence activates two modes of regulation that are
often used by anti-apoptotic proteins, especially in neoplastic cells: 1) restoration of the ligands,
and 2) silencing or down-regulation of the receptors and associated proteins. Here, as in the case
of death receptors, caspases play an important part, complemented by overlapping roles played
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by mitochondrial components of the intrinsic pathway. Depending on the type of receptor,
dependence-mediated apoptosis can be mediated by otherwise intrinsic pathway via the CASP9CASP3 cascade (e.g., DCC, UNC5B, and NTRK3), Death Associated Protein Kinase 1
(DAPK1), or CASP9 (PTCH1) [85-95].

2. Intrinsic apoptosis

According to the most recent definition proposed by NCCD, intrinsic

apoptosis is a type of RCD characterized by mitochondrial outer membrane permeabilization
(MOMP) and activation of executioner caspases (caspases that attack vital cytoplasmic proteins),
both induced in response to certain intracellular perturbations [1]. The intrinsic branch is almost
entirely regulated by the mitochondria, in response to DNA damage, growth factor withdrawal,
loss of contact with the extracellular matrix, endoplasmic reticulum (ER) stress, oxidative stress,
alterations of microtubules, anomalous replication or mitotic defect. In addition to the size of
mitochondria, the lipid composition (especially ceramide) of the mitochondrial membrane is also
crucial for pro-apoptotic signaling. The central component of this pathway is the irreversible
permeabilization of the outer membrane of mitochondria – an event called mitochondrial outer
membrane permeabilization (MOMP). The intrinsic apoptosis pathway is tightly regulated by
interactions between antagonistic (pro- and anti-apoptotic) proteins belonging to the Bcl-2
family, a group of proteins that possess one or more of the four Bcl-2 homology (BH) domains.
Effectors, which are pro-apoptotic Bcl-2 proteins that directly bring upon MOMP, facilitate
cellular demise; these proteins contain all four BH domains (BH-1, 2,3,4). Other pro-apoptotic
proteins called activators and sensitizers help in the functioning of the effectors by binding to
anti-apoptotic proteins also known as guardians [96-105].
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The two effectors that have been extensively studied are Bcl-2 associated X (BAX) and
Bcl-2 apoptosis killer (BAK); a recently isolated protein BOK has been shown to work
independently of BAX and BAK. Under normal conditions, BAX shuttles between the outer
mitochondrial membrane (OMM) and cytosol. In contrast, BAK is localized in the OMM by
virtue of interaction between its hydrophobic C-terminal and the OMM lipid bilayer. When the
cell is perturbed by any of the intracellular stimuli of apoptosis, BAX retro-translocation into the
cytoplasm is stalled and the mitochondrial effector pool increases [106-118]. The activators in
turn are induced in response to the pro-apoptotic cellular stimuli. PUMA, BIM, and NOXA are
activated by transcriptional regulation, whereas BID is activated by post-translational
modification. The BH3-only activators (PUMA, NOXA, BIM, BID) then interact with BAX and
BAK and result in the rearrangement of their molecular structure (dissociation of the core and
latch domains) [112, 119-135]. This rearrangement further leads to the oligomerization of BAX
and BAK, which may form either homo- or hetero-dimers in different settings. All these events
are responsible for the rearrangement of the mitochondrial membrane, which involves the
formation of pores (by BAX dimers) in OMM and the eventual initiation of MOMP [136-141].

As a counter-reaction, the pro-survival proteins, more commonly known as anti-apoptotic
guardians of the cell, block the apoptotic response (MOMP and pore-formation in the OMM).
Like the effectors they block, the guardians are also Bcl-2 family proteins that contain all the
four BH-domains, a feature most important from a structural and functional point of view as
these domains (especially 1,2,3) enable the proteins to insert into the mitochondrial and ER
membranes and interact directly with the effectors. These proteins block apoptosis directly by
sequestration of the effectors or indirectly by the inactivation of the activators, which in some
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conditions results in the depletion of the mitochondrial Bax/Bak pool. Apart from physical
sequestration and inactivation of pro-apoptotic proteins, the guardians also promote cell survival
through Ca2+ homeostasis (ER), increased ATP synthesis and regulation of redox balance [97,
99, 103, 142-163]. A third class of BH3-only pro-apoptotic proteins, the sensitizers, blocks the
activity of the anti-apoptotic proteins by binding to them and limiting their capability to
sequester the pro-apoptotic proteins. In this context, it is important to acknowledge that the
sensitizers (proteins like BAD, HRK, and MRF) are not always functionally distinct from the
activators (PUMA, NOXA, BID, BIM) as the latter also bind anti-apoptotic proteins and
inactivate them. However, in most cases, the sensitizers act upstream of the activators. The
importance of the BH3-only proteins in cell survival and as a consequence in tumor formation
can be demonstrated by the fact that several BH3-mimetics have been shown to inhibit tumor
formation [131, 140, 155, 164-169].

BAX/BAK mediated MOMP is not however limited to the regulatory effects of BH3only proteins, as has been demonstrated in knockout cells. More “non-canonical” pathways of
BAX/BAK activity are being studied and other proteins like PIN1, P53 and ATR have been
identified as activators [170-174]. The importance of the ER in this regard is very important, as
both BAX and BAK can impact its physical structure, and affect its permeability. The resultant
leakage of chaperones and Ca2+ ions, coupled with the mitochondria-associated ER membranes,
can offer an alternative to the classical model of BAX/BAK activation in intrinsic apoptosis. The
identification of the ER-resident BOK as a third effector that has shown very little indication of
dependence on BAX/BAK has further highlighted the importance of ER in RCD [175]. The
classical sensitizers and activators do not regulate BOK; instead it is controlled by signals
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exclusive to the ER, e.g., ER-associated degradation (ERAD) and inositol-1, 4,5-trisphosphate
(IP3) receptors.

The downstream effect of the permeabilization of mitochondria is the subsequent release
of HTRA2/Omi, Apoptosis-Inducing Factor, Endonuclease G, cytochrome c (CYCS), direct IAP
binding mitochondrial protein with low pI (DIABLO) and secondary mitochondrial activator of
caspase (SMAC) from mitochondria into the cytosol. The CYCS binds to apoptotic peptidase
activating factor type 1 (APAF-1) and the zymogen pro-caspase 9 (CASP9) to form the
apoptosome, a supramolecular complex. SMAC binds to a class of proteins called inhibitor of
apoptosis proteins (IAP) that includes X-linked IAP (XIAP), which binds to the apoptosome.

The apoptosome functions by the interaction between the respective caspase recruitment
domains (CARDs) of APAF-1 and CASP9, which subsequently activates CASP9 [176-180].
CASP9 acts as an initiator caspase, which then activates the executioner caspases CASP3 and
CASP7. Recent studies suggest that CASP6, hitherto regarded as executioner, may well function
as an initiator. CASP3 and CASP7 represent the culmination of the mitochondrial apoptosis
cascade and are responsible for most of the biochemical, morphological and molecular hallmarks
of this process; e.g., CASP3 is essential for phosphatidylserine (PS) externalization. However,
intrinsic apoptosis can switch modes to other forms of RCD if caspases are dysfunctional
because of either non-competitive inhibitor (like zVAD-FMK) or genetic mutation/knockout.
Cells can also exhibit partial adaptation to caspase activity in a condition known as anastasis,
where cells survive in spite of normal caspase activity.

Since executioner caspases also

influence the release of DAMPs from dying cells, they can regulate the immune response of a
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cell as well. This is important to appreciate, especially in the light of tumor formation. Anoikis, a
form of intrinsic cell death that initiates when cells lose integrin-dependent attachment, is
regulated by executioner caspases like CASP3, thus highlighting the relevance of these proteins
in metastasis and tumorigenesis. Yet another paradox is the existence of BAX/BAK-independent
pathway of CASP3 activation, which is probably mediated by mitochondrial ceramide levels and
other possibly unidentified factors.

6.1.2.

NECROSIS Some forms of necrosis are programmed and controlled through a specific

set of signal transduction pathways and degradative mechanisms. Cell death by specific necrosis
can also contribute to embryonic development and adult tissue homeostasis [181]. Necrosis can
be triggered by the same death signals that induce apoptosis [182]. The difference between
apoptosis and specific necrosis lies in the rapid cytoplasmic swelling and release of extracellular
components, seen in specific necrosis, which is often due to extreme physiochemical stress,
osmotic shock, mechanical stress and high concentration of hydrogen peroxide [183]. When a
cell is under such conditions, which can be produced by physiological or developmental
situations, cell death occurs accidentally and uncontrolled. Necrosis signaling complex forms by
interaction of receptor interacting protein 1 (RIPK1) with the receptor interacting protein 3
(RIPK3) [183]. Necrosis does not depend on caspase activation. In a study done by
Nikoletopoulou et al. 2013, two different cell lines were treated with a tumor necrosis factor-α.
In one cell line, apoptosis was triggered, whereas in another cell line it induced necrosis [184].

6.1.3.

NECROPTOSIS

Another form of cell death, associated with necrotic morphotype,

is necroptosis. Various death receptors associated with extrinsic apoptosis, including (but not
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limited to) FAS, TNFR1, TRAILR1 and TRAILR2, have been shown to induce necroptosis in
different cell types. Furthermore, necroptosis can be instigated by the members of the pathogen
recognition receptor (PRR) family, which are responsible for sensing pathogen-associated
molecular patterns (PAMP) [182]. Studies have shown that this form of RCD, apart from being
an important mode of stress adaptation, also play key role in developmental and immunological
homeostasis [185-195].

The best studied among these stimuli is the interaction between the extracellular ligand
TNF and its specific receptor TNFR1. The activation of TNFR1 results in the formation of the
necrosome, which contains RIPK1 and RIPK3, the latter being a non-redundant molecule in this
pathway. The formation of necrosome is tightly regulated by post-translational modification
(ubiquitination, phosphorylation) of the RIPK proteins. The inhibition of RIPK3 by CASP8 and
IAPs presents a form of interaction between intrinsic apoptosis and necroptosis [1, 195-205].

The central effector molecules of necroptosis are RIP kinase RIPK3 and mixed lineage kinase
domain-like pseudo kinase (MLKL). In the presence of an inactive CASP8, RIPK1 activates
RIPK3 through interaction between their respective homotypic interaction motifs (RHIMs).
RIPK3 can also be activated in a RIPK1-independent fashion through RHIM-mediated
interaction with Z-DNA binding protein (ZBP-1). Active RIPK3, in turn, activates MLKL by a
monomer-oligomer transition; the active MLKL is translocated to plasma membrane where it
initiates its permeabilization [186, 187, 190, 196, 198, 201, 206-210].
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The translocation of MLKL to the plasma membrane, followed by the disintegration of
the membrane, is associated with an increased Ca2+ influx into the cell as well as externalization
of PS. The latter might point to a potential crosstalk between MLKL and CASP3 but this relation
must be studied. Apart from the shedding of plasma membrane-associated proteins, MLKL has
also been reported to form Mg2+-permeant channels in the membrane [211-215].
6.1.4.

MPT-DRIVEN NECROSIS

This is a specific form of cyclophilin D (CYPD)-

dependent necrosis driven by membrane permeabilization transition (MPT, or permeabilization
of the inner mitochondrial membrane (IMM)) in response to intracellular perturbations. This
form of RCD is initiated by the opening of the permeabilization transition pore complex 1
(PTPC1), a super-complex spanning the IMM and OMM, in response to intracellular conditions
like oxidative stress or an overload of cytosolic Ca2+. CYPD is thought to play an important role
in this process, although other proteins have also been identified. One such protein is the F1-F0
ATPase, which interacts with CYPD as well as Ca2+ ions, thus leading to the permeabilization of
the IMM to smaller solutes. However, studies with ATP synthase deficient cells indicate that this
protein might be redundant in MPT-driven necrosis [216-232].

MPT-driven necrosis is also modulated by components of the PTPC, some of which overlap
with the intrinsic apoptosis pathway, including both pro-apoptotic (BAX/BAK/BID) and antiapoptotic (BCL-1/BCL-XL) proteins. Other key molecules involved in PTPC activity are DRP-1
(activated by the calcium/calmodulin dependent kinase CaMKII) and p53 (shown in cardiac
ischemia). Since Ca2+ homeostasis is an important trigger for MPT, calcium uniporters present in
the IMM also play an important role in MPT-driven necrosis. Like intrinsic apoptosis, this form
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of necrosis also highlights the importance of mitochondria in maintenance of cellular integrity in
the face of severe stress [233-242].

6.1.5.

NETotic CELL DEATH

This is a less studied form of RCD, characterized by a

ROS-dependent extrusion of neutrophil extrusion traps (NETs) from cells infected with
pathogens. NETs, which are biochemically networks of chromatin and histone-containing fibers
bound to cytoplasmic and granular proteins, serve as extracellular platforms designed for
microbial degradation. Besides neutrophils, NETs are also released by eosinophils and mast cells
[243-250].

The function of NETs is strictly dependent on the activation of NADPH oxidase and the
resulting ROS production. This activation is regulated by mitogen activated kinase type 2
(MAPK2), ERK2 and a proto-oncogene RAF1. In infected cells, ROS activates elastase
neutrophil expressed (ELANE) which culminates in the disintegration of filamentous-actin (FActin), as well as histone degradation and chromatin decondensation. A combination of all these
events is manifested in the form of NET release from infected cells [251-258].

6.1.6.

LYSOSOMAL CELL DEATH

This form of RCD is characterized by

lysosomal membrane permeabilization (LMP) that culminates in the release of the lysosomal
protease Cathepsin (CTS) in the cytosol; this permeabilization might involve MOMP and
caspases. Lysosomal cell death is induced in response to an alteration in cellular homeostasis that
can trigger the loss of lysosomal membrane integrity. It is an important signaling pathway in
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pathophysiological conditions related to ageing, neurodegeneration, cardiac failure, as well as
essential developmental processes like post-lactation involution of mammary glands [259-261].

The central role in this RCD is certainly executed by the cathepsins (CTS) released into
the cytoplasm in an apoptosis-dependent or independent manner. Although demonstrated to be
upstream of LMP in certain experimental settings, the involvement of RCD is dispensable in
lysosomal cell death. However, in several instances, CTS activity in the cytosol can activate
MOMP and intrinsic apoptosis, in which case LMP must have occurred upstream of apoptosis.
A more universal trigger seems to be ROS production, which is instrumental in the alteration of
the lipid content as well as the Ca2+ channels in the lysosomal membrane. In special conditions,
as in post-lactation mammary glands, STAT-3 induces the expression of cathepsins B
(CTSB/CtsB) and L (CTSL/CtsL) in cytosol. Lysosomal cell death also maintains a balance
between autophagy and other cell death pathways in stress conditions. It is therefore believed to
be a signaling mechanism that has the ability to interact with both apoptosis and autophagy [259272].

6.1.7.

IMMUNOGENIC CELL DEATH This is a form of RCD that initiates adaptive

immune response, when certain DAMPs are released by dying cells in response to exogenous
(virus, pharmacological chemicals) and endogenous factors. Six types of DAMPs are associated
with ICD: 1) Calreticulin (CALR) which when exposed reveals an “eat me” signal, 2) ATP,
which when extracellular acts as a “find me” signal, 3) type I IFN, frequently released by cancer
cells, 4) Nucleic acids (dsRNA, DNA), also released by cancer cells, 5) High mobility group box
1 (HMGB-1), and 6) Annexin1 (ANXA1) [273-289].
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CALR, an ER-resident protein that senses Ca2+ homeostasis, is transported to the outer leaflet
of plasma membrane due to one or more signaling pathways, like PERK-dependent eIF2α
phosphorylation, CASP-8 mediated BAX/BAK activation, and exocytosis. Extracellular ATP,
which exhibits an immunostimulatory effect, is expressed on the plasma membrane following
autophagy-mediated ATP localization in the lysosome, translocation of LAMP1 to the plasma
membrane, ROCK-induced membrane blebbing and the opening of PANX1 channels. Type I
IFN is expressed in dying cancer cells that detect endogenous dsRNA/DNA (by TLR3/cGAS)
for ICD. Apart from boosting immune response in cells expressing the IFN alpha receptor
(IFNAR), IFN also induces a paracrine/autocrine signaling in malignant cells, a mechanism that
is also involved in nucleic acid mediated ICD of cancer cells. HMGB1 and ANX1 are thought to
induce adaptive immune response, resulting in antigen processing and presentation. Since certain
caspases such as CASP8 and CASP3 has been shown to suppress ICD, more investigation should
be carried out on this interconnection especially in cancer cells [290-305].

6.1.8.

FERROPTOSIS

In response to alteration in intracellular homeostasis, cells undergo

a ROS-mediated RCD that can be inhibited by iron chelators and lipophilic antioxidants. This
process, known as ferroptosis, arises due to events like lipid peroxidation, which destabilize the
internal homeostasis of the cell [306-309].

6.1.9.

PYROPTOSIS

Proteins of the gasdermin family are involved in the plasma

membrane permeabilization of infected cells, an RCD pathway referred to as pyroptosis that in
certain cases might be regulated by inflammatory caspases [310].
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6.1.10.

PARTHANATOS

A distinct form of RCD, parthanatos, is triggered by AIF- and

MIF- dependent DNA damage and the hyperactivation of PARP-1 [311].

6.1.11.

ENTOTIC CELL DEATH This is a form of cytoskeleton-dependent cell cannibalism

(cell-cell internalization) that is carried out by lysosomes [312].

6.1.12.

AUTOPHAGY-DEPENDENT CELL DEATH

This is a form of RCD associated

with autophagy – thus inhibition (pharmacological/ genetic) of autophagy can delay this type of
cell death. As we shall explain in the following paragraphs, autophagy is mostly regarded as a
cytoprotective mechanism in spite of being characterized initially as a form of “type II cell
death”. However, in special cases like developing Drosophila larva or in specific
pathophysiological conditions, blocking the activity of autophagy genes can result in a delay in
RCD, which is usually necessary for developmental events like larval midgut degradation.
Another form of autophagy-dependent cell death – autosis, frequently observed in hypoxic and
starved cells, involves the Na+/ K+-ATPase present in cell membrane [22, 313-324].

As mentioned above, autophagy is regarded as a recycling process that is mostly
cytoprotective, contributing to RCD only in rare cases (non-protective autophagy). In the
following section we shall expound upon the pro-survival aspect of various forms of autophagy
that has been identified till date [325].
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6.2. AUTOPHAGY IS A RECYCLING PROCESS THAT IS IMPORTANT FOR
MAINTENANCE OF CELL HOMEOSTASIS

The paradox of classifying autophagy as a

form of RCD lies in the fact that the inhibition of specific forms of autophagy (e.g.,
macroautophagy) by pharmacological or genetic means can facilitate cellular demise, although in
a few instances distinct waves of autophagy–a protective “mild” and “lethal”– have been
identified in virus-infected cells [325, 326]. The apparent contradiction in the classification of
autophagy as a form of “type II cell death” can also be attributed to the fact that in the earliest
phase of autophagy studies, researchers observed dying cells with a high accumulation of
autophagosomes or autolysosomes. Noting the difference between this cells and apoptotic cells,
they decided to classify it as a form of RCD. This is a living testimony to the diverse pathways
and effects involved in autophagy, which was named in the 1960 by the Belgian scientist
Christian De Duve after the Greek word for a “self-eating” cell [325]. Today, we certainly have
more evidence that suggests that autophagy is much more than a self-degradation process; a
significant portion of this evidence came from studies conducted in yeast in the early 90s by the
2016 Nobel Laureate Yoshinuri Ohsumi. It is a highly conserved catabolic process that is
believed to have preceded apoptosis in evolution [327]. As more studies delineate the mechanism
of different pathways of autophagy, it is essential to characterize its unique features and
distinguish it from other degradative processes as pinocytosis, phagocytosis and endocytosis or
homeostatic processes like proteasome degradation. The authors of a 2017 review sought to
broadly define autophagy as a cellular homeostatic mechanism that involves the uptake of
endogenous or exogenous particles or proteins by cytosolic vesicles and their subsequent
degradation in the lysosomal compartment (or in late endosomes, in special cases) [325]. As
autophagy is deregulated in several pathophysiological conditions as ageing, autoimmunity,
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cardiac diseases, viral infection, and different forms of tumorigenesis, it is a viable therapeutic
target that needs to be fully understood and explored. In Table 2, a comprehensive list of the
different forms of autophagy as well as their salient features has been summarized.
Table 2: Different forms of autophagy, and their unique characteristics
Types of autophagy
MACROAUTOPHAGY
MICROPHAGY
CHAPERONE-MEDIATED
MITOPHAGY
PEXOPHAGY
NUCLEOPHAGY
AGGREPHAGY
RIBOPHAGY
RETICULOPHAGY
(ER-PHAGY)
LYSOPHAGY
XENOPHAGY
LIPOPHAGY
PROTEAPHAGY
MYELINOPHAGY
GRANULOPHAGY
ZYMOPHAGY
FERRITINOPHAGY
Ø Macroautophagy

Salient features
Formation of autophagosomes involving a subset of
genes from the ATG family
LAMP2A-independent pathway leading to direct
invagination on lysosomes or late endosomes and
the internalization of cargo inside these vesicles
Translocation of substrates across the lysosomal
membrane in a HSPA8- and LAMP2A-dependent
fashion
Specific removal of damaged, superfluous or
malfunctioning mitochondria
Targets and degrades peroxisomes either through
macroautophagy or microphagy
Specific removal of nucleus that involves
components
of
either
microphagy
or
macroautophagy
Specific removal of anomalous protein aggregates
Degradation of ribosomes
Removal of selected parts of the endoplasmic
reticulum (ER)
Specific degradation of lysosomes
Removal of bacteria that escapes the phagocytic
machinery, as well as viral components in the
cytoplasm
Specific degradation of neutral lipid droplets
Removal of inactive proteasomes
Removal of myelin (Schwann cells)
Removal of zymogen granules
Removal of stress granules
Degradation of ferritin

The most widely studied form of autophagy is the one that involves the

formation of large double membrane vesicles called autophagosomes. Macroautophagy is a
surveillance process that is involved in the recycling of basic biomolecules, the transport of
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proteins, lipids, and organelles to double-membrane vesicles (autophagosomes) and thence to
lysosomes for subsequent degradation [328, 329]. This process reaches its apogee in a stressed
cell. The prime mediators of autophagy signaling comprise sensors of cellular energy (like
AMPK/adenosine

monophosphate-activated

protein

kinase)

and

nutrition

(like

mTOR/mammalian target of rapamycin). As has been shown in Figure 1, the process can be
categorized broadly into five steps: 1) the nucleation of phagophore, the recruitment of a piece
of membrane borrowed probably from ER, Golgi or plasma membrane; 2) Expansion of the
phagophore membrane around the target ‘cargo’ by mechanisms involving LC3II and ATG9
proteins; 3) closure of the membrane, thus forming the autophagosome; 4) the fusion of the
autophagosome and lysosome, thus forming the autolysosome: and 5) hydrolase-mediated
degradation of the cargo stored inside the inner autophagosome membrane, followed by
permease-mediated efflux into cytosol [330-332]. Macroautophagy is monitored by two
ubiquitin-like conjugation systems. The first system employs E1-like enzyme Autophagy Related
Gene 7 (ATG7) and E2-like enzyme ATG10 to promote the conjugation of ATG5: ATG12 (E3like protein) and further build a complex of ATG5/ATG12/ATG16L1.

The second system recruits E1-like ATG7 and E2-like ATG3, alongside the
ATG5/ATG12/ATG16L1 complex, to transfer phosphatidylethanolamine (PE) to the
microtubule-associated protein 1 light chain 3 beta (MAP1LC3B, or simply LC3B). This
lipidation of LC3B is characterized by its cleavage into a shorter form, known as LC3II, which
colocalizes with the membrane of the expanding autophagosome. The formation of LC3 puncta
(autophagosomes), identified through fluorescence microscopy, is used as a marker of
autophagy. However, recent studies have also demonstrated the involvement of LC3II in
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processes as diverse as the fusion of autophagosome and lysosome and lysosomal degradation as
well as autophagy-independent processes as LC3-associated phagocytosis (LAP) [325]. The
identification of six homologues of LC3 (MAP1LC3A, MAP1LC3B, MAP1LC3C, etc.) has also
added to the complexity of the nature and function of these proteins [333-351].

Figure 1: The different pathways converging at the formation of autophagosome
A detailed diagram showing the different upstream regulators and components that are
involved in the initiation of autophagosome formation and the subsequent degradation of
autolysosome.
Following its nucleation, the pre-autophagosome membrane (PAS)/ phagophore is still
expanding/ elongating prior to its closure around the target ‘cargo’; this ‘pre-initiation’ depends
heavily upon the formation of several complexes, including the ULK1 (Unc-like kinase/ATG1 in
yeast) complex, the beclin-1–VPS34 (vacuolar protein-sorting protein 34; class III
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phosphatidylinositol 3-kinase)–AMBRA1 (autophagy/beclin-1 regulator) complex, the ATG9–
WIPI (WD repeat domain, phosphoinositide interacting/ATG 18 homolog) transmembrane
complex and the ubiquitin-like ATG12–LC3 (microtubule-associated protein 1 light chain 3)
complex [352]. These represent a major checkpoint in the formation of the autophagosome
membrane, as they are tightly regulated in a healthy cell by the inhibitory effect of mammalian
target of rapamycin complex 1 (mTORC1).

In a normal/ healthy cell, mTORC1 restricts autophagy to a baseline level by imposing
inhibitory phosphorylation on Unc-51-like kinase (ULK1/Ser 757) and ATG13 [335, 337, 338,
344, 345, 347, 353-357]. Under stress, this block is removed by several factors, such as PTEN,
AMPK, and TSC2. AMPK, an upstream regulator of mTORC1 can induce autophagy by
activation of the Ulk1 protein [353, 358-360]. Activation of ULK1, which forms a complex with
ATG13/FIP200/ATG101, leads to the nucleation of the pre-autophagosome structure (PAS).
This nucleation involves the phosphatidylinositol-3-kinase class III (PI3K III)–VPS34–Beclin 1
(BECN1/ATG6) complex and the product of VPS34, phosphatidyl-3-inositol phosphate (PI3P)
[361, 362]. Overall, ATG3, ATG5, ATG7, ULK1, BECN1, VPS34 and PI3P are regarded as
strictly required for the formation and maturation of the autophagosome, although this theory has
been challenged recently through studies showing the existence of macroautophagy responses
that were independent of these proteins [363-383].
Another set of regulators for the mTOR pathway is the death-associated protein kinase
(DAPk) and DAPk-related protein kinase (DRP-1), members of the DAPk subfamily implicated
in programmed cell death. These are Ca+2/calmodulin-regulated Ser/Thr death kinases that
promote membrane blebbing and autophagy.
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DAPK phosphorylates Beclin 1 on the BH3 domain leading to its dissociation from Bcl-xL
and increase in autophagy and activation of PI3 Kinase. Another member of this family, DAP1,
is tightly regulated in response to starvation and negatively regulates autophagy. DAP 1 is
dephosphorylated when mTOR is activated leading to down-regulation of autophagy [384, 385].

In most cases, however, these coordinated and combined steps accomplish the formation of
a mature autophagosome that then fuses with a lysosome through a canonical endocytic pathway
[26, 386-388]. The fusion of these giant membrane-bound compartments is controlled by
proteins involved in the endocytic pathway, e.g., the GTPase RAB7A, syntaxin 17 (STX17),
SNARE, as well as autophagy proteins like LC3 (phosphorylated and lipidated), ATG14 and
lysosomal proteins like LAMP2B. The fusion is followed by a drop in the pH of the lysosomal
lumen, which is regulated by a vacuolar (V)-type ATPase. This activates the lysosomal
hydrolases that then catabolize the cargo completely into individual units, as opposed to
proteasomal degradation where the end products are usually oligopeptides (8-12 amino acids).
SQSTM1/p62 is a proteasome-associated receptor protein that is degraded during the final phase
of autolysosomal degradation. It is commonly used in studies as an indicator of the rate of
autolysosomal degradation, commonly referred to as the ‘autophagy flux’. The exact role of p62
is still being studied; in some cases it has been reported to colocalize with the LC3II molecule on
the autophagosome membrane, yet other studies have shown that p62 undergoes selfoligomerization and localizes to the ER-associated autophagosome formation site and interact
with ULK1 in an LC3II-independent fashion [389-410].
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Ø Microphagy Although Microphagy is the least studied of all the variants of autophagy, we
nevertheless have enough information to characterize it as a homeostatic process that does not
rely strictly on autophagosome formation; instead the cytosolic cargo is taken up by a vesicle
(vacuole in yeast/plants, or lysosome) through membrane invagination. This process has been
demonstrated in several model organisms, including S. cerevisiae (yeast), D. melanogaster (fruit
fly), and C. elegans (worms) as well as plants and mammalian systems. This form of autophagy
degrades anthocyanin (plants), mitochondria, lipid droplets, nucleus, peroxisomes, and several
other organelles. In yeast and other systems, several macroautophagy proteins like ATG7, ATG8
and ATG9 have been shown to regulate this autophagy [411-418].

In special cases, this process is more selective (endosomal microautophagy) and it relies on
the endosomal protein sorting system to degrade proteins containing the KFERQ-motif. This
selectivity has been recorded in several model systems, including yeast, flies and mammals, and
it involves proteins from the endosomal-sorting complex required for transport (ESCRT) system.
Endosomal microautophagy is also dependent on the activity of heat shock protein 70 (HSP70)
family member HSPA8; however, it is independent of the lysosomal protein LAMP2A [418423].

Ø Chaperone-mediated autophagy (CMA)

CMA is somewhat similar to endosomal

microautophagy and has been extensively studied; it probably is the most well characterized
form of autophagy after macroautophagy. This process can be broadly defined as a chaperonemediated transport of proteins from the cytosol directly to the lysosome for degradation. Since
30% of the cytosolic proteins are degraded through CMA, it is crucial for maintenance of

24

genome integrity and healthy ageing, as well as pathophysiological conditions like oncogenesis
and neurodegeneration. In CMA, the HSP70 member chaperone HSPA8 protein selectively
binds proteins containing a KFERQ-like motif. The substrate proteins are then transported to the
lysosomal lumen, by the action of the lysosomal translocation protein LAMP2A that switches
from an inactive monomer form to an active oligomer [424-436].

The LAMP2A-substrate conjugate is then transported across the lysosomal membrane into
the lumen where the lysosomal HSPA8 binds to the cargo and prevents its retro-translocation
back to cytosol. The cargo is then degraded in a lipid-rich environment that involves cathepsin A
mediated LAMP2A degradation. As in macroautophagy, this process is also strictly regulated by
other proteins, notably AKT serine/threonine kinase (AKT) as well as mTORC2. These negative
regulations are removed by the action of pro-CMA proteins like glial fibrillary acidic protein
(GFAP) and PHLPP1 [424, 437-442].

Ø Selective autophagy These processes can be, at times, selective towards a specific pathogen or
a cell organelle. Such pathways have been observed in various model organisms, including
yeasts, worms, mammals and even plants [325].

•

Mitophagy

One of the most well studied of all the selective processes is Mitophagy, which

removes superfluous or degraded/cytotoxic mitochondria through an autolysosomal pathway. It
is crucial for tissues with a high metabolic rate to eliminate from their intracellular environment
any theoretically cytotoxic organelle like dysfunctional or permeabilized mitochondria. The
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selective removal of mitochondria is also important for several physiological processes like
maturation of erythrocytes, embryonic development, and metamorphosis [414, 443-451].

Several proteins that facilitate the uptake and degradation of ‘troublesome’ mitochondria
have been identified across various model systems. As in most selective pathways, both microand macroautophagy have been observed in this case. In yeast, proteins belonging to the SUN
family (UTH1) have been implicated in microautophagy-dependent Mitophagy, whereas ATG32
has been linked to the macroautophagy branch. In mammals, the role played by yeast ATG32 is
performed by the homologous BCL2L13, along with classical members of macroautophagy like
LC3, p62, and optineurin (OPTN). Proteins that interact with autophagy receptors like LC3
include PTEN induced putative kinase (PINK1), and Parkinson disease 2 parkin (PARK2). In
response to some stimuli, the mitochondrial lipid cardiolipin has been observed to interact with
the LC3 protein [414, 452-464].

•

Xenophagy

Autophagy acts rapidly against viral and bacterial infections, with the earliest

observations dating back to the early 1990s. Viruses are eliminated through a specific pathway
known as Virophagy (viral xenophagy). This Virophagy has been validated in ATG5-/- and
BECN1-/- cells where viral titer increased in the absence of a mature autophagosome. Apart
from the core machinery, proteins involved in the fusion and degradation of autophagosomes,
like P62, SMURF1, act as receptors for viral components. Besides degrading the viral
components directly, autophagy can also function in innate and adaptive antiviral responses,
including activation of TLRs and IFNs, and mediating antigen processing to T-cells. The relation
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between autophagy and viral infection is expounded in more detail in the following sections
[465-469].

Bacterial Xenophagy is quite similar to Virophagy. This process is targeted against
cytoplasmic bacteria that managed to evade phagocytosis. Unlike in phagocytosis, in Xenophagy
bacteria are not hidden from the cytoplasmic proteins, especially the ones involved in
autophagosome formation. Several proteins like P62, NDP52, OPTN can act as receptors of
cytoplasmic bacteria, although some of these proteins may also take part in autophagosome
expansion around the bacteria. NDP52 interacts with LC3A and B to form a mature
autophagosome, a process in which other macroautophagy components like WIPI also take part.
Interestingly, there is a significant crosstalk between macroautophagy and endosomal pathways
in this context: proteins involved in the tagging of endosomes, like Galectin 3 and Galectin 8,
have been implicated in this pathway. Consequently, as a counter-response, several bacteria have
evolved to subvert the Xenophagy pathway [470-479].

•

Lipophagy

The selective degradation of lipid droplets through autophagy is an important

pathway that is often hijacked by viruses, because lipid droplets can offer a rich source for
production of membranes as well as energy for the intruding pathogen. In yeast, components
from both microautophagy (ESCRT) as well as macroautophagy (ATG7) have been linked to
lipid degradation. In mammals, the process is regulated by transcriptional control of specific
genes as peroxisome proliferator-activated receptor alpha (PPARα) and cAMP responsive
element binding protein (CREB). Components of the CMA, especially those involved in
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degradation of lipid droplet associated proteins, has also given rise to the possibility of a
crosstalk among different branches of autophagy in this process [418, 429, 480-486].

•

Other forms of selective autophagy

Apart from the processes described above, other

forms of selective autophagy have also been identified, albeit to a lesser extent. These include
Pexophagy (removal of peroxisomes), Proteaphagy (degradation of nonfunctional proteasomes),
Lysophagy (degradation of toxic/nonfunctional lysosomes), Reticulophagy (ER degradation
believed to be distinct from both micro- and macro-autophagy), Nucleophagy (chromatin
degradation), Ribophagy (degradation of ribosomes), Aggrephagy (degradation of protein
aggregates),

Myelinophagy

(myelin/Schwann

cells),

Zymophagy

(zymogen

granules),

Granulophagy (stress granules), and Ferritinophagy (ferritin receptors) [243, 325, 415, 487524].
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6.3. ENDOPLASMIC RETICULUM IS A MAJOR REGULATOR OF STRESS RESPONSE
IN MAMMALIAN CELLS

6.3.1.

WHAT IS ER STRESS?

Endoplasmic reticulum (ER) is a major cell organelle that

regulates many functions, such as maintenance of Ca2+ homeostasis, transportation of cellular
materials, secretion, expansion of surface area and production of proteins, steroids, and fats. One
of the major productions and quality control centers of a cell, the ER is loaded with ribosomes
(for translation) as well as chaperones and foldases (to ensure proper folding), especially in
differentiating and secretory cells. This centrality also makes the ER vulnerable to a change in
Ca2+ balance, impaired protein glycosylation, interruption in the ER-Golgi transport, and viral
infection, some of which can be chemically induced for in vitro studies. For instance, we have
used tunicamycin to block protein glycosylation. Since the quality control machinery ensures
that only properly folded proteins are transported to the Golgi apparatus for secretion, disruption
of folding creates an alert in the ER and leads to the induction of a holistic response known as
the ER stress response [10, 525-528].

Misfolded proteins are channeled through a distal secretory pathway called the ER-Associated
Degradation (ERAD) pathway, a retro-translocation from ER to the cytoplasm through Cdc48pp97. Two distinct types of ERAD have been identified: a type I Ubiquitin-Proteasome and a type
II Autophagy-Lysosome [529-532] pathway. The former mostly targets and eliminates soluble
misfolded proteins and involves the canonical ubiquitin enzymes (E1, E2, E3) and a 26S
proteasome that degrades K48-specific polyubiquitin proteins. In contrast, ERAD II eliminates
both soluble and insoluble misfolded proteins through autophagy adaptors like HDAC6 and p62
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that degrade both K48- and K63-specific polyubiquitin chains in the autophagolysosomal vesicle
[533, 534]. The latter mechanism represents one of the many connections between ER stress and
autophagy, a theme that is expounded upon in the following sections. Besides ERAD, misfolded
proteins also trigger the Unfolded Protein Response (described in detail in the following section).

6.3.2.

UNFOLDED PROTEIN RESPONSE (UPR) - A MAJOR BRANCH OF ER

STRESS

Membrane rearrangement and anomalous protein folding in the ER activates one

or more branches of the Unfolded Protein Response (UPR), a combined effect of three distinct
yet interconnected pathways, in addition to triggering pro-apoptotic pathways as BOK, NOXA
and PUMA pathways [175, 535, 536]. The pro-apoptotic role of ER stress has been observed in
several types of tumor (prostate, glioblastoma) cells, linking ER stress to possible therapeutic
interventions for these diseases.

The downstream implication of UPR ranges over several pathways that are triggered in
response to infection, from expression of Type-I Interferon (IFNs) to induction of autophagy.
Three branches of UPR have been characterized so far: 1) PERK (protein kinase R like
endoplasmic reticulum kinase), 2) ATF6 (Activating Transcription Factor 6), and 3) IRE1α
(Inositol Requiring Enzyme 1 α) [525]. Each of these pathways has links to cell survival/death
(apoptosis, autophagy) pathways e.g., PERK activates pro-apoptotic pathways in hypoxiainduced tumor progression [537-547]. Thus, the downstream effects of endoplasmic reticulum
associated degradation (ERAD) may function in concert with each other, at least under special
circumstances.
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6.3.3.

PERK PATHWAY IS AN IMPORTANT COMPONENT OF THE UPR Like other

key players of the UPR, such as ATF6 and IRE1α, PERK is also bound to the chaperone
GRP78/BiP under stress-free conditions. Numerous stress conditions, some of which are
associated with tumor microenvironments, cause the release of the type I ER transmembrane
receptor PERK, which contains a serine-threonine cytoplasmic domain [548, 549]. Once PERK
is disassociated from the BiP protein, it undergoes self-dimerization and auto-phosphorylation.
This transition activates the kinase domain, which was otherwise non-functional as long as it was
bound to BiP/GRP78; all these events now allow PERK to phosphorylate eIF2α at Ser-51. This
phosphorylation leads to a suppression of global protein translation, and a major mechanism
involved is inhibition of CyclinD1 activity (G1/S transition – G1 progression into the S phase)
that results in slower cell division. These events present an important regulation step that is
critical to cope with the stress and decrease the translational “load” on the ER [550-554].

However, some proteins are exempted from this shutdown, one of them being the transcription
factor ATF4. The role of ATF4 is interesting in the light of the biochemistry of a stressed cell.
During shorter periods of ER stress, ATF4 enhances the expression of pro-survival proteins
responsible for nutrient uptake and antioxidation [555, 556]. However, in prolonged ER stress,
the cell slowly switches to a pro-apoptotic mode. ATF4 translocates to the nucleus and increases
the expression of pro-apoptotic CHOP and GADD34 (a phosphatase) among other proteins that
act as chaperones and foldases [557-559]. CHOP has frequently been linked to suppression of
anti-apoptotic proteins and activation of pro-apoptotic proteins and has been implicated in
numerous pathogenic conditions such as tumor formation, diabetes and neurodegeneration [560,
561]. The role of CHOP is crucial in this entire pathway because it can switch the response to ER

31

stress from pro-survival to pro-apoptosis, and is likely targeted by flavivirus [562, 563]. Apart
from its proapoptotic features, CHOP also activates GADD34, which dephosphorylates eIF2α
and promotes translational recovery; thus, it acts as a negative feedback mechanism to increase
the ER load [558, 559].

6.3.4.

WHAT IS THE LINK BETWEEN ER STRESS AND AUTOPHAGY? ER stress is

linked to ROS-mediated autophagy. Monocyte chemotactic protein-1 (MCP-1), known to
mediate cardiac injury, induces ROS, ER stress, and autophagy in cardiac myoblasts (H9c2 cells)
[564]. In most cases, as in mouse disease models, induction of autophagy by ER stress serves as
a protective mechanism against apoptotic cell death [565]. One of the most important branches
of ER stress/unfolded protein response (UPR) signaling – eukaryotic translation initiation factor2α (eIF2α/protein kinase R-like endoplasmic reticulum kinase (PERK)) – is activated in response
to accumulation of proteins with polyglutamine repeats and functions in LC3 lipidation and
autophagosome formation [566]. PERK-induced autophagy also protects mouse and human
lymphomas during pathogenic conditions (Myc-induced tumorigenesis) [567]. Downstream ER
stress components like C/EBP homologous protein (CHOP), a PERK-regulated protein, and
inositol-requiring protein 1 (IRE1) also increase autophagy in colon cancer cell lines like HT29
(human colon adenocarcinoma cell line), SW480 (human colorectal adenocarcinoma cell line)
and Caco-2, demonstrating the involvement of ER stress signaling in the induction of autophagy
[568].

32

Figure 2: Autophagy and PERK
Different pathways have been reported that connect ER stress/ UPR and autophagy. For the sake
of convenience, we have focused only upon the links between PERK and autophagy here.
ER stress can also trigger autophagy by other means. Ca2+ influx, ceramide signaling, IRE1𝛼,
PERK pathways all contribute to the induction of autophagy either through canonical mTOR or
the alternate DAPK1 – Beclin1 pathway. Ca2+ release from the ER can trigger kinases (CaMKK)
that can activate AMPK to induce autophagy [569]. Alternatively, ceramide-induced PP2A
activates DAPK, which can dissociate Beclin1 from Bcl-2 and cause autophagy [570]. The IRE1
branch of UPR leads to JNK activation and increased Bcl-2 phosphorylation, thus releasing
Beclin-1, which can then take part in formation of autophagosome [571-573]. As shown in
Figure 2, The PERK pathway can trigger autophagy through ATF4-dependent expression of
ATG12 [566, 573-575]. As an alternate pathway, CHOP (mediated by ATF4) can activate the
pseudo kinase TRB3, which can cause autophagy through inhibition of Akt-mTOR [575-577].
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Although macroautophagy is the form of autophagy most commonly linked to UPR responses,
other forms of autophagy are also modulated by different UPR responses. In animal models of
Parkinson’s Disease, CMA is activated by the PERK/eIF2α/p38 pathway, a phenomenon that
has been referred to as ER-stress induced CMA (ERICA) [578].
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6.4. ATAXIA TELANGIECTASIA MUTATION (ATM) KINASE - A POTENTIAL
UPSTREAM REGULATOR

6.4.1.

ATM KINASE AND ITS ASSOCIATION WITH AUTOPHAGY
Ataxia Telangiectasia Mutation (ATM) kinase is a serine threonine kinase that acts

downstream of various factors like ionizing radiation (IR), radiomimetic agents, or reactive
oxygen species (ROS) that induce DNA damage. A major component of the DNA damage
response (DDR) milieu, ATM is a nuclear protein that is responsible for the maintenance of
genome integrity and cell survival when DNA is destabilized by double-strand breaks (DSBs),
single-strand breaks (SSBs), impaired DNA replication, or other processes. An important DNA
damage sensor, ATM kinase also functions in chromatin organization, gene expression and
DNA/RNA/protein metabolism [579]. Another important protein in this regard is the ATM and
Rad53 related (ATR) kinase, which, like ATM, belongs to the phosphatidyl-3-inositol phosphate
like kinase (PIKK) family. In the face of genotoxic stress like ROS, RNS (Reactive Nitrogen
Species), or radiation, ATM activates a series of phosphorylation that primarily induce cell cycle
arrest (S phase or G2/M phase). Both CHK1 and CHK2 proteins are activated by
phosphorylation, and they induce cell cycle arrest by various mechanisms, including inactivation
of CDC25 phosphatase, impaired mitotic spindle formation and stabilization of the tumor
suppressor Tumor Protein 53 (TP53/p53). Other downstream proteins like NRF2 are induced in
response to high intracellular ROS. All these inductions and activations lead to cell cycle arrest-which has also been harnessed for anticancer drug therapy. Loss of ATM activity leads to a
pathological condition known as the Ataxia Telangiectasia, which is characterized by
neurodegeneration, premature ageing, and susceptibility to tumorigenesis. Disease progression
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correlates with elevated levels of ROS in these patients. Studies with ATM-/- mice and cells have
shown the importance of ATM kinase in scavenging ROS. Although the cytosolic involvement
of ATM is still being studied, it is clear that high ROS production leads to the formation of ATM
dimers in the cytosol, possibly through disulfide bonds. The active dimers participate in ROS
clearance by numerous cytosolic mechanisms, including primarily Pexophagy, regulation of
glutathione level, and activation of pentose phosphate pathway [360, 579-588].

All these studies have established ATM as a prominent tumor-suppressor protein, although this
view has also been challenged, following a report of ATM promoting tumor formation in HER2
positive breast cancer cells [589]. The same study also showed a link between the activities of
ATM kinase and an ATG4C protease, the only protein of autophagy that acts as an oxidative
stress sensor [589]. Induction of ATM correlates with autophagy in cells exposed to stress
factors like ROS, RNS, and hypoxia. Under these circumstances, ATM is exported from nucleus
to the cytoplasm, where among other functions, it blocks the activity of mTOR through a cascade
of phosphorylation involving liver kinase B1 (LKB1), AMPK and the tumor suppressor tuberous
sclerosis 2 (TSC2). TSC2 inhibits the GTPase Ras homolog enriched in brain (RHEB), thus
blocking the activity of mTOR and its downstream targets like p70 ribosome S6 kinase
(p70S6K) and eukaryotic initiation factor 4E-binding protein 1 (4EBP1) [331, 360, 362, 590596]. The relation between ATM and autophagy has further been demonstrated in several cell
types, including lymphocytes from Ataxia Telangiectasia patients, colorectal cancer cells,
budding yeast, and cadmium (Cd)-treated mouse spermatocyte (GC-2) cells. Notably, ATM
interacts with the autophagy pathway through an energy sensor protein like AMPK (activated
under conditions of low ATP). AMPK is an important transcriptional and epigenetic regulator of
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autophagy, through its interactions with SMPK

2

and coactivator-associated arginine

methyltransferase 1 (CARM1). In budding yeast, ATM activation induces a distinct form of
autophagy independent of the mTOR-dependent branch. This distinct form was termed
Genotoxic stress Targeted autophagy (GTA) and genome analysis indicated that ATG11 (rather
than any members of the mTOR-dependent macroautophagy) was important for this pathway
[360, 590, 591, 597-603].

Many investigators have linked ATM activation to forms of autophagy other than the
canonical mTOR-dependent macroautophagy, in different types of cell, from yeast to higher
eukaryotes. These other forms of autophagy include selective forms like Mitophagy and
Pexophagy, which is not surprising, given the fact that mitochondria and peroxisomes are the
two most abundant sources of ROS in cell. Direct interaction between ATM and the effector
molecules of Mitophagy (PINK1-Parkin) and Pexophagy (PEX5) has been demonstrated, thus
highlighting the relevance of ATM in the maintenance of redox homeostasis and proteostasis.
Whether these processes depend on DDR needs to be studied [588, 604-608].

6.4.2.

THE RELATION BETWEEN ATM KINASE AND ER STRESS

The

relation

between ATM kinase and ER stress or UPR pathways is a theme that has not been extensively
explored. In spite of the scarcity of studies, we have a basic idea how these pathways interact in
certain scenarios. Initial studies, in the 2000s, using ATM-deficient thymocytes, astrocytes, and
fibroblasts showed increased ROS production and ER-stress in these knockout cells. Restoration
of expression of ATM in these cells blocked ER-stress induced intrinsic (Bax/Bak) apoptosis in
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An F-box protein of the SCF E3 ubiquitin ligase complex
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response to ionizing radiation and other genotoxic stress agents. In the same study, PERKeIF2α-ATF4-CHOP axis was also negatively regulated in presence of an active ATM kinase. As
described earlier, CHOP is one of the primary checkpoints that determine the switch between the
antagonistic effects of transient ER stress (pro-survival/pro-adaptive) and prolonged ER stress
(pro-apoptotic). Hence CHOP is a potential target for ATM mediated damage repair [609-611].

However, the relation between ATM activity and ER stress is not straightforward; it possibly
depends on the cell type and methods used to detect ATM activity. Tunicamycin-induced ER
stress causes upregulation of UPR-related genes EIF2AK3, ERN1 and ATF6 and the activation
of the ATM pathway [612-614]. Recent studies using specific inhibitors for ATM, ATR and
PERK as candidate anticancer drugs suggest that these serine-threonine kinases may crosstalk to
a certain degree in progressing tumors. This argument is based on the observation that among all
the ER stress or UPR effector molecules, PERK is the most closely related to cell cycle changes
like arrest of cell division. PERK also activates proteins (CaMKII, Ero1α, NOX2) involved in
ROS generation, which may act as a trigger for accumulation of ATM in the cytosol. Thus,
PERK can potentially mediate the DDR and non-DDR effects of ATM kinase activity. In Gallic
Acid (GA)-treated oral cancer cells (SSC-4), induction of ER-Ca2+-dependent ROS led to the
activation of ATM kinase. Although most of these studies place ER stress and UPR upstream of
ATM activation, others suggest ATM-dependent ER stress. When Quercetin, an inhibitor of
lipo-oxygenases, is supplied, p53-dependent ER stress as well as ATM activation are suppressed,
thus indicating that these latter are instrumental in radio sensitization of human ovarian cancer
cells. As activation of ATM kinase is one of the primary triggers for stabilization of p53, ATM
kinase could theoretically act upstream of p53-dependent ER stress [389, 615-617]. However,
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more studies are needed to delineate the relationship between ATM activity and ER stress
pathways, because this relationship has immense potential for therapies against cancer and
infectious diseases.
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6.5. FLAVIVIRUS AND THEIR ROLE IN THE MODULATION OF THE STRESS
RESPONSE AND HOMEOSTATIC MECHANISMS OF THE HOST CELL

6.5.1.

FLAVIVIRUS – A GENERAL INTRODUCTION

Flaviviridae are responsible

for serious pathological conditions in human and other important mammals. The family is
comprised of four distinct genera: Flavivirus, Hepacivirus, Pegivirus and Pestivirus. The largest
and clinically the most relevant of three, Flavivirus contain almost 70 members, most of them
transmitted to humans by mosquitos or ticks. Among the mosquito-borne are the most virulent
viruses like dengue (DENV) [618, 619], West Nile (WNV) [620], Japanese encephalitis (JEV)
and Yellow fever (YFV) [184]. Although dengue is the most threatening of all, other members of
the Flaviviridae family are also known to affect humans. For instance, Flavivirus like West Nile
Virus (WNV), Japanese Encephalitis Virus (JEV), and Zika virus (ZIKV), are neurotropic and
cause neural disorders whereas Hepacivirus like Hepatitis C virus (HCV) is responsible for liver
diseases [621].

Members of Flaviviridae family are icosahedral, enveloped (+)-single stranded (ss) RNA
viruses measuring approximately 500Å in diameter. The typical Flavivirus (Latin flavus –
yellow, indicating Yellow Fever) virion is composed of the genetic material surrounded by the
capsid protein and 180 copies of two glycoproteins. The average genome size of the Flavivirus is
11kb, coding for a single polyprotein. The amino terminal accounts for the structural proteins:
capsid (C), membrane precursor (prM) and envelope (E), and the remaining genome gives rise to
the non-structural proteins (NS1, 2A, 2B, 3, 4A, 4B, and 5) that form the viral replication
complex (RC) [622, 623].

40

Dengue has been declared endemic in more than 100 countries [624] and nearly two-thirds of
the global human population is at risk of being infected. Recent WHO statistics have placed the
count of reported cases at 40 million per year [625, 626]. Widespread infections, especially in
hyper-endemic areas of the tropics and sub-tropics, cost an estimated 9 billion USD per year
[627]. In the last half century, this virus has spread widely thanks to an increase in global trade,
transportation, human migration and urbanization, especially the emergence of densely populated
quarters with low quality hygiene [628].

A wide range of viruses from different families (Poxviridae, Adenoviridae, Retroviridae,
Picornoviridae, Flaviviridae, Orthomyxoviridae) have life cycles that intertwine with critical
pathways involved in cell death and survival. As the aim of the virus is to reproduce and, in
doing so, it affects the cell death or survival pathway, having discussed cell death we now
address Flavivirus – structure, infectivity, replication and cell survival. In the following sections,
we shall discuss about the three most widely studied flavivirus, - West Nile (WNV), Japanese
Encephalitis (JEV), and Dengue (DENV).

1. WEST NILE VIRUS

West Nile virus (WNV), first encountered in the New World in New

York City (1999), has been the cause of three major arboviral neuroinvasive outbreaks in the
United States [629, 630]. It belongs to the same flavivirus serocomplex as the Japanese encephalitis
virus (JEV) and St. Louis encephalitis virus 15, following a bird-mosquito-bird transmission cycle.
In the United States, Culex pipiens serves as the major arthropod vector. The human is a ‘‘deadend host’’ for WNV due to low serum viremia [630]. WNV consists of five phylogenetic lineages,
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of which 1 and 2 have been associated with significant outbreaks. The earliest targets are
keratinocytes and specialized skin dendritic (Langerhans) cells; the latter migrate to visceral organs
and the central nervous system. The neurovirulence of WNV is dependent on varying factors -- its
ability to cross the endothelium of blood-brain barrier (helped by cytokine mediated increased
vascular permeability), the transport of infected macrophages into the CNS (Trojan horse
mechanism) and viral retrograde transport from peripheral neurons to CNS [631-633].

Like dengue, outcome of infection varies from mild fever (WNV fever), accompanied by
headache and diarrhea, to neurological symptoms (WNV neuroinvasive disease). While only 1% of
infected individuals develop the latter, mild fever can be seen in 25%. However, neuroinvasive
infections have a 10% fatality, which classifies the virus as extremely lethal. The serious
pathological conditions (meningitis, encephalitis, acute flaccid paralysis) are also accompanied by
chills, rash and visual disturbance. The severity is higher in elder patients, as is evident from the
higher death rate (17%) in individuals’ aged at least 70 than in those in their mid-40s (0.8%) [630,
634]. Complete recovery following acute infection is extremely rare, and fatigue, cognitive
difficulties, depression and muscle aches have been reported even after a year [635-638].
Diagnosis is dependent on detection of IgM levels in the cerebrospinal fluid by MAC-ELISA,
although false positive results have been reported during infection with related flavivirus [639,
640]. To date, treatment has been supportive, relying on vector control, and no vaccine is licensed
for human use. Since humans are a ‘‘dead-end host’’, future vaccinations will not prevent
spreading of the virus in nature [641-643]. It is extremely important that molecular mechanisms
adopted by the virus, like manipulation of the cell survival pathway, be studied. This would help in
developing an effective antiviral therapy.
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2. JAPANESE ENCEPHALITIS VIRUS

Japanese encephalitis virus (JEV) is spreading

throughout Asia, China, India, Australia, and Pakistan and is responsible for between 12,500 to
17,500 deaths reported annually. JEV is transmitted by a primary mosquito vector (Culex
tritaeniorhynchus) and secondary mosquito vectors (Culex gelidus, Culex fuscocephala and Culex
vishnui) that primarily target domestic animals and human hosts [644]. Humans are a “dead end
host” since they cannot infect the feeding mosquitoes because of low viremia. Children are at
higher risk for an infection with Japanese encephalitis than adults, especially in rural areas. They
are also at higher risk for death due to their weaker immune system as compared to the adults. In
addition, people who visit Asia and Indonesia are particularly prone to this viral infection since
they lack the protective antibodies. Asymptomatic infection depends on host’s age, immunity,
general make-up and current health status. Symptoms include headache, fever, tremor,
gastrointestinal discomfort as well as severe conditions of encephalitis and Parkinson-like seizures
[645]. The means of the entry of the virus into the system plays an important role on the progress
of the infection. If the carrier, the mosquito, bites directly into the blood vessel, it is easier for the
virus to spread directly to the central nervous system. Efforts to make a vaccine against JEV have
been impeded by frequent climate changes. Wind-blown mosquitoes, bird migration and people
traveling with infected virus, which further spread the disease, assist the spread of Japanese
encephalitis virus. Programs in underdeveloped countries are established to prevent the increasing
number of yearly deaths caused by Japanese encephalitis virus. These programs include mosquito
control by using pesticide, mosquito nets, cattle segregation and vaccination of cattle as well as
humans [644, 646].
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3. DENGUE VIRUS

In the current study, we have focused on the most widespread of all the

Flaviviruses - Dengue (DENV). In the following paragraphs we shall present a synopsis of the
epidemiology and molecular biology of this virus.

EPIDEMIOLOGY Five serotypes of Dengue have been identified, although only the
first four (Dengue 1-4) are reported to infect humans [647]. These serotypes display 65-70%
amino acid homology and they have all spread to every corner of the tropical/subtropical belt,
owing to increased trade and transportation [648, 649]. Dengue infection can range from a mild
fever (dengue fever/DF) to severe hemorrhage (DH) that can further progress into endothelial
permeability (dengue shock syndrome/DSS) characterized by multi-organ failure. The severity
of infection depends mostly on the age of the afflicted, with infants being the worst affected; in
fact, dengue-induced hemorrhage (DH) remains the most lethal form of hemorrhage in the AsiaPacific region [647]. In other regions like the South Americas, elderly patients are also badly
affected. The most common source of dengue-related lethality in healthy adults is secondary
infection – when primary infection by one serotype is followed by secondary infection with a
different serotype. This leads to a condition known as Antibody-Dependent Enhancement (ADE),
also referred to as Antigenic Sin, where the antibodies developed during the primary infection
bind to the virus particles and facilitate their transport throughout the body, instead of
neutralizing them [626, 650, 651]. Such a complicated interplay among different serotypes and
the host immune system makes it difficult for vaccines to act against infection. In fact, the only
commercial vaccine (developed by Sanofi) is also facing serious challenges because of
complications in immuno-compromised individuals and it has been shown to exert different
effects in primary and secondary infections [652].
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Among the members of Flavivirus family, Dengue is transmitted to humans (in urban
areas) and other primates (in forests) by the urban-adapted mosquito strain Aedes aegypti
(primary vector) and the emerging Aedes albopictus [653]. Dengue has been declared endemic in
approximately 100 countries with 40 percent of the global population susceptible to infection.
Dengue infection has doubled over the last two decades, and current annual figures have risen to
50-100 million humans affected [654]. The four antigenically distinct serotypes (DENV 1-4),
each having multiple phenotypes, originated in different parts of the globe [655]. The
distribution of these serotypes has spread alarmingly since 1970, when only South Asia had all
four [656]. This spread has added to the complexity of dengue-induced pathogenesis since very
little cross-immunity has been recorded between these serotypes, leading to multiple sequential
infections and overwhelmed immune response [657, 658]. DF, the most important arboviral
disease in humans, features rapid onset of fever, accompanied by headache, retro-orbital pain,
myalgia, and gastrointestinal irritation [659, 660]. DHF, which claims more lives (5% mortality)
than any other hemorrhagic fever, is characterized by bleeding, thrombocytopenia, increased
vascular permeability beyond the usual DF symptoms [661]. An equally lethal condition, DSS, is
also characterized by vascular leakage, which is more pronounced in young children, and very
low blood pressure [662]. Autopsies conducted on patients (predominantly children) dying from
DSS have revealed a broad range of dengue susceptible tissues as shown by virus infecting skin,
liver, spleen, lymph node, kidney, bone marrow, lung, thymus and brain [663-666].

GENOMIC STRUCTURE The genetic material of all Flaviviridae members is a
positive-strand RNA. In dengue and in most Flavivirus, this 11kb RNA codes for a polyprotein
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that consists of three structural proteins: Capsid (C), membrane (pr-M), Envelope (E); and seven
non-structural proteins: NS1, 2A, 2B, 3, 4A, 4B and 5. This contiguous polypeptide is then
cleaved by viral and host proteases (Furin) to release the individual proteins. The structural
proteins are involved in binding/attachment and internalization into the host cell, whereas the
non-structural proteins are enzymes that help in the replication and maturation of the nascent
virus. Some of the non-structural proteins insert into the membrane of the ER, thereby
precipitating a massive rearrangement and triggering severe stress responses, as will be discussed
later [648, 667-670].

Dengue has a genome of 10.7 kb positive sense single strand RNA that contains a type I
cap at its 5’ terminus [671]. The enveloped icosahedral virion measures 50nm in diameter. The
RNA is translated by the host cell machinery into a 3391-amino acid polyprotein that undergoes
co- and post-translational processing by viral (NS2B-3) and cellular proteases [672-674]. The
first quarter of the viral genome from the 5’ end codes for the structural proteins C (capsid), prM
(membrane), and E (lipopolysaccharide envelope), leaving the rest to code for eight nonstructural proteins (NS1, 2A, 2B, 3, 4A, 2K peptide, 4B, 5) which are expressed only inside the
host [675]. While the structural proteins are involved in determining the shape of virion, their
non-structural counterparts govern the replication machinery inside the host. They are involved
in the formation of replication complex (RC: NS1, NS4A), post-transcriptional modification
(NS5) and post-replication assembly of mature virion (NS2A). They also function as viral
protease (NS2B/NS3) and antagonist of host interferon response (NS4B).
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One of the least studied among flavivirus proteins, dengue NS4A (~16kD) has four
internal hydrophobic domains used to associate with membranes. An important component of the
membrane-bound viral RC, NS4A promotes curvature of the ER membrane. The proteolytic
cleavage of its C-terminal domain (2K fragment) is essential for inducing membrane alterations.
Although role of NS4A in viral replication has been established, the specific mechanism is
poorly understood. NS4A docks itself into the ER membrane with the help of its trans-membrane
domains (pTMS1, 2, 3, 4), the N terminal protruding into the cytoplasm and the C terminal (also
called 2K) serving as a localization signal for NS4B. The proteolytic removal of the C terminus
of NS4A seems to help in membrane alterations, which are important for the RC formation.

REPLICATION AND MATURATION

The life cycle of the Dengue virus cycles

between the vector Aedes aegypti (or Aedes albopictus) and the human or primate host. It is
likely that the virus switched hosts to human, from a non-human primate, in the rainforests of
Asia and Africa. The mosquito vector plays an important role in virus pathogenesis; a female
mosquito bites a viremic human host and the virus is deposited in the midgut and other tissues of
the vector, where it reproduces. After approximately one week, the virus reaches salivary glands
of the mosquito, and from there it is transmitted to a healthy host [628, 676, 677].

The primary response against viral infection is launched by the innate immune system,
followed by a concerted defense launched by interferon. Since the virus is transmitted into the
bloodstream of a healthy individual by an infected female mosquito, the earliest targets are
almost always the keratinocytes, the most common cell type found in our skin [678]. Once the
keratinocytes have been infected, the virus spreads to other cell types like macrophages and
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monocytes, leading to viremia. As the infected lymphocytes spread to different parts of the body,
other cells are also infected and some, especially epithelial cells (liver, kidneys), develop a high
viral load [679]. There is also evidence that the virus can reduce interferon type I response in
human dendritic cells [680].
Figure 3: The life cycle of DENV inside host cell
In this diagram we have summarized the life cycle of the DENV inside the host cell and its
interaction with the pathways described above. 1) The virus is internalized by receptor-mediated
endocytosis. The virus travels inside the endosome until the LATE ENDOSOME reaches the
acidic interior of the cell. 2) The RNA is released and it translocates to the rough endoplasmic
reticulum (RER) where it undergoes translation and replication. 3) The structural and nonstructural proteins, thus translated, are engaged in building new progeny virus and ensuring a
smooth replication, respectively. 4) The assembled, but not yet mature, virus translocates to the
trans-Golgi network where the prM is cleaved by the furin protease. 5, 6) The mature virion is
now released into the extracellular milieu by exocytosis. 7) DENV induces autophagy in some
cell types.
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The structural proteins, especially the glycoprotein envelope (E) play a crucial role in
binding to the host cell membrane. The most important of mammalian host receptors involved in
attachment of the virus are heparin sulfate (HS) and endocytic C-type lectins (DC-SIGN, LSIGN); however other molecules such as Laminin receptor, CD-14, PtdSer receptors (TAM,
TIM), and heat shock proteins (HSPs) 70 and 90 have also been identified in different cells
[681]. The virus is internalized into early endosomes (EE) using a clathrin-mediated endocytosis
(Figure 3, 1) [573, 626]. The fusion of the viral E protein and the endosomal membrane is an
important step that has been targeted for the development of antiviral therapy [682]. Once the
fusion is complete, the EE vesicle travels deep inside the cell until it matures into Late
Endosome (LE) and an acidic pH triggers the release of the viral RNA into the cytoplasm of the
host cell (Figure 3, 2). The RNA then undergoes translation on ribosomes attached to the rough
Endoplasmic Reticulum (RER) [626].

The resultant polyprotein undergoes co- and post-translational processing by viral and
host proteases to give rise to the individual proteins. The structural proteins then assemble on the
ER surface along with the RNA that is replicated on intracellular membranes (Figure 3, 3). This
is then cleaved into three structural and seven non-structural proteins. The viral RNA and capsid
(C protein), collectively known as nucleocapsid, enters the endoplasmic reticulum (ER) where it
is joined by the envelope (E) and membrane (M) proteins. [683-689]. The non-structural
proteins, each displaying a distinct enzymatic property, have attracted attention for mining
antiviral targets for therapeutic purposes [690, 691]. As in other RNA viruses, dengue NS
proteins are also involved in the formation of a platform, primarily in the endoplasmic reticulum
(ER), to replicate the viral genome. The virus uses the ER as a replication complex (RC),
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forming vesicles inside the lumen commonly referred as double membrane vesicles (DMV),
vesicle packets (VP) or paracrystalline arrays. Others argue that dengue induces the formation of
spherical single-membrane vesicles (80-100 nm diameter) in the lumen of ER [692-696].
Proteins like NS4A and NS4B change the conformation of the ER membrane through insertion;
this change is responsible for the induction of ER stress and downstream induction of unfolded
protein response (UPR) [697, 698]. NS2B acts as a cofactor to the protease NS3; together they
form a protease complex (NS2B-NS3pro) that is important for release of individual proteins
from the polyprotein chain. NS1 and NS5 are involved in RNA replication; NS5 has multiple
enzymatic properties including methyl-transferase, and RNA-dependent RNA polymerase
(RdRp) [696, 697, 699, 700].

Following replication, assembly of the virus takes place in the ER, where encapsulation
of the genome into the progeny virus is initiated. Encapsulation is accompanied by the assembly
of 180 copies of E and the prM each, forming in the process 60 trimeric (heterohexameric)
spikes. The immature virus is then transported to the trans-Golgi network where the pr-M protein
is cleaved by the host protease Furin (Figure 3, 4). An efficient cleavage of the M protein is
essential for the infectivity of the released virion. The mature infective virion, once released by
exocytosis, has a smooth surface, being devoid of the prM spikes. However, based on the host
cell type, immature or partially mature virions (containing spikes) are also released by exocytosis
(Figure 3, 5,6). The latter types of virus are compromised in their ability to infect other host cells
[626, 689, 696].
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6.5.2.

FLAVIVIRUS DERIVES A SIGNIFICANT PORTION OF ITS PATHOGENCITY

BY SEVERELY AFFECTING CELL SURVIVAL AND DEATH

Flaviviruses

among

others interact with the cell death pathways in that they often protect cells from death while the
virus is replicating, and may later activate specific cell death pathways to affect their escape from
the cell. The following section contains a discussion on the effects of viral infection on the cell
survival and stress response pathways, and vice versa. For the sake of brevity and convenience,
we have focused on the three most widely studied members of the Flavivirus genera - WNV,
JEV and DENV.

1. WHAT IS THE CELL SURVIVAL SCENARIO LIKE DURING WEST NILE
INFECTION?

The relationship between WNV infectivity and cell survival pathways has

been studied for more than a decade. WNV-mediated cell death and cytotoxicity depend on the
severity of the initial infection. Vero cells infected with many virus particles (multiplicity of
infection, m.o.i > 10) showed signs of necrosis (leakage of HMGB1 and high LDH activity)
within 8 h of infection. In contrast, cells infected with a lower load (m.o.i < 10) showed signs of
apoptotic cell death at a later stage (32 hpi) [701, 702]. WNV induces apoptotic cell death in
several cell types, such as immune cells (human leukemic-K562), neuronal cells (mouse
neuroblastoma - Neuro 2a, brain tumors), epithelial cells (Vero, A549), fibroblasts (MEF,
BHK21), and embryonic cells (HEK293T) [702-704].

WNV can regulate both extrinsic and intrinsic pathways to launch pathogenesis. The
virus induces Bax-dependent intracellular apoptosis in human leukemic (K562) and mouse
neuroblastoma (Neuro 2a) cells. UV-inactivated strains were severely compromised in their
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ability to establish infection as well as initiation of apoptosis [702]. WNV encephalitis in CNSderived mouse neurons was highly dependent on the activation of caspase-3, and infection in the
permissive T98G (brain-derived tumor) cells involved both extrinsic and intrinsic apoptotic
pathways [703, 704]. Tetracyclines are well-established antiviral compounds, and minocycline
strongly inhibited WNV infection in three CNS-derived human cell types (HBN, HRPE, and
T98G). The antibiotic blocked viral replication, apoptosis and the viral activation of JNK/c-jun
pathway, establishing a link among them [705]. Kobayashi et al proposed that the presence of
ubiquitinated proteins had functional implication in apoptosis of WNV-infected mouse
neuroblastoma (Neuro-2a) cells [706]. Migration of CD8+- T lymphocytes to drained lymph
nodes (dLNs) was hindered in the CNS of Cd22-/- mice, which had a higher viral load than the
wild type. This finding suggests a role for the B-cell marker, also an important component in cell
survival, in modulating cellular immunity during infection [707].

Apoptosis often restricts viral replication and infection. Shrestha et al showed the
beneficial role of TNF-α related apoptosis inducing ligand (TRAIL), produced by CD8+- T cells,
in limiting WNV infection in mouse central nervous system [708]. CD8+- T cells in TRAIL-/mice encountered difficulty in clearing the viral particles from the neurons. Zhang et al
demonstrated, using mouse neuron as an infection model, a rise in TNF-α during infection [709].
The rise served to down regulate the chemokine CXCR3, which would otherwise bind antiviral
CXCL10 circulating in the central nervous system (CNS). This interaction results in calcium
transients that lead to caspase-3 mediated apoptosis in the neurons, an adaptive mechanism that
limits viral production. Smith et al showed an important aspect of WNV infection in human cell
culture (HEK293, SK-N-MC) and mouse neuronal tissues - regulation of non-coding microRNAs
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(miRNAs) [710]. Among several miRNAs, Hs_154 is significantly upregulated in infected cells.
Two of the targets of Hs_154, CCCTC-binding factor (CTCF) and epidermal growth factor
receptor (EGFR), are associated with cell survival; this accounts for the role of Hs_154 in
suppressing apoptosis. While this activation lowers viral replication, apoptotic cell death is also
the basis for WNV pathogenesis.

As in dengue, both structural and non-structural proteins play a role in survival of infected
cells. WNV capsid (Cp) protein triggers a caspase-dependent apoptosis, leading to inflammation,
in mouse brain and muscle [711]. WNV capsid is dependent upon p53 for its apoptotic effects. Cp
has been shown to sequester HDM2, a negative regulator of p53, into the nucleolus. This results
in a higher stability of p53, which can then target Bax to induce apoptosis in MEF cells [712].
Inhibitor-based studies on four types of mammalian cells (A549, HEK293T, Vero-76, BHK-21)
suggest a role for WNV capsid (C) protein in the inhibition of apoptosis through
Phosphatidylinositol-3-kinase (PI3K)-Akt pro-survival pathway [713]. The helicase and protease
domains of NS3 protein are instrumental in inducing a caspase-8 dependent apoptosis in three
types of mammalian cells (Neuro 2a, HeLa, and Vero) [714].

Currently there is no evidence for any significant role of autophagy in WNV
pathogenesis, although we have evidence of PI3K-dependent autophagy in infected mouse brain
slices as well as mammalian cells [715, 716].
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2. HOW IMPORTANT IS CELL SURVIVAL OR DEATH IN JAPANESE ENCEPHALITIS
INFECTION?

JEV-induced apoptotic cell death is reliant on endoplasmic reticulum (ER)

stress and production of reactive oxygen species (ROS). ER stress-induced activation of UPR
factors (CHOP-p38MAPK) is essential for triggering the apoptotic response in fibroblasts (BHK21) and neuronal cells (N18, NT-2) [717]. Even replication-incompetent strains (UV-JEV), as
shown by Lin et al, retain their ability to kill neuronal cells (N18, NT-2) by inducing ROS
production and activating NF-κB [718]. The structural E protein from JEV-YL induces apoptotic
cytotoxicity in HepG2 and Vero cells [719]. Earlier studies had pointed to a link between nonstructural NS3 protein and induction of apoptosis. Transfection of pEGFP-NS3 1-619 plasmid
(whole NS3 protein) into Vero cells caused apoptotic cell death. The same study also evaluated
the role of caspases; NS3 activates only the intrinsic branch (CASP -9, -3) of apoptosis [720,
721]. Bcl-2 proteins can prevent apoptosis by controlling the release of cytochrome C.
Overexpression of Bcl-2, however, did not block viral replication and distribution in mouse
neuroblastoma N18 cells, though it delayed cell death in BHK-21 cells. Moreover, in BHK-21
and CHO cells, overexpression of the anti-apoptotic Bcl-2 established persistent infection.
Though JEV induced classical intrinsic pathway in N18 neuroblastoma cells, it activated both
caspase-8 (part of the extrinsic pathway) and caspase-9 in a predominantly mitochondriadependent pathway in MCF cells [722-724].

Japanese Encephalitis virus induces autophagy to facilitate viral replication in certain cell
types. Li et al showed induction of autophagy by virulent (RP-9) and attenuated (RP-2ms) JEV
strain in human NT-2 cells. They also showed that of rapamycin-induced autophagy increased
viral replication and maturation, and suppression of replication when autophagy was blocked
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[725, 726]. Infection with Japanese encephalitis virus triggers innate immune response (through
RIG-1/IRF-3 and P13K/NF signaling pathway) and activates inflammatory cytokines, chemokine
and IFN-inducible proteins. JEV Infection also induces autophagy in a human microglial (CHME5) cell line, leading to pro-inflammatory cytokine response [726].

3. HOW IS DENGUE INFECTION INVOLVED IN CELL SURVIVAL OR DEATH? The
role of cell death in dengue pathogenicity in various cell types has now been studied for nearly
two decades. Most of the initial studies were done with regard to apoptosis, though it has been
lately shown that autophagy too plays an important part in some cells. For this reason, more is
known about apoptosis in the time of dengue infection. Understanding of how dengue affects
cell survival is central to this thesis. We shall summarize the role of autophagy in dengue
infection (the central theme of this thesis) in the following paragraphs and conclude the
section with a discussion on apoptosis in DENV infection. Although the current study
doesn’t directly look at apoptosis, it is an important aspect of infection and thus needs to be
revisited.

Autophagy plays an important role in the pathogenicity of dengue virus. Involvement of
autophagy in dengue infection is a relatively new finding, shown first in 2008, when DENV2
was linked with ATG5-dependent autophagy in hepatic (Huh7) and fibroblast (MEF) cells. It
was identified as a mechanism that was conducive to viral replication as well as increased titer.
Similarly, blocking autophagy in Huh7. a.1, BHK21 cell lines and AG129 mice resulted in a
heat-sensitive and non-infectious dengue virion. Studies conducted using specific autophagy
inhibitors like spautin-1 further revealed the role autophagy plays in maturation of dengue virion.
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However, with more studies it became clear that like apoptosis, the relation between autophagy
and DENV infection depends on the infected cell type. While most of these studies were aimed
at looking for viral replication in directly infected cells, studies with human monocytes3 (U937)
showed that induction of autophagy decreased viral replication. Studies conducted by our lab
demonstrated that DENV2-mediated autophagy protects canine kidney epithelial (MDCK) and
mouse fibroblast (MEF) cells from toxic stimuli but not protect murine macrophages, where
infection leads to apoptotic cell death. Thus it is important to look at the effects of infection on
the status of autophagy in cell types from different sources [727-729].

In our laboratory we have established a link between autophagy and pathogenicity. Our
data shows that the ability of all dengue strains to protect epithelial cells or fibroblasts against
other stressors correlates with their ability to induce autophagy. NS4A was also the sole effector
behind cell protection by these flavivirus. We showed that expression of dengue NS4A protein,
like infection with live virus, induces PI3K-mediated autophagy and protects these cells against
death from toxins. In contrast, expression of other structural and non-structural proteins could
not produce this protective effect [652]. Most of these proteins (expressed in mammalian cells
from a pCAGGS-HA plasmid vector) did not protect MDCK (canine renal epithelial) cells from
Camptothecin; rather NS2A and NS5 killed slightly more. The protection by NS4A is diminished
in an autophagy deficient background (Vps 34 inhibitor/ Rapamycin/ Beclin1-/-, ATG5-/knockout MEFs) thus correlating autophagy and flavivirus replication [652]. In our current
study, we have extended this approach to look at the role of PERK pathway - an upstream
effector of autophagy - on replication and maturation of the virus. Our results also establish
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The virus does not directly infect these cells.
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PERK as a mediator of autophagy and cell protection. The same study also demonstrates the
early activation of Ataxia Telangiectasia Mutated (ATM) kinase, a DNA Damage Response
(DDR) protein, and its potential role in activating PERK, autophagy and subsequent pro-survival
in infected cells [10]. In contrast, the virus induces apoptosis of macrophages or neurons,
suggesting that it functions differently in different cell types.

Apoptosis has been illustrated across a wide range of mammalian cell types infected by
different DENV serotypes. Studies have shown that DENV 1 (human isolates of dengue type 1
virus FGA/89 and BR/90, neurovirulent variant FGA/NA d1d), DENV 2 (strain NGC, 16681)
and DENV 3 (DENV3/5532) all are capable of inducing apoptotic cell death within 25 to 36
hours post infection. Apoptosis has been recorded in infected cells from the central nervous
system (human and mice neuroblastoma, murine cortical and hippocampal neurons, human
cerebral cells), liver (human hepatoma immune system (human peripheral blood mononuclear
cells like CD8+-T lymphocytes, monocyte-derived macrophages, human mast cells like KU812,
HMC-1, and primary murine macrophages), vascular system (human umbilical cord vein
endothelial cells, human microvascular endothelial cells, pulmonary microvascular endothelial
cells, EA.hy296), digestive system (intestinal cells) and kidney (human embryonic kidney HEK
293, VERO).

Apoptosis is important in dengue pathogenesis and infectivity, although the effect on
infected cells is different from DENV-induced autophagy. Unlike lytic viruses that
indiscriminately trigger cell death, pro-apoptotic variants of dengue may not always kill infected
cells. The neurovirulent variant FGA/NA d1d kills neuroblastoma but not hepatoma cells [730].
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Apoptosis seen during infection of human umbilical cord vein endothelial cells (ECV304) and
Swiss Webster primary macrophages by Dengue-2 virus strain 16681 is not seen in MDCK,
HeLa, HEK 293T, Vero or Swiss Webster primary MEF even after 144 hours (6 days) post
infection [652, 731]. The differences in pathogenicity of dengue outbreaks are partly explained
by differences in cell killing by clinical isolates. Isolates of virus from a fatal case (Paraguay
2007; DENV3/5532) had a higher replication rate in monocyte-derived human dendritic cells
(mdDCs) than isolates of virus from a non-fatal breakout (Brazil 2002; DENV3/290). The former
also induced more proinflammatory cytokines associated with apoptosis [732].

Regardless of the status of cell death, it is evident that Dengue derives its pathogenic
effects by inducing apoptosis. It targets immune cells for apoptotic death, as was shown by an
increase in the number of peripheral blood mononuclear cells (PBMCs) in dengue-infected
children. The proportion of apoptotic cells and the mediators of apoptosis (CD95) among the
circulating PBMCs are much higher in individuals progressing towards hemorrhage (DHF) than
those developing febrile symptoms (DF), indicating a higher viral load in the former. The
immune response to increased dengue-induced apoptosis does not always curb virus
proliferation. Apoptosis, in the context of dengue infection, fails to arrest viral reproduction and
even correlates with increased virus production [733, 734].

Both extrinsic and intrinsic apoptosis have been observed in DENV infection. Increased
levels of pro-apoptotic proinflammatory cytokines (TNF-α and interleukin–10) and
Apo2L/TRAIL are observed after infection with dengue 3, which the virus possibly induces
through the TNF-α route [732]. Profiling of genes reveals the activation of death receptors
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FAS/CD 95, TNFR superfamily member 9/CD 137, TNFRI/TNF-α (caspase-independent) and
IL-1β/NFκB (caspase-dependent) pathways [733, 734]. Infection with live dengue virus leads to
differential expression of several interferon-inducible genes, the most important being XAF1.
XAF1 upregulates caspase 3 thirty-six hours after infection and mediates apoptosis [735]. The
activation of caspase leads to the characteristic nuclear fragmentation and cytoplasmic blebbing
of apoptosis. The reactive oxygen species (ROS) O2. - and H2O2, produced in mitochondria,
increase during infection. Toxic levels of ROS can activate calpains and lead to apoptosis.
Secondary messenger oxides like nitric oxide (NO) also mediate dengue-triggered apoptosis in a
caspase dependent manner [736]. As infected cells undergo apoptosis, the extrinsic and intrinsic
apoptotic pathways converge at the exteriorization of phosphatidylserine (PS), which leads to
phagocytosis of apoptotic cells by phagocytes [737].

Like whole virus infection, expression of individual viral proteins has also been shown to
initiate extrinsic and intrinsic apoptosis. Viral protein NS5 interacts with death protein 6
(Daxx), which among other functions interacts with death receptor FAS, to activate RANTES
(CCL5), a cytokine closely associated with dengue hemorrhagic fever (DHF) [738, 739].
Moreover, transfection with wild type capsid protein increases the expression of CD137, a
member of the TNFR family. Receptor-interacting serine/threonine protein kinase 2 (RIPK2), a
master regulator of stress pathways [740], is also necessary for capsid-induced apoptosis [740].
Intracellular production of the M protein from all dengue strains activated the intrinsic pathway
apoptosis in mouse neuroblastoma (Neuro2a) and human hepatoma (HepG2) cells. ApoptoM, a
nine-residue sequence (M-32 to -40) from the M ectodomain (M-1 to -40), is instrumental in the
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cytopathic effect of the flavivirus [741]. Differences in cell toxicity among dengue variants have
been attributed to mutations in the E and NS3 [730].

To summarize, the ability of different strains to induce apoptosis, and consequent cell
death, depends upon the type and origin of the infected host cell. Although apoptosis has been
found to be conducive to viral infectivity in most cases, more studies should be dedicated at
looking into non-conventional pathways of apoptosis like the BOK-induced intrinsic pathway
and others. This would enable researchers to identify a putative target for antiviral therapy.

6.5.3.

WHAT ARE THE FUNCTIONS OF AUTOPHAGY, ATM KINASE AND ER

STRESS IN VIRAL INFECTION?All the pathways described above represent the crux of our
current study. We have investigated the roles played by these pathways in Dengue-infected cells.
In the following sections, we shall present a brief overview about the function of these processes
in viral infection, and then focus on Flavivirus.

1. MACROAUTOPHAGY AND OTHER FORMS OF AUTOPHAGY ARE FREQUENTLY
MANIPULATED IN VIRAL INFECTION

As has been described earlier, autophagy,

and specifically macroautophagy, can present both pro-viral and antiviral aspects. In viral
infection, autophagosomes can act as a source of membranes and lipid droplets (through
Lipophagy) for the viruses; a double membrane vesicle (like ER) is always a potential
‘replication hub’ for the virus. On the other hand, autophagy can also trigger antiviral immune
responses and play an instrumental role in the removal of the viral pathogens, especially in viral
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xenophagy. Thus, the challenge to the virus lies in balancing the outcomes of autophagy in the
host cell and in turning the ‘autophagy wave’ into its own replication and maturation [485, 742744].

Many viruses, especially RNA viruses, either subvert the autophagy apparatus to their
own benefit, or to block the pathway altogether and block the autophagy-dependent antiviral
response.

Picornaviruses,

Coronaviruses,

Retrovirus,

Flaviviruses,

Hepaciviruses,

Herpesviruses and Orthomyxovirus manipulate different steps or components of macroautophagy
to facilitate replication and in certain cases, even viral maturation and exocytosis [742]. Many
researchers identify viral proteins that interact with the autophagy machinery, e.g., Poliovirus
2BC and 3A, which mediates formation of double membrane vesicles (DMV) and LC3
lipidation. Other examples include West Nile (WNV) NS4A/NS4B (induce autophagy
independently of the UPR pathways), Zika (ZIKV) NS4A/NS4B (which activate mTORCdependent autophagy) and NS2B-3 (inhibition of Reticulophagy), Hepatitis C virus (HCV) NS4B
(initiates RUBICON-mediated suppression of autophagosome maturation) and NS5B (interaction
with ATG5), Dengue (DENV-2) NS4A (PI3K-dependent autophagy/ cell protection) and NS2B3 (inhibition of Reticulophagy), Influenza A virus (IAV) matrix 2 (M2)/NS1/HA (interaction
with LC3) [742, 745-759].

Since lipid droplets are extremely rich sources of membranes that can serve as
‘replication hotspots’, as well as free fatty acids that can boost energy (ATP) formation, they are
often hijacked by viruses to facilitate assembly and replication. Viruses target a selective form of
autophagy, Lipophagy, which involves degradation of lipid droplets in lysosome, for this

62

purpose. It is believed that RNA viruses like DENV and HCV block the maturation of lipid-rich
autophagosomes, thereby increasing the cytosolic level of lipid droplets and cholesterol in the
infected cells. The colocalization of DENV capsid protein in lipid droplets also point to the
possibility of these being used as a platform for viral assembly and maturation. In HCV infected
cells, the autophagosomes have a high density of lipid-raft associated proteins like annexin and
caveolin, and chemical depletion of cholesterol has been shown to reduce viral titer [760-765].

Apart from early events like replication, viruses also hijack the autophagy network to
expedite their release by exocytosis. Both enveloped Flaviviruses as well as non-enveloped RNA
viruses like Picornaviruses rely heavily upon the autophagosome membranes for exocytosis.
Lytic viruses like Herpesvirus also use the autophagy machinery to acquire envelopes before
release from the cells. Both autophagy and exocytosis share molecular machinery like the
participation of GTPase RAB and SNARE proteins. The presence of LC3 in exosomes also
highlights the overlap between autophagy and exocytosis in infected cells [751, 753, 756, 766773].

Besides subverting the regular processes involved in autophagy, a second approach is
also adopted by viruses - to escape autophagy or block the process altogether. This is essential in
cases when autophagy is intricately linked to both innate and adaptive immune response.
Autophagy plays an important role in mounting an innate antiviral response, by closely working
with the Toll Like Receptors (TLR) and mediating the expression of interferons. The TLRs
(most commonly TLRs 3/8/9) are capable of binding to pathogen associated molecular patterns
(PAMPs) present on the viruses and inducing production of interferon. This process also
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activates autophagy by the dissociation of BECN1 from its negative regulator BCL-2;
autophagy, on the other hand, exerts a positive effect on TLR-mediated IFN production in cells
infected with Herpes Simplex virus type-1 (HSV-1), vesicular stomatitis virus (VSV) and Sendai
virus (SEV). The relation between autophagy and immune antiviral response is however
complicated, because autophagy, especially the ATG5-ATG12 complex formation, blocks
retinoic acid inducible gene-1 (RIG-1) mediated IFN production [774-780].

Autophagy is also instrumental in mounting an adaptive immune response against viral
infection. In several MHC type II positive cells autophagosomes play an important role in the
degradation and presentation of specific viral proteins (e.g., EBV nuclear antigen 1, HIV-gag
derived proteins) to CD4+-T cells. In contrast, although MHC type I cells are usually inhibited by
autophagosome degradation, infection by human cytomegalovirus (HCMV) and HSV-1 can
induce autophagy to favor MHC type I presentation in a vacuole-dependent pathway. Both these
viruses block antigen peptide transporter (TAP), thus pointing to a common pathway of antigen
presentation. Autophagy is also involved in cross-presentation of viral antigen/peptides to MHC
type I cells through an exocytosis-dependent manner [781-787].

2. ATM KINASE ACTIVITY IS REGULATED DURING INFECTION BY SEVERAL
VIRUSES

ATM kinase, along with the rest of DDR machinery, has long been associated

with the replication of DNA and RNA viruses. Although the activation of a damage response
(designed to stall cell cycle and replication) in infected cells seems paradoxical, numerous
mechanisms suggest that this is just another pathway hijacked by the virus. In other cases, the
virus, quite expectedly, suppresses the DNA damage mechanism, thereby removing any potential
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checkpoints from cell replication. Just like autophagy and ER stress, the viral proteins also
manipulate ATM. Most researchers believe that DNA and RNA viruses differ in their ability to
manipulate the various DNA damage response proteins, including ATM kinase. DNA viruses are
more aggressive in their subversion of the DNA repair mechanism; in contrast, RNA viruses
only indirectly activate ATM, as an antiviral response. However, there is an increasingly large
body of evidence that supports a more direct role of RNA viruses in ATM activation, and
different viruses have been found to either activate or suppress the damage response in different
cell types [788, 789].

Ebola virus, an RNA virus from family Filoviridae, suppresses ATM kinase. A high
throughput screening study associated the activation of DNA damage response, specifically
ATM kinase, with IFN induction. Several topoisomerase inhibitors, including chemotherapeutic
agents, showed that viral VP35 protein partially suppressed RIG-1 like receptor (RIG-1)
dependent production of interferon (IFN-α). Blocking VP35 in infected 293T and A549 cells
effectively bypassed the virus-imposed evasion of innate immune response and released
production of virus from inhibition. Most of these compounds, including Doxorubicin and
Daunorubicin, were found to induce IFN-α production in an ATM-p53-dependent manner, thus
mounting antiviral innate immune response. In this case, ATM exhibited a non-DDR function
that nevertheless restricted viral growth. In contrast, members of the Flaviviridae family like
Dengue (DENV), Japanese Encephalitis virus (JEV) and Hepatitis C virus (HCV) all induce
ATM and related proteins, although the mechanisms of induction are different. Whereas HCV
induced ROS-dependent DNA damage in liver cells (Huh-7) that further activated ATM, ATR
and DNA-PK, DENV activated ATM (and, possibly ATR) at a very early stage in a ROS-
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independent fashion. The interaction between HCV proteins (NS3, NS4A, and NS5) and ATM
kinase, and the activation of ATM-CHK2 in JEV-infected U87 cells further validates the proviral
nature of the DDR pathways when cells are infected with Flaviviridae. This response was
observed even in cells harboring a latent HIV-1 virus; proteins involved in DDR and downstream
pathways, like ATM, CHK2 and P53 were all activated in infected Jurkat-derived cell lines [10,
619, 620, 761, 790-794].

Among DNA viruses, the relation between human papillomaviruses (HPV) and
ATM/ATR signaling has been extensively investigated. As explained above, the interaction
between DNA viruses and ATM kinase is more directly executed than between RNA viruses and
ATM kinase. ATM directly facilitates replication of varicella zoster (VZV) and polyomavirus. In
macrophages infected with gamma herpesvirus, replication is upregulated by ATM through
inhibition of type I Interferon. Inactivation or knockdown of the ATM in these cells not only
restores type I Interferon, but also increases susceptibility to type II Interferon. This highlights
the importance of ATM in innate antiviral response, although it is carried out in exactly the
opposite way of that in Ebola virus infection (described above). ATM is also activated, although
with different consequences, in HPV infection, especially the high-risk (HR-HPV). HR-HPV is a
major cause of cervical, ano-genital and oropharyngeal cancers. Unlike healthy cells, in which
replication is completely stalled until ATM/ATR has repaired the DNA lesions, HPV-infected
cells usually exhibit ATM activity simultaneously with viral replication, meaning that viral DNA
continues to be replicated. These findings, coupled with evidence that ATM and other DDR
proteins are highly localized in these cells, suggest that ATM induction in these virus-infected
cells is less (compared to chemically damaged cells) and that DDR is probably subverted to aid
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viral replication and establishment. In HPV infection, several viral proteins appear to be
associated with induction of DDR. Among these, the E1-E2 replication complex is involved in
repeated rounds of DNA replication in host cells, thus resulting in the formation of “onion-like”
structures that are recognized by the DDR system as lesions. E2 interacts with TOPBP1 protein,
which is involved in the mutual crosstalk between ATM and ATR; E1-E2 can also interact with
SIRT1 deacetylase in order to activate ATM. Other viral proteins like E6 and E7 also modulate
downstream pathways of ATM/ATR activation, most notably stabilizing P53. STAT-1 may also
activate ATM/ATR in infected cells, thus suggesting possible interaction among viral proteins,
the host DDR response complex, and host transcription factors. Other tumor-causing DNA
viruses like human cytomegalovirus (HMCV) and hepatitis B virus (HBV), associated with brain
tumors and liver cancer respectively, activate the ATM-CHK2-γH2AX axis. In the case of the
oncogenic herpesvirus Epstein Barr (EBV), upregulation of certain micro-RNAs (miR-BART55p, BART7-3p, BART9-3p, and BART14-3p) has been implicated in activation of ATM, a
prerequisite for the formation of viral replication complex. Localization of phosphorylated ATM
has been extensively recorded in cells infected with different herpesviruses such as Kaposi’s
Sarcoma

Associated

Herpesvirus

(KSAV)

and

Herpes

Simplex

Virus-1

(HSV-1).

Pharmacological inhibition of ATM (by KU55933) reduced the incidence of Herpes Simplex
Virus-1 (HSV-1)-induced keratitis. However, the positive effects of ATM activation, blockage of
replication of host DNA, are not conserved among all DNA viruses. Some DNA viruses block
the activation of ATM kinase and its downstream targets like CHK1 and γH2AX. Adenovirus
core protein VII, which has histone-like properties, and localizes with cellular chromatin, blocks
the activation of DDR through downregulation of ATM and γH2AX activity. Mechanistic studies
reveal an interaction between VII core protein and oncogene SET. Since VII protein is active
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only in the late stage of replication, DDR downregulation may be important after viral
replication has commenced inside the host cell [792, 795-809].

In brief and in general, RNA viruses appear to affect ATM kinase and other components
of the DNA damage response indirectly and in some cases through a mechanism that starkly
contrasts to that of DNA viruses. However, it should also be recognized that more DNA viruses
have been studied in this regard and therefore it is hard to reach a definite conclusion at this
moment. Finally, ATM kinase activation has a pleiotropic effect in virus infection, and it is
strongly regulated by the nature of the virus and the infected host. Apart from acting as a
surveillance protein that detects genetic lesions and induces cell cycle arrest, this protein has also
been implicated in mounting immune response as well as maintenance of redox homeostasis.
Furthermore, the very nature of its function makes ATM kinase one of the most favorable targets
for antiviral therapy against tumor viruses like HPV, HCMV, HBV, HCV and adenovirus.

3. ER STRESS/ UPR HAVE BEEN IMPLICATED IN VIRAL INFECTION, ESPECIALLY
IN RNA VIRUSES

Since ER is a major site for replication and translation, it is one of

the organelles where RNA viruses colocalize and thrive. It is where the virus replicates its
genome, expresses its proteins, and assembles and prepares the viruses for release by exocytosis.
ER stress is frequently triggered by Ca2+ imbalance (caused by Viroporins4), accumulation of
misfolded proteins and the rearrangement and loss of ER membrane. Many RNA viruses,
including Flavivirus, have been reported to induce one or more of these events. Poliovirus (PV),

4

A class of hydrophobic viral proteins expressed by both DNA and RNA viruses. They
oligomerize inside the host membrane and form hydrophilic pores, thus disrupting calcium
homeostasis in infected cells.
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Coxsackievirus B3 (CBV3), alongside Dengue (DENV) and Hepatitis C virus (HCV) replicate
within the stressed ER [469, 532, 810-812]. Interference with protein-glycosylation is a
prominent mechanism used by Influenza A (IAV), Japanese Encephalitis virus (JEV), West Nile
Virus (WNV) and Hepatitis C virus to induce ER stress in host cells [813-816]. In many types of
cells, WNV infection increases the influx of Ca2+ into the cells, resulting in the rearrangement of
the ER [817].

As in apoptosis, individual viral proteins are involved in the induction of ER stress. With
Rotavirus, the capsid protein VP7 cooperates with VP4 and the nonstructural protein NSP4 to
‘steal’ some of the ER membrane and to accumulate it into its own structure during assembly and
release as an infectious triple-layered particle [818]. Viroporins disrupt the integrity of
membrane-bound vesicles such as the ER [812]. IAV M2 protein, rotavirus NSP4 protein and
picornavirus 2B proteins disrupt Ca2+ homeostasis in the host cell and use this to improve
budding and release [819-821]. The enterovirus 71 (EV71) non-structural protein 2C and HCV
NS4B interact with the ER membrane protein reticulon 3 (RTN3) to induce membrane
rearrangement to facilitate viral replication [822-824]. DENV non-structural protein (NS2B,
NS4A) redistributes the ER membrane through a ROCK-dependent vimentin rearrangement
[825-827].

An important product of viral infection is an increased “translation burden” on the host
cell, as the translation machinery is often hijacked by the virus and given the additional task of
expressing the viral proteins. The mammalian part of the dengue life cycle is remarkably
compartmentalized, hijacking ER-specific translation but having little effect on cytoplasmic
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translation, where host proteins continue to be manufactured [828, 829]. The ER responds to this
situation by turning off global protein translation, employing one or more Unfolded Protein
Response (UPR) pathways that regulate the activity of the elongation or initiation factors [830].
The UPR pathways are also activated in response to TLR signaling, excessive ROS production
and viral infection [831]. Accumulation of misfolded proteins in the ER lumen, as is often the
case in viral infection, causes the release of BiP (Binding Immunoglobulin protein)/GRP78 from
the initiator molecules of all three UPR branches.

4. ER STRESS AND MULTIPLE BRANCHES OF UPR HAVE BEEN RECORDED IN
FLAVIVIRUS INFECTION

Like improper glycosylation, impaired ERAD (ER-

associated degradation) machinery, oxidative stress, and hypoxia, viral infection is a major
trigger for ER stress; and not surprisingly it has been linked to every branch of the UPR.
Flavivirus has an intricate and complex relationship with the endoplasmic reticulum [693].

The upstream events leading to apoptotic death in WNV infected cells include
endoplasmic reticulum (ER) stress. West Nile Virus (WNV) activates the ATF6 and PERK
pathways in human neuroblastoma (SK-N-MC) and primary rat hippocampal neurons, and as a
consequence, infected cells activate CHOP-mediated apoptosis [832]. As with apoptosis,
infection-mediated induction of UPR is strongly dependent upon the strain of the virus and the
type of host cell. West Nile virus Kunjin strain (WNVKUN) inhibits the PERK pathway and
interferon-mediated STAT phosphorylation, simultaneously activating ATF6 and IRE1
pathways. Studies with ATF6-/- and IRE1-/- MEFs reveal a synergetic pattern through which
infection restricts apoptosis and increases viral load, an effect somewhat akin to dengue
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protecting MDCK cells and increasing the viral load. The hydrophobic non-structural proteins
NS4A and NS4B of WNVKUN activate IRE1/ATF6 and inhibit the JAK-STAT signaling branch
of the host antiviral response. A follow-up study using the same model and knockout cells
highlighted the relative importance of ATF6, compared to IRE1, in manipulating the PERK
pathway and restricting apoptosis and antiviral responses [652, 833, 834].

JEV activates UPR-induced apoptotic cell death in BHK21 fibroblasts and neuronal N18
and N-2 cells, but not in apoptosis-resistant K562 cells. p38 and CHOP mediate the effects of ER
stress in inducing UPR-dependent apoptosis [835]. One or more UPR pathways are activated in
JEV infection. JEV SA14-14-2 strain induces apoptosis through an IRE1/JNK pathway in BHK21 cells [836]. Other pathways of cell death are also regulated during JEV infection: IRE1dependent XBP1 splicing and ATF6 activation are linked to induction of autophagy and cell
survival in mouse embryonic fibroblasts and neuronal cells [837]. The induction of autophagy, in
this case, inhibits viral production, in sharp contrast to what we found for dengue in MDCK cells
[10, 652]. JEV can co-opt the IRE1-dependent decay pathway (RIDD) to increase viral protein
and viral titer in mouse neuroblastoma cells (Neuro2a) [838]. In Japanese Encephalitis virus
(JEV) infected BHK21 cells, the BiP protein colocalizes with the viral E (envelope) protein,
supporting the maturation and release of infective virion particles [839]. Proteomic studies in
JEV-infected human neural stem cells (hNS1) revealed an increase in the amount of several
proteins responsible for sustained ER stress, including BiP/GRP78, mitochondrial Prohibitin, and
heterogeneous nucleus ribonucleoprotein hnRNPC (C1/C2) [840].
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Like many other RNA viruses, including members from the Flaviviridae like HCV, IAV,
JEV, Dengue (DENV) too relies heavily upon their ability to modulate the ER and regulate the
downstream metabolic processes, i.e., translation, apoptosis, autophagy, ROS production and
protein folding [525, 841]. Dengue-induced ER stress has been reported in a wide variety of
cells, including monocytes and liver cells (HepG2) [842, 843]. These processes are believed to
favor dengue production and cytopathogenicity as well as to suppress the host antiviral response
[844]. In fibrosarcoma cells, dengue modulates the PERK pathway during early stages of
infection, first activating this pathway and later turning it off in a time-dependent fashion. IRE1XBP1 and ATF6 pathways are then activated during the mid- and late-stages respectively [829].
In this case as in WNV infection, the timeline of UPR regulation varies with the function and the
type of the host cell. In epithelial cells, the flavivirus replication complex (RC) co-localizes with
autophagosomes, which are derived from the ER membrane. The accumulation of viral proteins
on ER membranes causes high ER stress that can activate one or more UPR pathways. Apart
from mammalian cells, DENV (serotype 2/strain: 16681) NS4B also modulates host immune
response through UPR activation in Drosophila melanogaster cells [845]. In concordance with
our results (in MDCK and PERK-/- MEF cells), another group has shown the involvement of
both PERK-eIF2α and IRE1α-JNK in inducing autophagy and facilitating DENV-2 pathogenesis
in Huh7 and BHK-21 cells [10, 841].

Many Flaviviruses modulate the PERK pathway, either specifically or in combination
with other UPR pathways. In a novel study using Neuro2a and MEF cells, infection with JEV
(Vellore strain) and WNV induced a PERK-dependent up regulation of a long non-coding RNA
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Malat1, which is linked to cell survival [846]. This validates numerous findings that have
suggested that UPR pathways are integral to cell survival in infected cells.

The capability of DENV to induce UPR/PERK can be used as a potential target to block
viral infection and production, as has been proposed in numerous studies performed on a nuclear
transport inhibitor (4-HPR) in infected PBMC cells and an ADE-mouse model. 4-HPR inhibits
the interaction between DENV NS5 and host nuclear import proteins; it manipulates the PERK
pathway to restrict viral replication and maturation. Apart from PERK pathway, 4-HPR also
induced nuclear localization of ATF4 and eIF2α phosphorylation in a PERK-independent
manner, i.e., through the effect of ISR kinases [847, 848]. The evolutionary importance of this
pathway was recently highlighted by a study where infected mosquito (C6/36) cells activated the
PERK pathway, which led to increased survival of the host (possibly by turning off pro-apoptotic
genes) and extended the incubation period of the virus inside the vector [676].
Since dengue increases the load on host translation, the cell tries to block global
translation. However, prolonged repression of translation is harmful to the cells; hence this
process is subject to stringent regulation. In cases like infection by a pathogen, this control of
translation is even more critical, because of the ongoing “translation”-race. This is where
GADD34 (protein phosphatase 1 regulatory subunit 15A) plays an important role, as it
dephosphorylates eIF2α, thereby restoring the function of eIF2α and the function of the host
translation machinery [543]. In our studies we have used salubrinal as an inhibitor of the
negative feedback imposed by GADD34, to determine the role of PERK in dengue infection
[544].
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6.6.

In light of the information provided above, our understanding of how dengue and other
Flaviviruses affect the different signaling pathways is still in its nascent stage. While in some
cells dengue induces pro-apoptotic pathways, in other instances it promotes survival, by the
activation of macroautophagy. As shown by our previous study, this induction of
macroautophagy results in protection of cells from toxins and other cell-lethal agents, and is
conducive to production of virus [652]. However the path of this induction was not clear. As
there is accumulating evidence that ER stress leads to autophagy, we asked if DENV2-induced
autophagy were the ramification of ER stress induction. Apart from ER stress, ATM kinase also
acts upstream of autophagy and is also regulated when cells are infected by virus. We therefore
examined the involvement of ATM in DENV2 infection and induction of autophagy as well.

Our strategy to find the answer presented in this thesis has been to look at different players
in DENV2-infected cell: ER stress/ UPR and ATM activity, and their relationship with
autophagy, cellular protection and propagation of virus (Figure 4). We first examined a global
marker of ER stress activation in infected cells (Figure 4, 1). Next we investigated whether the
PERK pathway is the mediator of the ER stress (Figure 4, 2). To this end, we looked at
downstream substrates of PERK: ATF4, CHOP and GADD34 (Figure 4, 3). The involvement
of PERK activity was then demonstrated in virus replication, cell protection, and autophagy
(Figure 4, 4,5). Finally, we used chemical inhibitors to demonstrate that early activation of
ATM is responsible for autophagy, cell protection and PERK activity in infected cells (Figure 4,
6,7). Our data presented in the RESULTS section below indicate that early activation of ATM
kinase is responsible for induction of ER stress (in the form of increased PERK activity), which
in turn is implicated in autophagy, cell protection and virus propagation. To our knowledge,
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this is the first time that the relation between these pathways has been established for cells
infected by any dengue virus.

Figure 4: A proposed work plan for the current study
In this diagram we summarize the major points of interaction between the virus and the
cellular pathways that we have investigated in our current study. 1) We looked at the global
marker of ER stress, calreticulin (CALR) in DENV2-infected cells. 2) We then focused on the
PERK pathway, through which ER stress is mediated during viral infection. The PERK protein
is released from the BiP/GRP78 chaperone and it undergoes self-dimerization and
phosphorylation. This turns off global translation by phosphorylating the eIF2α. 3) The
transcription factor ATF4 is exempt from this inhibition and it translocates to the nucleus where
it activates CHOP, GADD34 and other genes. We investigated the expression of ATF4, CHOP,
and GADD34 as markers of PERK activity. 4, 5) We then studied the links between PERK
pathway and macroautophagy. We looked at the expression and localization of LC3II (as a
marker of formation of autophagosomes) and autolysosomal P62 degradation (as a measurement
of autophagic flux). 6, 7) Finally, we focused on ATM kinase as an upstream regulator of
autophagy and PERK in infected cells.
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Figure 4

7. MATERIALS AND METHODS
7.1. CELL CULTURES
7.1.1.

MADINE DARBY CANINE KIDNEY (MDCK) Most of our experiments, especially

those involving the virus infections, were performed on MDCK cells (ATCC#CCL34). These are
epithelial cells isolated from the kidney of a female cocker spaniel (Canis familiaris) and have
been widely used as a host for a wide range of viruses. We obtained this cell line as a generous
gift from Dr. Anastasia Gregoriades of Queens College.
•

These cells were maintained in high-glucose/L-glutamine (+) Dulbecco’s Modified Eagle
Medium (GIBCO 5 #12800-017), supplemented with 3.7g/L of sodium bicarbonate (Sigma 6
#S8875), 10% heat inactivated Fetal Bovine Serum (GIBCO#10438-026) and 1% PenicillinStreptomycin (GIBCO#15140-122).

•

On obtaining the cells, we thawed the frozen stock by carefully submerging the bottom of the
cryovial in the 37°C water bath.

•

The thawed cells were mixed with 10mL of pre-warmed maintenance media in a Falcon® tube
and were spun down at 1500 revolutions per minute (RPM) for 5 minutes.

•

The supernatant was discarded and the cell pellet was re-suspended in approximately 2 mL warm
medium and plated in a new flask. The cell suspension was covered with more medium (1215mL/75cm2 flask; 4-5 ml/25cm2 flask).

•

The medium was removed the following day to eliminate any traces of the cryo-preservative
Dimethyl Sulfoxide (DMSO).

5
6

Address: Gibco Laboratories, 8717 Grove Mont Cir, Gaithersburg, MD 20877
Address: Sigma-Aldrich Corp. St. Louis, MO, USA
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•

The cell population was then carefully inspected and was maintained by passaging once the
culture exceeded 80% confluence in the plate/flask. To subculture (‘passage’) the cells, the
medium was decanted and the cells were washed with pre-warmed 1x Phosphate Buffered Saline
(PBS).

•

The cells were then detached by adding a dissociation agent 0.25% Trypsin (made of the 2.5%
stock, Thermo Fisher7 15090046). After the adherent cells detached, trypsin was deactivated by
adding medium (4-5 times the volume of trypsin used).

•

Samples of the medium containing trypsin and detached cells were pooled in a Falcon tube and
centrifuged at 3000 rpm for 5 minutes. The supernatant was then discarded and the cell pellet
resuspended in warm medium and a fraction of the suspension was plated.

We have followed this general protocol for the following cell lines unless otherwise stated
below.

7.1.2.

MDCK-GFP-LC3

We collaborated with Dr. Michael Overholtzer (Memorial Sloan

Kettering Cancer Center) to generate MDCK cells expressing GFP tagged LC3 protein. To this
end, we used Lipofectamine to transfect the MDCK cells with retroviral plasmid carrying the
GFP-LC3 construct.

The virus-Lipofectamine complex was prepared as described below.

7

Address: Thermo Fisher Scientific, 168 Third Avenue Waltham, MA USA 02451
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•

The following were mixed and incubated at room temperature (RT) for 5 minutes: i) 0.4 µg
Retroviral plasmid, ii) 0.2 µg VSV-G 8plasmid, iii) 0.25 µg Gag/Pol9 and iv) 100 µL Opti-MEM
(reduced serum media/ Thermo Fisher Scientific# 31985062).

•

Simultaneously, 2.5 µL of Lipofectamine 2000 (ThermoFisher#11668027) was dissolved in 100
µL Opti-MEM. The mixture was mixed thoroughly by inverting several times and then let sit at
RT for 5 minutes.

•

These solutions were again mixed gently and incubated at RT for 20-30 minutes. The MDCK
cells were washed with Opti-MEM before being fed with a cocktail (1ml) of Opti-MEM and the
Virus-Lipofectamine mixture in the ratio of 4:1.

•

After 6 hours, the cells were covered with maintenance media.

•

The cells were collected at different times from 48 hours onwards and were tested for GFP
signals using fluorescence microscopy.

7.1.3.

BABY HAMSTER KIDNEY CELLS (BHK-21) We used BHK-21 (ATCC 10 #CCL-

10) cells to titer and grow dengue 2 viruses. These are fibroblast cells derived from the kidney
of Syrian golden hamster (Mesocricetus auratus). Like MDCK, these cells are susceptible to
virus infection and hence they are a convenient choice for plaque assay. These cells were
maintained in the DMEM+/+ media. In some cases, they were also grown in α-MEM media
(Mediatech#50-012-PC) supplemented with 10% FBS, 1% P-S and 2.2g/L NaHCO3.

8

It is an envelope plasmid (bacterial dsDNA) used for lentivirus production.
Packaging genes used for lentivirus production – Gag is a structural precursor protein and Pol is
a polymerase
10
Address: American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas,
VA 20110 USA
9
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7.1.4.

D1-4G2-4-15 We used this hybridoma cell line (ATCC#HB112) to generate antibodies

against the envelope protein expressed on flavivirus. Thus, these cells are useful tools for
detection of dengue and Zika infection by immunofluorescence. These lymphoblast-like cells
were isolated from mouse (Mus musculus) immunized with the dengue type 2 virus antigens.
Fusing spleen cells with P3X63Ag8 myeloma cells generated the hybridoma. These cells were
maintained in Hybricare media (ATCC-46X) supplemented with FBS, P/S and 1.5g/L NaHCO3.
Unlike most of the cells used, this is a suspension cell culture. After thawing the frozen stock and
eliminating the toxic cryo-preservative, we let the cells grow for 4-5 days and release enough
antibodies in the media. We then pooled the supernatant in a Falcon tube and centrifuged at 3000
rpm for 5 minutes. The supernatant containing the antibodies was collected in a fresh tube and
stored at 4° C. The cell pellet was resuspended in warm media and was sub cultured in a ratio
(4-5 fold).

7.1.5.

AEDES ALBOPICTUS (C6/36)

The

Aedes

albopictus

clone

C6/36

(ATCC#CRL1660) cells were used to grow high titers of dengue viruses. Since mosquito is a
secondary host and a vector for arbovirus, these cells are widely used for the propagation of the
virus. These cells were maintained in an enriched RPMI media containing 10%FBS, 1%P-S, 1%
non-essential amino acids (Sigma#M7145), 1% sodium pyruvate (Sigma#S8636), 1% LGlutamine (ThermoFisher#25030081) and 3% NaHCO3 (5%). For some variants of these cells,
L-Glutamine containing EMEM11 (ATCC#30-2003) media was used to replace RPMI. Once
thawed in the medium, the cells were incubated at 28 or 33° C in 5% CO2.

11

Eagle’s minimum essential medium
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7.1.6.

PERK (WT, KO) MEF

We obtained mouse embryonic fibroblasts (MEFs) where

the PERK (12kinase involved in the unfolded protein response) protein has been eliminated by
knockout of the gene. These cells were generated in the laboratory of our collaborator Dr.
Patrizia Agostinis (KU Leuven, Belgium) and were used in our lab to examine the role of the
PERK pathway in virus infection, cell survival and regulation of autophagy. These cells were
either infected with the virus or transfected with plasmids expressing a viral gene. These cells
were maintained in DMEM+/+ media.

7.1.7.

HEK-BLUE-2

We used these cells (InVivoGen Catalog#rep-pt1) for detection of

mycoplasma in the supernatant of our secondary cell lines. HEK293 cells have been stably
transfected with TLR2 and other genes involved in the Toll-like receptor pathway. In presence
of mycoplasma, TLR-2 is activated and several transcription factors (like NF-κβ) are turned on.
These factors then promote the expression of an engineered secretory alkaline phosphatase (sAP)
that can be detected by the color change of a customized medium. These cells were thawed in
DMEM media supplemented with 10% FBS, 1%P-S and 100µg/ml Normocin (Invivogen#antnr-1). After the native cells had reached optimal (80-90%) confluence, they were detached by
gently tapping or scraping (trypsin was not used for these cells as it has been reported to alter cell
metabolism). Selection was carried out by maintaining and sub culturing the cells in growth
media supplemented with the 1X HEK-Blue selection (InvivoGen#hb-sel). The selection
contains a set of antibiotics that ensures the persistent expression of the different transgenes
expressed in HEK. This growth medium was replaced twice a week unless we had sufficient

12

Protein kinase RNA–like endoplasmic reticulum kinase
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expansion to prepare frozen stocks. The mycoplasma detection was performed using the
remaining cells.

7.2. TREATMENTS

In our project, mammalian cells were treated with a variety of chemicals

mostly pharmacological regulators of ATM kinase, ER stress, and autophagy. In case the
treatment was to be used in conjunction with viral infection, the cells were incubated with the
chemicals an hour before virus was added for adsorption for 2 hours. After this period, the
chemicals were added back to the media and the cells were incubated for the desired time period.
A list of chemicals used has been provided below.
Table 3: A list of chemicals used for treatment of cells

CHEMICAL

EFFECT

FINAL
CONCN.

ATM kinase inhibitor
(KU55933)
[Calbiochem#118500]
Torin 1
[Cell Signaling
Technology#14379]
Rapamycin
[Cell Signaling
Technology#9904]
Chloroquine

Blocks ATM kinase activity

5 µM

Induces autophagy

1 µM

Induces autophagy

50-100 nM

Blocks fusion of autophagosome and lysosome

50 µM

Wortmannin

Inhibits Phosphatidyl Inositol – 3 Kinases

50-100 nM

Salubrinal
[Santa Cruz
Biotechnology#sc202332]
Tunicamycin

Blocks eIF2 phosphorylation by PERK

3 µM

(S)-(+)-Camptothecin
(Sigma#C9911)

Inhibits type II Topoisomerase and induces 75 µM
apoptotic cell death

Induced global ER stress by blocking N- 3 µM
glycosylation of proteins
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7.3. ANALYSIS OF CELL DEATH (TRYPAN BLUE EXCLUSION ASSAY)
Ø Cells treated with toxins or infected with viruses and were analyzed for survival using trypan
blue exclusion [849, 850].
Ø Since dead cells would be floating in the media, the supernatant was collected before the
adherent cells were dissociated from the well by trypsin. After dissociation, the supernatant was
used to deactivate the trypsin and the entire solution was pooled together and the cells were spun
down at 1200 rpm for 10 minutes.
Ø The cell pellet was suspended in a small volume of media and 10 µL of the suspension was
mixed with an equal volume of 0.4% trypan blue solution (Thermo Fisher#15250061) and kept
at RT for 5 minutes.
Ø 10 µL of this solution was then added to the hemocytometer. Trypan blue is an impermeable dye
that can penetrate only the disintegrated membrane of a dead cell. Hence, only the dead cells
appeared blue under the microscope.
Ø Typically, we counted the number of cells (both live and dead) in all the four quadrants of a
hemocytometer. The total cell count and the percentage of dead cells were then calculated using
the following formula:
Total number of cells = (Number of cells counted in 4 quadrants*5000*dilution factor)
Dead cells = (Number of blue cells counted in 4 quadrants*5000*dilution factor)
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7.4. VIRUS GROWTH AND QUANTIFICATION

The following was generously shared by the

labs of Dr. Adolfo Garcia Sastre and Dr. Ana Fernandez Sesma (Mount Sinai Medical School,
New York): Dengue 2 serotype (strain: 16681/ TH36).

7.4.1.

GROWTH AND PROPAGATION

Ø Approximately 106 C6/36 or VeroE6 cells were plated in a T-75 flask one day before we
scheduled the infection. This would give us a culture that was 70-80% confluent at the time of
infection.
Ø After the cells had attached, the medium was removed and the cells were washed with the
Flavivirus Dilution Media (FDM) – 1X PBS with 0.2% Bovine Serum Albumin (BSA-Roche#10
735 078 001), Pen-Strep and Calcium-Magnesium mix. This dilution media (1X PBS/BSA)
facilitates the binding of the viral particles to the host cells.
Ø The appropriate volume of virus (we used m.o.i s of 1, 0.1, 0.01) was diluted in 2 ml of FDM and
added to the cells. The [virus was left for 1.5-2 hours at 33/37°C (C636/ VeroE6) with constant
shaking. If a shaker was not available we manually swirled the flasks every 15 minutes. Shaking
during the adsorption step ensures that the virus inoculum contacts as many cells as possible.
Ø After adsorption, 10 ml growth medium (with 2% FBS, P-S optional) was added to the initial
inoculum and the cells were left in the appropriate incubator for 6-7 days. The reduced serum
ensures a slow rate of cell proliferation and a more efficient binding of the virus. The former also
keeps the virus from being stressed due to over-confluence of host cells, given the fact that the
cells are stored for almost a week.
Ø The cells were kept under surveillance for signs of cytopathic effects (CPE) that do not usually
develop until 6-7 days into incubation. We considered that the amount of cell death should not
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25-30% for a culture from which we harvested virus. In case of the DEN2 16681, there should be
no detectable signs of CPE.
Ø The supernatant was collected from the flasks and pooled into a Falcon tube. The cells were
washed with the medium to collect any viral particles bound to the cells. This medium was
combined with the supernatant and the whole mix was centrifuged at 1000 rpm for 5 minutes
(4°C). The supernatant was collected in a fresh tube and aliquots (smaller volumes) were
prepared in sterile Eppendorf® (micro centrifuge) or cryovial tubes. 95% ethanol was added to
dry ice kept in a container meant to store in cryovial and held for 5 minutes. The aliquots of virus
were frozen on the dry ethanol (quick freeze) and then stored in the -80° C freezer.

7.4.2.

PURIFICATION/ CONCENTRATION

Under specific circumstances, we had to

maximize the yield of virus growth, e.g., when we had to grow the virus in Vero cells due to
unavailability of C6/36 or Vero-E6 and we could foresee a low yield.

Ø As in the usual harvest procedure, the supernatant was collected in a Falcon tube and combined
with medium used to wash the cells. The solution was centrifuged at 4120 rpm for 10 minutes.

Ø The supernatant was transferred to a fresh Falcon tube and kept on ice. 15 ml of the supernatant
was added to a 100 kDA-cutoff Amicon filter tube (Fisher Scientific# UFC9-100-096) so that the
supernatant sits on top of the filter. Each filter can be used twice. The tubes were then
centrifuged at 4120 rpm for 35-45 minutes at 4° C.
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Ø The supernatant on top of the filter consists of the concentrated stock of virus. Using a P-200
pipette, the concentrate was transferred to a fresh cryovial/micro centrifuge (re-centrifuged) and
the flow-through was discarded.

Ø These steps were repeated for another 15 ml of supernatant and the sequence was repeated until
we had filtered the entire supernatant obtained from the cells. Aliquots containing appropriate
volume of the concentrated stocks were then stored in the -80° C freezer.

7.4.3.

§

ANALYSIS OF VIRAL PROPAGATION

Plaque assay We followed the basic steps of traditional plaque assay method (as described here
[851]) to quantify and determine the titer of the virus stock grown in the insect (C6/36) and
mammalian (VeroE6) cells. When needed, minor modifications were introduced depending on
the nature of the virus and their cytopathic effects on the cell lines used.

Ø Approximately 2.5-3x105 BHK21 were plated in each well of a 12-well plate and left to attach
overnight. While plating, the cells were dispensed at the center of the well and the plate was
swirled gently. This was done in order to ensure that the cells formed a monolayer the following
day at the time of infection.
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Ø Serial dilutions were made from the viral stock that had to be titered. The serial dilutions were
performed in -/- media13 (without FBS, P-S). About 200-250 µl of each dilution (as well as the
undiluted viral stock) were added to the corresponding wells containing the monolayer.
Ø The plates were incubated at 37°C for 1.5-2 hours with occasional shaking (they were swirled
every 15-20 minutes). The cells were then covered with an agarose overlay (made of 50% Low
Melting Point Agarose/ Fisher # BMA 50100, 45% 2X MEM/ Invitrogen # 11935046, 5% FBS).
The overlay was allowed to solidify inside the biosafety cabinet and incubated at 37° C for 6-7
days.
Ø The overlay was gently removed after adding a few drops of warm tap water. The cells were then
incubated with 1% crystal violet solution in 30% ethanol for approximately 20 minutes at room
temperature. The plates were then thoroughly but gently washed with tap water and were then
counted for plaques.

7.5. QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR)

7.5.1.

PRIMER DESIGN We designed primers for analysis of transcription of a target gene

on the cDNA. Hence, we had to choose a pair of primers that would amplify a cDNA segment,
which is between 150-200 bp in length. The following steps were performed in silico to design a
pair of primers for a target gene. Occasionally, we would obtain predesigned primer sequences
from a collaborator or a peer-reviewed research article.

13

We have indicated the media as being “-/-“ if it did not contain FBS and P-S. It is also referred
to as “naïve” media.
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The transcript sequence of the target gene was retrieved from the GENE database of the
National Center for Biotechnology Information (NCBI) website. Since we designed cDNAspecific primers, we needed the transcript sequence of the target gene and thus we selected the
GenBank option.

We used Primer3 (http://bioinfo.ut.ee/primer3/) to design the primers for qPCR. The fasta
sequence of the transcript was imported into the Primer3 sequence window. Then conditions like
primer size (usually 18-22 bases), melting temperature (Tm), GC content and selfcomplementarity were set according to the general requirements of real time PCR, e.g., Tm
(usually 55-60°C) difference between forward and reverse primers were restricted to a few
degrees. The software was then instructed to pick up the best pair that met our requirements.
Alternatively, we also used the ApE software to design cDNA-specific primers for qPCR. This
platform enabled us to scan the entire mRNA/CDS to pick up a specific pair of primers
amplifying a segment not longer than 200 bp.

7.5.2.

RNA EXTRACTION

Total RNA was extracted from cells using the RNeasy mini

kit (QIAGEN14#74104). The cells were trypsinized after the desired treatment/ time period and
cell pellet was obtained. The pellet was either stored at -80°C or immediately used for RNA
extraction. We followed the protocol prescribed by the manufacturer to extract total RNA from
these samples.

14

Address: 19300 Germantown Road, Germantown, MD 20874
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7.5.3.

ANALYSIS AND QUANTIFICATION

The RNA thus extracted was analyzed using

the Nano Drop Lite Spectrophotometer (Thermo Scientific). Apart from the concentration of
RNA relative to a blank solution (RNase-free water), the device also measures the absorbance of
light at 260nm and 280nm. We could thus look at the value of A260/A280 and evaluate the purity
of the RNA sample. A ratio of ~2 is considered a pure RNA sample.
Ø In order to complement and verify the Nano Drop data, we analyzed our RNA samples on
Agarose gel and looked for 28S and 18S rRNA bands.
Ø We set up the gel by pouring a solution containing 1.5% Agarose, prepared in 1X MOPSformaldehyde buffer (see REAGENTS). Once the Agarose powder was added to the buffer, the
solution was boiled in microwave.
Ø For visualization of RNA on the gel: After it had cooled down to 60°C, the intercalating
reagent Ethidium Bromide (EtBr) was used at a final concentration of 0.5µg/ ml in the Agarose
solution. It was then poured into the casting tray.
Ø All the solutions for this experiment were prepared in DEPC (diethylpyrocarbonate)-treated
water (Invitrogen#46-2224). Once gel had solidified, it was covered by 1X MOPS buffer (no
formaldehyde).
Ø To prepare the samples, 5µg RNA was transferred to an RNase-free tube and volume was made
up to 6µl by DEPC-treated water.
Ø The following mix was then added to this tube: 10 µL Formamide, 4 µL Formaldehyde, 2 µL
10X MOPS and 1 µL bromophenol blue (6X loading dye).
Ø The solution was heated at 65°C for 10 minutes, cooled on ice and spun briefly. They were put
back on ice and loaded quickly. Care was taken so that the samples were loaded within an hour
of the gel solidifying, so as to preclude the dilution of formaldehyde in the gel.
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Ø Once loaded, the gel was run for at least ten minutes at 5V/cm in 1X MOPS buffer. As soon as
the samples had entered the wells, voltage was increased and the gel let to run until the dye had
migrated about 2/3-3/4 of the total length of the gel.
Ø After the run had finished, the gel was kept on a Gel-Doc platform and exposed to UV rays. A
clean RNA sample would give two bands for 28S and 18S rRNA (in a roughly 2:1 density ratio).
7.5.4.

cDNA PREPARATION/ REAL TIME qPCR

The total RNA was converted to

complementary DNA (cDNA) to be used for quantitative PCR (qPCR). To this end, we used the
Power SYBR Green RT to Ct 1-step kit (Applied Biosystems15#4391178) that enabled us to
perform Reverse Transcription16 and real time PCR17 in the same tube. The manufacturer’s
protocol was followed to carry out these reactions. Due to the high sensitivity of these reagents,
we only used 100ng of RNA and 100 to 200nM of the primers per reaction. Triplicates were run
for each condition. All the samples and reagents were kept on ice throughout the preparation
process to prevent degradation. The final reaction was carried out on a MicroAmp® Fast
Optical 48-well reaction plate (PN 4375816) in a Step One Real Time PCR (Applied
Biosystems). The following components were provided by the manufacturer in the kit.
Power SYBR Green RT-PCR Mix (2X)
SYBR Green I dye,
AmpliTaq Gold® DNA polymerase (ultrapure)
dNTPs (dATP, dCTP, dGTP, dTTP, and dUTP)
PCR buffer
RT enzyme mix (125 X)
15

Address: 850 Lincoln Center Drive, Foster City, CA 94404
A reaction to make cDNA from total RNA, that involves the reverse transcriptase enzyme
17
Quantification of target gene transcripts using the fluorescent SYBR green dye
16
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Array Script™ UP Reverse Transcriptase
RNase inhibitor
While analyzing the results on the Step One software, the Comparative CT mode was
selected, as it is suitable for the high-throughput measurement of relative gene expression in
multiple samples. Each reaction had an endogenous control (ß-Actin) that served as reference for
the target genes. In most cases, unless otherwise specified, the mock-treated or mock-infected
samples were chosen as the Reference sample.
7.5.5.

PRIMERS USED
Target
Forward primer (5’-3’)

Reverse primer (5’-3’)

ß-ACTIN

GTCCACCTTCCAGCAAATGT

AAAGCCATGCCAATCTCATC

ATF4

GCGTTGCTGTAACCGACAAA

TCAGGAAGCTCATTTCGGTCA

GADD34

CCAGAAACCCCTACTCATGAT

CCAATTGTTCATGCTTGGTG

NS4A

CGCACTGGACAACTTAGCAG

CGTGACTGTAGCCAGAAGTGTC

CHOP

CAGAACCAGCAGAGGTCACA

CCAATTGTTCATGCTTGGTG

7.6. ANALYSIS OF PROTEIN EXPRESSION IN MAMMALIAN CELLS
7.6.1.

EXTRACTION AND QUANTIFICATION OF PROTEINS

Ø EXTRACTION

Cells were washed with ice-cold 1x PBS after they had been treated and

infected. The cells (in flask or plates) were placed on ice while being treated for protein
extraction.
•

After PBS wash, the cells were treated with ice-cold Radio Immuno Precipitation (RIPA) buffer
(see REAGENTS) and a cold plastic cell scraper was used to detach the adherent cells.
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•

The RIPA and the detached cells were collected in a cold centrifuge tube and incubated on a
shaker at 4° C for 30 minutes. The lysate was centrifuged at (~13,000 rpm18) for 15-20 minutes.
The supernatant was collected in a fresh cold centrifuge tube and stored as aliquots in -20°C.

Ø QUANTIFICATION

The proteins, thus extracted, were then quantified using the Bio-

Rad protein assay dye reagent concentrate (Bio-Rad#5000006). This solution is a based upon the
Bradford technique for quantifying solubilized protein.
•

The dye solution was prepared by mixing 1 part of the concentrate with 4 parts of deionized
water. 1 ml of this solution was dispensed into centrifuge tubes. The standards and the test
samples were added to this solution.

•

Bovine Serum Albumin (BSA) was used as the standard sample. 0, 1, 5, 10, 15, 20, 25 µg/ ml of
BSA were used as standards. A 1mg/ml stock solution of BSA was used to prepare the standards
and the test protein samples were added to the diluted dye in a proportion of 1:1000.

•

The solutions were left at room temperature for not more than 45 minutes. Absorbance was then
measured at 595 nm using a spectrophotometer.

•

The relative concentrations of the samples were determined using the concentrations of the BSA
standards. Calculations were made for volumes needed to load 20-30 µg of the samples on an
SDS-PAGE gel.

7.6.2.
•

SDS-PAGE

Sodium Dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was used to separate
proteins in a cell on the basis of their molecular mass (in kD). The resolving gel (see
REAGENTS section for the composition) was used to separate the proteins on basis of their

18

Revolutions per minute.
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molecular mass. The anionic detergent SDS, which binds to all the proteins present in the lysates,
rendering them heavily negatively charged, neutralized the net charge on the different amino
acids.
•

Depending on the size of our target protein, the percentage of acrylamide was modified in the
resolving gel and that determined the pattern of resolution of proteins and the time required to
complete the run, e.g., a resolving gel with a higher percentage of acrylamide would take longer
time for the maximum resolution of protein samples. Given below is a chart (from
www.abcam.com) that was used to prepare resolving gel according to our experiment.

•

The resolving gel was poured into glass plates, separated by a spacer (1 or 1.5 mm wide). Three
quarters of the area between the glass plates was filled with resolving gel and isobutanol was
poured on top to prevent auto oxidation of the gel. Once the resolving gel had solidified the
isobutanol was discarded and stacking gel (see REAGENTS section for composition) was
poured on top of resolving gel. A plastic comb with 10/12 wells was immediately inserted into
the stacking gel. These wells were eventually used to load the samples.

•

The following guideline (Table 4) was consulted to prepare resolving gels for target proteins of
different sizes.
Table 4: A guide for choosing the percentage of PAGE, according to the size of the protein
PROTEIN SIZE (in kDA)

ACRYLAMIDE PERCENTAGE

4-40

20

12-45

15

10-70

12.5

15-100

10

25-200

8
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•

Samples were prepared as described in Datan et al and loaded on to the gel [10]. Typically, the
gel was run at a low voltage (60V) while the samples were in the stacking gel and the voltage
was increased to 100V when samples left the stacking gel. In order to track protein migration, 5
uL of a pre-stained (GE19#RPN800E) protein marker was loaded along with the samples.

•

After

the

run

was

over,

the

gel

was

stained

with

Coomassie

Brilliant

Blue

(ThermoFisher#20278) for determination of total protein content. Typically, the gel was
submerged in the stain solution (see REAGENTS section for composition) and heated in a
microwave (regular setting) for 10 seconds. This helps the gel to swell and this is essential for
the stain to diffuse to the proteins. The gel was then kept in the stain at room temperature with
constant shaking for 30 minutes. Excess stain was removed by successive washes with the
destainer (see REAGENTS). Generally, an overnight destaining was required in most cases to
clearly see the individual protein bands.
7.6.3.

WESTERN BLOTTING

For Western blotting or immunoblotting gel were was

removed from the glass plates and was kept inside a sandwich, pre-soaked in 1X transfer buffer
(see REAGENTS), composed of two sponges with filter papers between them and next to the gel
[10].
§

Once the gel had been carefully positioned between the filter papers, one of the filter papers was
removed and replaced after the wet nitrocellulose had been placed on the gel. If the target protein
was 100kDa or less, a 0.2 µm (Bio-Rad20#1620112) pore size membrane was used; for larger
proteins, a 0.45 µm (Bio-Rad #1620115) pore size membrane was used.

19
20

Address: Chicago, Illinois, USA
Address: Alfred Nobel Drive, Hercules, California 94547
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§

The sandwich was then placed inside a cassette and kept in enough 1X transfer buffer so that
the entire surface of the sandwich was submerged Since negatively charged proteins would be
transferred from the gel to the membrane, the membrane was kept facing the positive electrode.

§

After the assembly was complete, a glass rod was rubbed along the length of the sandwich, in
order to squeeze out any bubbles trapped between the gel and the filter papers.

§

The electrophoresis-mediated transfer was carried out at low voltage (typically 23-35V) for 1216 hours.

§

After the transfer was over, the membrane was washed with 1X TBST solution and then stained
with Ponceau Red (see REAGENTS) for checking the efficiency of transfer. Ideally, there
wouldn’t be any trace of the prestained marker on the gel and all the colors would have
transferred to the membrane. Unlike Coomassie, Ponceau binds reversibly to the proteins on the
membrane and hence can be washed off after the red bands have been visualized on the
membrane.

§

The membrane was then kept in a “blocking buffer”– usually 5% bovine serum albumin (BSACell Signaling technology#9998) or non-fat dry milk (Biorad#1706404XTU) in 1X TBST- at RT
for 1-2 hours or overnight at 4° C. BSA was preferred over milk if the target was a
phosphoprotein, as the endogenous casein of milk is highly phosphorylated and thus usually
interferes with the signal. The milk or BSA binds to proteins and prevents the primary antibodies
from binding to non-target proteins, but is competitively driven off by the antibodies to the target
proteins.

§

The blocking buffer was discarded and the membrane was washed with 1X TBST 3 times for 5
minutes. The membrane was then kept in primary antibody (diluted in 1X TBST) at 4° C for 14-
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18 hours. We usually used the dilution of the antibody specified by the manufacturer. A list of
primary antibodies used has been appended at the end of this section.
§

Excess primary antibody was washed off by 1X TBST (3 times/5 minutes) and secondary
antibody was added to the membrane. The secondary antibodies used depended on the species in
which the primaries were raised, e.g., if the primary had been raised in rabbit, an anti-rabbit
secondary was used. Regardless of the origin of the secondary, all had a hydrogen peroxidase
conjugate that would later on react with the ECL substrate. The membrane was incubated with
the secondary antibody for 1-2 hours at RT. The membrane was then washed with 1X TBST (3
times/5 minutes).

§

The membrane was then developed for color detection. The Signal Fire Plus ECL reagent (Cell
Signaling 21 #12630) was used as the substrate for the HRP conjugated to the secondary
antibodies. After the substrate was incubated for one minute, a hyper film ECL photo
radiographic film (28906835, GE Healthcare) was placed atop the membrane inside an
autoradiography cassette and was kept in the dark for 5-15 minutes.

§

Detection of silver deposition (exposure) on the film was observed by successive washes with
GBX developer/replenisher (Sigma#P7042) and GBX fixer/replenisher (Sigma#P7167).

§

Quantification of Signals

The NIH software Image J was used to perform the densitometry

analysis of the bands obtained on an X-ray film. The film was scanned and saved (.tiff/ 600dpi).
The file was saved in a safe location and a copy was opened on Adobe Photoshop – the file type
was changed (.tiff to .jpeg) and the mode was changed to GRAYSCALE. The new file was
opened on Image J and the density of each band was measured using the following commands:
ANALYZE -> SET MEASUREMENTS -> GREY MEAN VALUE. A Region of Interest (ROI) was
21

Address: Global headquarters (U.S.A) – 3 Trask Lane, Danvers, MA 01923
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selected for each row of proteins – it is the smallest area that covers the largest band in that row.
The frame is saved and used to measure all the bands in that row as well as the background
(simply by placing the frame outside the band) – this process is repeated for all the rows and the
values are exported to a spreadsheet file. The inverted pixel value of each band (band/
background) was calculated by subtracting the values obtained from 255. The net inverted pixel
value for each protein was then calculated by subtracting the values of background from the
band. The ratio of the target protein expression, relative to the loading control, was then plotted
in the form of an excel chart/ graph.
7.6.4.

IMMUNOFLUORESCENCE

Immunofluorescence is a useful tool to monitor

localization and expression of proteins inside the cell; we used it to study protein expression in
infected cells.
§

Cells were plated on coverslips and allowed to attach overnight before being treated and or
infected. The supernatant was next discarded and cells were washed with 1X PBS (see
REAGENTS) 2-3 times. The cells were fixed in 4% paraformaldehyde (PFA/pH 7.4) for 10-15
minutes at room temperature. After fixation, cells were washed with 1X PBS.

§

Since all the proteins we examined were intracellular proteins, we used 0.1-0.25% Triton-X–100
(in 1X PBS) to permeabilize the cells. This step is necessary to ensure that the primary
antibodies can access their target proteins. After 10 minutes of permeabilization, samples were
washed 3 times with 1X PBS and were stored in the blocking buffer for one hour at RT.

§

The cells were then incubated in the primary antibody (diluted in the blocking buffer) at 4° C
overnight. As in western blotting, we initially used the dilution specified by the manufacturer but
often adjusted it to improve visualization.
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§

1X PBS washed off excess primary antibodies and the appropriate secondary antibody (diluted in
blocking buffer) was added.

§

We used secondary antibodies that differed from the ones used for western. These antibodies had
Alexa Fluor conjugates (488/Green, 555/Red), which would absorb and emit fluorescent signals
that were detectable under the microscope. For this reason, samples were incubated in the
secondary antibody solution for 1-2 hours at RT in the dark.

§

The coverslips were then washed with 1X PBS (3 times/5 minutes each) and were treated with a
nuclear dye like DAPI22 or Hoechst (Thermo Fisher#H3570) for 10-15 minutes in the dark.
These nuclear stains served as counterstains.

§

Excess stain was washed off by PBS washes and the coverslips were mounted upon slides using
a Fluor mount medium (Sigmsa#F4680). Once the mounting medium had dried, the coverslips
were sealed with nail polish to prevent dehydration of the cells.

§

The slides were then analyzed for fluorescence signals using the Zeiss23 Apotome or Leica24
confocal laser-scanning microscope.

§

Quantification of Signals

The NIH software Image J was used to quantify the intensity of

fluorescence in the cells. The images captured under the microscope were opened on Image J and
each cell was selected, mostly using the FREEFORM SELECTION TOOL. The fluorescence in
each cell was measured using the commands: ANALYZE -> SET MEASUREMENTS -> check
AREA, INTEGRATED DENSITY, And MEAN VALUE. Selecting regions outside the cells and
running the same commands also measured the background noise. Once these values had been
22

A blue fluorescent stain that binds strongly to the A-T rich regions in DNA. [IUPAC ID: 2-(4amidinophenyl)-1H -indole-6-carboxamidine]
23
Carl Zeiss Microscopy LLC (One Zeiss Drive, Thornwood, NY 10594, USA)
24
Leica Microsystems Inc. (1700 Leider Lane, Buffalo Grove, IL 60089, USA)
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exported to an excel spreadsheet, the Corrected Total Cell Fluorescence was calculated using the
formula: CTCF = Integrated density – (Area of selected cell – mean fluorescence of background
reading). The values were then plotted in a chart.

7.6.5.

LIST OF ANTIBODIES USED
CATALOG

NAME

ISOTYPE

APPLICATION

Sigma-Aldrich
# L7543

LC3B

Rabbit

Cell Signaling
Technology
# 12741

LC3A/B
(D3U4C) XP®

Rabbit

Sigma-Aldrich
# A3853

Actin

Mouse

Cell Signaling
Technology
# 5883
Cell Signaling
Technology
# 12238

Phospho-ATM
(Ser1981)

Rabbit

Western Blotting
1:500–1:1000
Immunofluorescence
1:100 – 1:200
Western Blotting
1:1000
Immunofluorescence
1:100
Western Blotting
1:3000
Immunofluorescence
1:75-1:150
Western-Blotting
1:1000

Calreticulin

Rabbit

Abcam
# ab56416

P62

Mouse

Cell Signaling
Technology
# 7695
Sigma-Aldrich
# T6074

P62

Rabbit

α-Tubulin

Mouse

Western Blotting
1:4000-1:8000
Immunofluorescence
1:2000-1:4000

EMD Millipore
#06-597

Phospho Histone Rabbit
H1

Western Blotting
1:1000
Immunofluorescence
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Western Blotting
1:1000
Immunofluorescence
1:400
Western Blotting
1:100-1:500
Immunofluorescence
1:50
Immunofluorescence
1:100

1:200
Sigma-Aldrich
# T5293
Thermo Fisher
#A21422

β-Tubulin

Mouse
Mouse MAb

Cell Signaling
Technology
#7074

Goat anti-Mouse
IgG
(H+L)
Cross-Adsorbed
Secondary
Antibody, Alexa
Fluor 555
Goat anti-Mouse
IgG
(H+L)
Superclonal™
Secondary
Antibody, Alexa
Fluor 488
Donkey
antiMouse
IgG
(H+L) Highly
CrossAdsorbed
Secondary
Antibody, Alexa
Fluor 555
Anti-rabbit IgG,
HRP-linked
antibody

Rabbit

Western Blotting
1:1000-1:3000

Cell Signaling
Technology
#7076

Anti-mouse IgG, Mouse
HRP-linked
antibody

Western Blotting
1:1000-1:3000

Thermo Fisher
#A28175

Thermo Fisher
#A31570

Immunofluorescence
1:1000
Immunofluorescence
1:1000

Mouse MAb
Immunofluorescence
1:1000

Mouse MAb
Immunofluorescence
1:200-1:2000
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7.7. REAGENTS

Ø 10X MOPS (1L)
o 41g MOPS
o 6.8g Sodium Acetate (M.W. 136.08)
o 20mL 0.5M EDTA
o 800mL dH2O
§

pH adjusted to 7 with NaOH and volume adjusted to a liter

Ø RESOLVING GEL (15mL)
o 30% acrylamide/bis-acrylamide – 0.5 X ml (X = final%)
o 1.5M Tris-HCl (pH 8.8) – 3.75mL
o 10%SDS – 150 µL
o TEMED – 7.5 µL
o 10% APS – 75 µL
§

Volume adjusted to 15mL with distilled water

Ø 4% STACKING GEL (15mL)
o 30% acrylamide/bis-acrylamide – 1.98 ml
o 0.5M Tris-HCl (pH 6.8) – 3.78mL
o 10%SDS – 150 µL
o TEMED – 15 µL
o 10% APS – 75 µL
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§

Volume adjusted to 15mL with distilled water

Ø PAGE RUNNING BUFFER
o 25mM Tris base
o 190mM Glycine
o 0.1% SDS (pH expected to be around 8.3)

Ø COOMASIE BRILLIANT BLUE (1L)
o 2.5g Coomassie Brilliant Blue R-250
o 400mL distilled water
o 100mL Acetic Acid
o 500mL Methanol

Ø DESTAINER (1L)
o 675mL distilled water
o 75mL Acetic Acid
o 250mL Methanol

Ø Ponceau Red stock
o 2% Ponceau S dissolved in 30% trichloroacetic acid and 30% sulfosalicylic acid
o For staining proteins on the membrane, the stock was diluted 1:10

Ø 10X PBS (phosphate buffer saline)
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o 25.6 g Na2HPO4·7H2O
o 80 g NaCl
o 2 g KCl
o 2 g KH2PO4
o Volume adjusted to 1 liter with H2O.

Ø 10X TBS (tris buffer saline)
o 24.23g Trizma HCl
o 80.06g NaCl
o 800 ml ultrapure water
§

pH adjusted to 7.6 using pure HCl – volume adjusted to 1L

Ø Transfer Buffer
o 48mM Tris
o 39mM Glycine
o 0.04% SDS (may be increased to 0.1% for larger proteins >100kD)
o 20% Methanol (10% for larger proteins >100kD)

Ø Flavivirus dilution media
o 50 mL autoclaved 1X PBS
o 3mL of filter-sterilized 35% BSA
o 5mL of autoclaved 1X Calcium-magnesium mix
o 5mL of 100x Pen-Strep mix
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o 437 mL autoclaved distilled water

Ø RIPA buffer
o 10mM Tris (pH 7.4)
o 150mM NaCl
o 1% Triton X100
o 1% deoxycholate
o 0.1% sodium dodecyl sulfate (SDS)
o 5mM EDTA
o Pierce (A32959) protease and phosphatase inhibitor mini tablets (1 tablet added to 10mL buffer)
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8. RESULTS

8.1. INDUCTION OF ENDOPLASMIC RETICULUM STRESS, ESPECIALLY PERK
PATHWAY, SUPPORTS INCREASED PRODUCTION OF DENGUE-2 VIRUS

8.1.1.

DENGUE-2 ACTIVATES CALRETICULIN IN MDCK CELLS, INVOLVING

THE PERK PATHWAY

As explained above, ER-tropic flaviviruses like Dengue-2 can

change the conformation of the endoplasmic reticulum and thus can potentially disrupt its
function. This disruption can serve as a major trigger for stress pathways, especially the unfolded
protein response (UPR). We verified if such disruption holds true for Dengue-2 infected MDCK
cells, the primary model that was used for our previous study [652]. As a positive control for this
study, we used 3 µM tunicamycin (TM), a chemical regulator that induces ER stress by
inhibiting protein N-glycosylation. As described in Materials and Methods, 106 MDCK cells
were plated and allowed to attach overnight. Cells were treated with 3 µM tunicamycin or
infected with Dengue-2 at multiplicity of infection (m. o. i.) of 5. After 24 hours of infection or
treatment, cells were lysed; proteins were extracted and analyzed by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting. β-Actin was used as
control for protein load and Calreticulin (CRT) was used as the marker for induction of ER
stress. The expression of CRT was compared among the different conditions, relative to actin
expression (Figure 5 Cal-Actin ratio). Tunicamycin treatment increased CRT expression more
than 3-fold (Figure 5 Cal-Actin ratio: 3.3) that of mock-treated cells (Figure 5 Cal-Actin ratio:
defined as 1), whereas Dengue-2 infection (Figure 5 Cal-Actin ratio: 2.4) resulted in a 2.4-fold
increase. The ratios (Cal-Actin) presented here are mean values of the ratios obtained from three
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different western blot experiments. The picture shown here is a representative image of all three
blots. Our finding indicates an activation of CRT by Dengue 2 to a level close to that of
tunicamycin, suggesting activation of ER stress.

Having established the induction of ER stress in infected cells, we examined the specific
branch of ER pathways that would lead to this activation by the virus. We began by examining
PERK pathway. To this end, we used 3 µM salubrinal (Sal), a chemical inhibitor of ER stress
that blocks the dephosphorylation of the elongation initiation factor (eIF2α) initially
phosphorylated by the PERK pathway [544]. We found, by the use of western blot, that Sal had
little impact on the CRT expression of uninfected cells (Figure 5 Salubrinal: Mock = 1.1:1).
However, Sal severely suppressed the activation of CRT caused by Dengue-2, from 2.4 to 0.5fold (Figure 5 Dengue-2 and Deng2 + Salubrinal, respectively). As expected, SAL addition to
TM-treated cells partially suppressed the expression of CRT from 3.3 to 2.3-fold (Figure 5
Tunicamycin and Tunica + Salubrinal, respectively). Since the inhibition of CRT expression
was more specific in Dengue-2 infected cells compared to TM-treated, we conclude that
infection causes ER stress through the PERK pathway, whereas the stress created by TM
involves other pathways as well, or that the stress created by TM is overwhelming or nearly
irreversible.

Having established that the PERK pathway is activated by Dengue-2, we examined the activity
of the downstream targets of PERK and how this pathway might affect viral production [10].
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8.1.2.

THE DOWNSTREAM TARGETS OF PERK PATHWAY, ARE ACTIVATED BY

INFECTION To substantiate the involvement of the PERK pathway we examined the
transcription of its downstream substrates like Activating Transcription Factor 4 (ATF4) and
Protein phosphatase 1 regulatory subunit 15A (GADD34). MDCK cells were infected with
Dengue-2 (m. o. i. = 5) for 12 and 24 hours. After the desired time, total RNA was isolated and
cDNA-specific primers were used to quantify gene expression by quantitative polymerase chain
reaction (qPCR). All qPCR experiments were normalized against β-actin as an endogenous
control. In this context, it must be noted that although the levels of actin varied from run to run,
there were no significant differences among experimental groups. Each cDNA/ transcript level
was normalized to the actin level for that specific experiment.

Mock infected (Figure 6 Mock) and Dengue-2 infected (Figure 6 Dengue) MDCK cells were
probed for β-actin expression using a cDNA-specific primer. No significant variation was
observed between the mock and infected samples after either 12 or 24 hours of infection. The
expression of target genes was therefore calculated relative to actin expression for each
condition. The fold change in expression between mock and infected cells was then calculated
using the 2-ddCt method as has been described by Li et al [852] as well as in Materials and
Methods.

There was a significant increase of ATF4 transcription in infected MDCK cells relative to
Mock infected after 12 hours (Figure 7 DEN2, Mock); this activation disappeared with the 24
hours post infection although the cells remained similar in morphology to that of the mock-
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infected. Thus, ATF4 activation (>40-fold change after 12 hours) is a relatively early and
transient event during dengue infection.

We also examined the transcription of GADD34 in infected MDCK cells. As described in the
introduction, GADD34 activation is a downstream effect of PERK activation via ATF4
translocation to the nucleus. Consistent with our findings with regard to ATF4, we see an even
stronger upregulation of GADD34 expression in infected MDCK cells (Figure 8 Den, Mock)
after 12 hours (>200-fold change) compared to the mock-infected cell. This difference gradually
abated (<10-fold change) by 24 hours post infection. This supports our previous data (Figure 5
Deng2+Salubrinal) where blocking the GADD34 activity by Sal sharply diminished the
expression of Calreticulin [10].

To avoid confusion, we have presented the ATF4 and GADD34 data, both as normalized over
β-actin as well as datasets without any normalization (Figures 6, 7). In the former case, we have
also added charts plotting the relative Ct values of each target gene, after subtracting the Ct
values of Actin. These graphs also contain the fold change values that have been calculated
relative to Actin (using the formula mentioned above). In case of the latter, we have added a
scale for relative RNA corresponding to threshold cycle (Ct) value. This method of evaluation
has been adopted for all the following qPCR data.

8.1.3.

PERK AFFECTS PRODUCTION OF VIRUS

Having established the activation of

PERK during dengue infection, we explored the relationship between the PERK pathway and
production of virus by first examining the transcription of viral NS4A gene after inhibition of the
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PERK pathway with Sal. Again, we used the expression of actin gene as internal control. We
examined three different conditions: mock-infection (Figure 9 Mock), infection (Figure 9 DEN),
and infection of cells pretreated with 3 µM Salubrinal (Figure 9 DEN-SAL). Fold change was
then determined as described above and in Materials and Methods [852].

NS4A transcription, relative to β-Actin, increased after infection with Dengue-2 alone and
plummeted in infected cells pretreated with Sal (<250-fold change over mock-infected) when
compared to infected cells (>600-fold change over mock-infected). Thus, we demonstrated that
dengue replication depends on PERK activity. As in the previous data, we have presented the
expression of NS4A, both as normalized over β-actin as well as individual datasets that were not
normalized (Figure 9). Fold changes have been shown in the graphs where the relative NS4A Ct
values were plotted, after subtracting the corresponding Actin Ct values. It must be noted that
since this was a different experiment, we had a different Actin dataset and this was considered
while calculations were performed to obtain the NS4A fold change (Figure 9).

We next verified this result by examining viral titer in infected cells. We did not use chemical
inhibitors like Sal for this study since these agents rarely inhibit a single molecule or pathway.
Instead, we examined the production of mature virions in infected PERK wild type (+/+) and
PERK knockout (-/-) mouse embryonic fibroblasts, employing the traditional plaque assay (see
Materials and Methods). In PERK -/- cells, the number of infective plaque forming units was
reduced to 16% (~2100 pfu) of that in infected +/+ (~13500 pfu) cells after 48 hours (Figure 10).
The PERK pathway was thus demonstrated to play an important role in viral maturation and
production in MEF cells [10].
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8.1.4.

PERK ENSURES PROTECTION OF INFECTED CELLS AGAINST TOXIC

COMPOUNDS

As reported in our previous study [652], infection increases survival of

MDCK cells exposed to camptothecin25 (CPT). Having established that PERK pathway supports
viral replication, we examined the relation between PERK and survival of infected cells. As in
the previous experiments, we used Sal pretreatment (Figure 11) to block the effects of PERK
pathway in mock (Figure 11 Salubrinal), infected (Figure 11 Dengue + Salubrinal) and CPTtreated (Figure 11 CPT + D2 + Sal) MDCK cells; appropriate controls (Figure 11 Mock,
Dengue, CPT + Deng) were used for each condition. Cell death was then quantified as described
in Materials and Methods.

Infected cells pretreated with Sal (Figure 11 CPT + D2 + Sal) showed a significant increase in
cell death due to CPT-toxicity, when compared to CPT-treated infected cells (Figure 11 CPT +
Deng). There was an upsurge in cell death from ~30% in CPT-treated infected cells, to ~85% in
Sal /CPT-treated infected cells (Figure 11 CPT + Deng, CPT + D2 + Sal). Overall health of the
infected cells was significantly better (Figure 11 CPT + Deng), as compared to CPT-treated
(Figure 11 CPT) and Sal /CPT treated cells (Figure 11 CPT + Sal), thus validating our previous
data. But it is noteworthy that regardless of infection, Sal itself (Figure 11 CPT + Sal) is
debilitating to cells already treated with CPT, an effect that was not neutralized by infection
(Figure 11 CPT+D2+Sal).

25

A topoisomerase type II inhibitor that induces apoptosis
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We further substantiated the importance of the PERK pathway in protecting cells by using
PERK knockout cells. Cell death was registered in mock (Figure 12 PERK +/+ MOCK and
PERK -/- MOCK), infected (DEN2), CPT-treated (CPT) and CPT-treated/infected (Figure 12
CPT DEN2) in both PERK+/+ and PERK+/+ cells. As the PERK pathway was totally abolished
using knockout, the protective ability of DENV against CPT also decreased significantly (Figure
12 PERK+/+ CPT DEN2, PERK-/- CPT DEN2). The infection by Dengue-2 increases the cell
survival in PERK +/+ and this protection is abolished in PERK -/- cells but not to the same
degree as MDCK cells treated with Sal.
The protective effect in PERK+/+ cells, albeit significant, is not as strong as in Sal-treated
MDCK cells. This result can probably be attributed to the non-specificity of chemical inhibition
compared to genetic knockout, as well as variation in susceptibility towards CPT between
MDCK (Figure 11 CPT - ~40% death) and MEF (Figure 12 PERK+/+ CPT - ~80% death) cells.
It must be noted that in the absence of either the virus (PERK +/+ and PERK -/-, CPT) or of
CPT (PERK +/+ and PERK -/-, DEN2), amounts of cell death were quite uniform, thereby
eliminating the argument that an external factor could explain the ability of the PERK pathway
to protect infected cells [10].

8.2. PERK REGULATES AUTOPHAGOSOME FORMATION AND AUTOPHAGIC FLUX
IN INFECTED CELLS

8.2.1.

RELATION BETWEEN PERK AND AUTOPHAGOSOME FORMATION IN

INFECTED CELLS In our previous study we had established that dengue infection does not
kill cells but rather protects them by inducing autophagy [652]. In the current study, we
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established that dengue infection activates the ER stress related PERK pathway. Here we ask the
next question: what is the relation between the induction of autophagy and activation of PERK
pathway during Dengue-2 infection?

We measured the rate of LC3 lipidation (LC3II formation) in PERK KO and WT MEF cells
infected for 24 hours with Dengue-2 (Figure 13 LC3I, LC3II). WT and KO MEF cells were
infected with Dengue-2 for 24 hours and were lysed for protein extraction. Proteins were
analyzed using western blotting (see Materials and Methods). The membrane was then probed
using specific antibodies for LC3I/II and ß-tubulin (loading control). After the bands were
developed on a film, a densitometry analysis was performed using ImageJ. The ratio of LC3I,
LC3II, and total LC3 were calculated relative to tubulin (Figure 13 table).

According to our data, infection in the PERK knockout cells resulted in higher LC3II
lipidation, compared to mock-infected PERK KO (Figure 13 PERK -/- MOCK, DEN2). The rate
of LC3-PE conjugation (lipidation) was also higher than that of infected and mock WT cells
(Figure 13 PERK +/+ Mock, DEN2). There was a mild increase (24%) in the LC3II/I ratio in the
mock-infected PERK-/-, compared to the mock-infected PERK+/+. Dengue-2 infection of
PERK+/+ cells led to a mild increase (36%) in the LC3II/LC3I ratio, compared to mock-infected
cells (Figure 13 PERK+/+ Mock, PERK+/+ DEN2). In contrast, infected PERK -/- cells
displayed a roughly two-fold increase (93%) in LC3 lipidation, compared to the mock-infected
PERK -/- cells (Figure 13 PERK-/- Mock, PERK-/- DEN2). Also, there was a significant
increase (74%) in the LC3II/I ratio in infected PERK-/- cells compared to infected PERK+/+
cells.
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All these shows a high rate of autophagosome formation, which besides pointing to an
increased rate of autophagy, could also indicate a block in the autophagy flux in infected PERK /- cells. To validate this hypothesis, we had to look at a more definitive marker of autophagic
flux26, instead of just looking at the maturation of autophagosomes [10].

8.2.2.

PERK PATHWAY IS NECESSARY TO MAINTAIN A HIGH AUTOPHAGY

FLUX, AND THE PERK-AUTOPHAGY AXIS PROMOTES EXPRESSION OF
DENGUE PROTEIN

To evaluate whether autophagy was increased or flux was blocked

in our model, we monitored the lysosomal protein Sequestosome 1(P62), which undergoes
proteasome-mediated degradation along with the autophagy cargo under conditions of a high
turnover. We thus looked for degradation of p62 as a marker for autophagy turnover, in infected
MDCK, PERK-WT and KO cells [853].

MDCK cells were grown on cover slips, infected with dengue virus, and incubated for 48
hours (at which time E protein was much more detectable). Cells were then fixed and treated
with specific antibodies for immunofluorescence analysis (see Materials and Methods). Images
were captured under a confocal microscope using the green filter to look at P62 in mock,
infected and Sal-treated infected cells (Figure 14 Anti-p62). The red filter was used to monitor
the levels of viral E protein (Figure 14 Anti-E). We merged the images to see how infection
affected P62 (Figure 14 Merge).

26

The final step of autophagy, when the contents of autolysosome are degraded by lysosomal
acidic enzymes.
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Infected MDCK cells had less p62, compared to the mock-infected cells (Figure 14 Dengue,
Mock), indicative of high autophagy turnover in the infected cells. To verify infection, we
looked at E protein expression. The infected cells show high expression of the E protein
compared to the mock-infected cells (Figure 14 Dengue, Mock). We thus established a link
between infection and p62 degradation (autophagy turnover).

To examine the role of the PERK in autophagy turnover, we pretreated infected cells with
Salubrinal, and looked at the same markers. Sal- treated cells expressed more p62 expression and
less E compared to the untreated infected cells (Figure 14 Dengue, Dengue/ Sal). Thus, Sal
exerted the same effect on E protein expression as for transcription of Dengue-2 NS4A [10].

8.2.3.

THE LINKS AMONG PERK ACTIVITY, AUTOPHAGY FLUX AND VIRAL

PROTEIN EXPRESSION ARE VERIFIED USING GENETICALLY MODIFIED MEF
CELLS

The data reported above suggest that suppression of PERK activity lowers

degradation by autophagy and consequently decreases viral translation. Since salubrinal inhibits
eIF2α phosphatases, leading to ER stress, we examined the pathway more directly using PERK
WT and KO cells. PERK +/+ (Figure 15) and -/- (Figure 16) cells were infected with dengue in
the presence or absence of salubrinal. Immunofluorescence was performed as in Fig. 14.

Infected PERK +/+ cells expressed significantly less p62 compared to mock-infected cells
(Figure 15 PERK+/+ Mock, Dengue), with infection verified by expression of E-specific red
signals. Pretreatment of infected +/+ cells with Sal (Figure 15 Dengue/Sal) mimicked the
MDCK data: p62 did not decrease, and the E protein was much reduced (Figure 15 PERK+/+
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Dengue, Dengue/Sal). Statistical analysis based on measurements using ImageJ showed that p62
was significantly lower in the infected cells, compared to mock and Sal-pretreatment (Figure 17).
For measurement using Image J, p62-positive puncta were counted (~ 200–300 cells) for each
condition. The images captured under the microscope were opened on Image J and each cell was
selected, mostly using the FREEFORM SELECTION TOOL. The fluorescence in each cell was
measured using the commands: ANALYZE -> SET MEASUREMENTS -> check AREA,
INTEGRATED DENSITY, and MEAN VALUE. Selecting regions outside the cells and running
the same commands also measured the background noise. Once these values had been exported
to an excel spreadsheet, the Corrected Total Cell Fluorescence was calculated using the formula:
CTCF = Integrated density – (Area of selected cell – mean fluorescence of background reading).
The values were then plotted in a chart.

Our analysis indicated a significant decrease in the puncta count in infected PERK+/+ cells,
but no significant difference in infected PERK −/− cells. Thus, infected PERK +/+ showed the
same pattern as the MDCK in the presence of SAL. In contrast, mock-infected PERK KO cells
expressed much more baseline p62 than their WT counterparts (compare Figure 15 Mock to
Figure 16 Mock) suggesting that autophagy in these cells is PERK-dependent. Also, infected KO
cells expressed much less viral E protein, compared to the infected WT cells (Figure 15, Figure
16 Dengue). The number of p62 puncta in the PERK -/- cells varied considerably but there was
no significant difference in p62 signals between mock PERK +/+ and PERK -/-; nor among
Mock, DEN2, and DEN2-SAL in the PERK -/- cells, reflecting the a slow rate of autophagy that
was not rescued by the low level of infection (Figure 17) [10].
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8.3. AN EARLY ACTIVATION OF ATM KINASE IS IMPORTANT FOR AUTOPHAGY, ER
STRESS AND CELL PROTECTION IN DENGUE INFECTION

8.3.1.

ATM IS ACTIVATED EARLY IN INFECTION

As described before, ATM

kinases can potentially upregulate autophagy under conditions of high stress. To test whether
ATM kinase is activated following infection by Dengue-2, we looked at the activity (measured
by phosphorylation of Ser 1981 in ATM) of ATM kinase in infected MDCK cells at different
times following infection (Figure 18) upper panel p-ATM Den). After infection, cells were lysed
for protein extraction and analysis by western blotting (see Materials and Methods). In this
experiment, ß-tubulin was used as a loading control and uniform protein quantity was verified
(Figure 18 upper panel ß-tubulin).

High ATM activity was recorded at the earliest stage of infection (1.5 hours post infection)
and this activation sustained until up to 12 hpi (Figure 18 upper panel p-ATM Den) after which
this wave subsided. To link ATM activation to autophagosome elongation, we also measured
LC3 lipidation (formation of LC3II, 16 kDA) in the same lysates. LC3II began to increase,
significantly compared to the mock-infected cell, after 24 hours and this activation lasted well
into 48 hours post infection (Figure 18 upper panel LC3 Den). Thus, a pattern emerged where
LC3 lipidation (formation of autophagosomes) closely followed ATM activity; indeed, LC3II
started rising only after ATM had returned to its basal level [10].

8.3.2.

ATM IS POSITIVELY LINKED TO INDUCTION OF AUTOPHAGY IN

INFECTED CELLS Having verified that ATM activation was a relatively early result of
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infection, compared to autophagy, we next investigated if ATM activity was directly linked to
autophagy. To this end, we blocked the ATM activity using the alkaloid inhibitor caffeine. Cells
were infected and treated for 24 hours and were lysed for protein analysis by western blotting
(see Materials and Methods). Actin was used as a loading control in this study (Figure 18 lower
panel Actin). To measure autophagy, we looked at the expression of LC3I (18 kDa) and LC3II
(16 kDA) (Figure 18 lower panel LC3).

After 24 hours, infected cells showed high LC3II lipidation, compared to mock and caffeinetreated cells (Figure 18 lower panel LC3 Mock, Den, Caf). This activation, which is a result of
LC3-PE conjugation, was significantly impaired when caffeine was administered prior to
infection as well as after the virus has been allowed to adsorb into the cells (Figure 18 lower
panel LC3 Den, Den Caf). This finding demonstrated that ATM activity, apart from being part
of an early response of the infected cell, also plays a key role in induction of autophagy [10].

8.3.3.

ATM

ACTIVATION

PROTECTION AGAINST CPT

IS

IMPORTANT

FOR

THE

VIRUS-MEDIATED

As we had earlier found a correlation between autophagy

and protection of cells against toxic agents, we proposed that ATM upregulation in infected cells
might be involved in protection against CPT [652]. We exposed infected MDCK cells to
KU55933/ATMi (Calbiochem#118500), a specific inhibitor of ATM kinase (Figure 19). After 24
hours of growth in the presence of both ATMi and the virus, the toxic topoisomerase I inhibitor
camptothecin (CPT) was added to the cell culture and incubation was continued for 24 hours.
CPT binds to DNA and blocks cell cycle, eventually precipitating apoptosis-mediated cell death
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[854]. Following 24 hours CPT treatment, cell death was measured using the trypan blue
exclusion assay (see Materials and Methods).

In cells treated with ATMi and/or infected with the virus, we could not record any
significant increase in cell death, greater than that seen in mock-infected cells (Figure 19 ATMi,
Den (-), Den ATMi). We also did not register a significant change in cytotoxicity in cells treated
with CPT alone compared to cells treated with both CPT and ATMi (Figure 19 CPT (-), CPT
ATMi). Thus, there appears to be no additive effect, even though both the chemicals are involved
in the disruption of genome stability. Finally, infected cells treated with CPT alone were
compared to those that were also exposed to ATMi. The ‘protective’ function created by the
virus was lost when ATM kinase was knocked out by ATMi (Figure 19 Den CPT (-), Den CPT
ATMi). Cell survival decreased significantly when a pharmacological inhibitor specifically
blocked ATM kinase. Therefore, ATM kinase is involved in both autophagosome maturation and
protection of infected cells from cytotoxic assaults [10].

8.3.4.

ATM IS REQUIRED FOR PERK ACTIVITY IN THE EARLY STAGE OF

INFECTION As demonstrated in previous sections; Dengue 2 activates the PERK branch of
UPR. PERK is also implicated in the maintenance of a high autophagy flux as well as protection
of cells in response to CPT [10]. Since the previous study also linked the activity of ATM kinase
to autophagosome formation and cell protection, we have identified a possible common
mechanism between ATM and PERK. In the following study, we looked at the effect of
inhibition of ATM on activation of PERK in infected cells. We asked if the early ATM
activation had an upstream effect on PERK activity in infected cells.
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To this end, and also to eliminate any form of target-bias, we looked at a different
downstream target of PERK: CCAAT-enhancer-binding protein homologous protein (CHOP).
As described earlier, CHOP undergoes transcriptional activation as ATF4 is selectively
translated during PERK activation.

MDCK cells were infected with dengue, with or without ATMi pretreatment and
incubation (Figure 20 Den, Den+ATMi). After 12 hours, cells were lysed and total RNA was
extracted, followed by a 1-step reaction where CHOP expression was measured using cDNAspecific primers in a SYBR green qPCR reaction. The cycle threshold (Ct) values were plotted
and statistically analyzed on MS Excel. Each PCR was run in triplicate. CHOP expression was
significantly higher in infected cells, compared to mock and ATMi-treated controls (Figure 20
Den, ATMi, Mock). In the presence of ATMi, CHOP transcription significantly decreased in
infected cells (Figure 20 Den+ATMi). From these data we propose a sequence in infected cells
starting with ATM activation and cell protection mediated through PERK and autophagy [10].
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9. DISCUSSION

Dengue virus is the most debilitating mosquito-borne virus, potentially

capable of infecting half the global population. It poses a serious threat to infants, especially in
heavily populated urban setups in the tropical and developing world. Like most RNA viruses,
especially members of the Flavivirus family, dengue also hijacks and subverts a large number of
host cellular organelles and pathways. The organelles most affected are those that provide sites
for virus replication and resources for membranes. Thus, the endoplasmic reticulum, Golgi and
other double membrane vesicles (autophagosomes) are potential ‘replication’ hotspots for the
virus.

The translocation of viral non-structural proteins to the ER, especially the membrane, affects
the ER in two ways: it rearranges the membrane structure, and increases the translation “load”.
Both these processes are implicated in the initiation of ER stress pathways, which in turn can
elicit both pro-survival and pro-apoptotic responses. One of the most widely studied markers of
induction of global stress within the ER is the calcium binding protein Calreticulin (CRT). CRT
is overexpressed under two conditions: a) presence of misfolded proteins in the ER lumen, and b)
release of Ca2+ ions from the ER lumen. We have shown the upregulation of CRT in Dengue 2
infection in our model, using Tunicamycin (TM)27 as a positive control for induction of stress.

Once extracellular or intracellular stimuli trigger ER stress, the stress can be communicated
through different branches of UPR, i.e., PERK, IRE1α and ATF6, as well as pro-apoptotic
pathways like PUMA and NOXA. Since there is substantial evidence that other members (HCV)
of the Flaviviridae, as well as Dengue itself (in different cell types), activate PERK we focused

27

An inhibitor of protein N-glycosylation.
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on the same. To this end, we monitored the transcription rate of downstream substrates of PERK,
such as ATF4, GADD34, and CHOP in infected cells. ATF4 is a common marker for PERK
activity since only ATF4 is spared from the translation repression imposed by phosphorylation of
eIF2α. ATF4 translocates to the nucleus and induces the expression of GADD34 and CHOP
(C/EBP-homologous protein), hence these are also used as markers for tracking PERK activity.
We have shown here that transcription ATF4, GADD34 and CHOP significantly increases, and
at least in one instance (CHOP) this upregulation is blocked when ATM kinase is inhibited [10].

GADD34 acts as a primary checkpoint for the switch between the pro-survival and proapoptotic branches of PERK and UPR. GADD34, a phosphatase, removes the PERK-imposed
phosphate group on eIF2α, thereby rescuing the cell from the translation blackout. To assess the
effect of a functional PERK pathway on viral infectivity, we employed a specific
pharmacological inhibitor salubrinal, which blocks the feedback of GADD34 on a downstream
substrate (eIF2α) of the PERK kinase; we also acknowledged the limitations of a chemical
inhibitor and validated our studies using PERK knockout MEF cell [10, 544]. The recovery of
the translation machinery, following GADD34-mediated dephosphorylation of eIF2α, might act
in favor of the virus replication and maturation, since both need to harness the host translation
machinery. This would be manifest in an increased transcription of the viral genome. The viral
genome consists of 3 genes for structural proteins and 7 genes for non-structural proteins, all of
which can be measured.

To measure the effect of SAL-mediated GADD34 inhibition or PERK knockout, we looked
at viral transcription. To this end, we quantified the transcription of the DENV non-structural
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protein 4A (NS4A) in presence of SAL. Although one of the least characterized of all flavivirus
proteins, NS4A has been reported to insert into the ER membrane and thus modify the topology
of the organelle, thereby inducing ER stress [826]. In our model, SAL pretreatment resulted in a
significant slowdown of NS4A transcription in infected cells. Our previous study had also
identified NS4A as the only viral genetic component that mimicked the ability of the whole virus
to induce mild autophagy and protect MDCK cells from the cytotoxic effects of camptothecin
(CPT) [652, 698]. Thus, the collective results from these studies indicate a possibility of PERKautophagy crosstalk, with NS4A probably playing the role of a mediator.

We previously demonstrated that infection by dengue-2 makes MDCK cells resistant to the
toxic effect of a cell-killing agent like camptothecin (CPT). The same study also linked the
protective effect to the induction of PI3K-dependent autophagy by the virus [652]. The
possibility that autophagy and PERK might converge in an infected cell prompted us to look at
the effects of PERK blockage in infected cells. Infected but SAL-exposed and PERK KO cells
both lost protection against CPT [10]. This result was the first piece of evidence that the virus
might mediate a pro-viral and pro-survival interaction between autophagy and PERK. Apart
from this study, we had other suggestions that these two pathways cooperated in infected cells.
The most important step carried out by the virus inside the host cell is the proper assembly and
processing before infective virions are released. Several organelles (ER, Golgi) are involved and
multiple pathways (exocytosis) are regulated by the virus to ensure that the structural proteins are
processed (Furin-mediated cleavage of pr and M) before the release. We had previously shown
that induction of mild autophagy is required for production of infective virions [652]. To
evaluate the role of PERK in the final stages of viral production, we quantified the plaque-
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forming ability of infected PERK WT and PERK KO cells. The current study shows that PERK
is partially necessary for the production and release of structurally infective virions.

This prompted us to explore more directly the links between PERK and autophagy. Due to
the pivotal roles that processes like endocytosis (virus internalization) and exocytosis (viral
release) play in the life cycle of the virus inside the host (human or other mammal) cell,
macroautophagy (which shares some of the molecular machinery with these pathways) and other
selective autophagy (Virophagy, Lipophagy) are also subject to viral manipulation. Since
autophagy is intricately linked to the innate and adaptive branches of antiviral immune response,
and often provides essential raw materials for membrane construction (release of lipid droplets
through selective Lipophagy), dengue and similar viruses (WNV, JEV, HCV) use this
homeostatic pathway to their own advantage in infected cells [17]. We looked at the final step
and the functional culmination of autophagy, i.e., formation of autolysosome and the degradation
of the cargo entrapped within the inner autophagosome membrane. We used P62 as a marker for
“autophagic flux”; in a cell undergoing rapid degradation, this ubiquitin-linked protein is also
destroyed. In absence of an active PERK pathway (infected KO cells), expression of the viral
envelope (E) protein was significantly lower, accompanied by low autophagic “flux” as
manifested by high p62. These results directly linked the following three pathways: the PERK
pathways, autophagic flux, and viral expression.

Our studies indicate that both PERK and autophagy took place and operated at a high level,
between 12-48 hours of infection. In search of earlier events that might trigger or upregulate the
PERK/autophagy nexus, we turned our attention to the Ataxia Telangiectasia Mutated (ATM)
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kinase. ATM, usually active in the nucleus, is a key component of the DNA-Damage Response.
Until recently, its involvement in cytosolic events was unclear. Studies with ATM -/- models
have shown that this protein is involved in the activation of redox homeostasis and autophagy
pathways, especially in tumor cells with high reactive oxygen species (ROS) and reactive
nitrogen species (RNS) [580]. Mechanistic studies had also shown that ATM upregulates the
initiation and nucleation of autophagy (ULK1 complex) by the activation of the AMPK-LKB1
pathway. Thus, dengue virus could be hijacking the same pathway; we validated this argument
further by preliminary studies (data not shown) using an ATM inhibitor (caffeine) and NS4Aoverexpressing MDCK cells. CPT remained very toxic in caffeine-treated cells, suggesting a
possible role of ATM in DENV infection.

Although DNA damage and ATM-CHK2 activation had been implicated in the infectivity of
a wide range of viruses (Epstein-Barr, Hepatitis B, Hepatitis C, latent HIV-1, papilloma viruses,
Herpes Simplex Virus-1, Kaposi’s Sarcoma associated herpesvirus, gamma herpesvirus), studies
with flaviviruses were wanting. We found that blocking ATM activity by caffeine and a more
specific inhibitor (KU55933/ATMi) resulted in a significant decrease in autophagosome
expansion (measured by LC3II) as well as a decrease in cell protection against CPT. Having
established a link between ATM activity and autophagy, we also tested if the former also
affected the PERK pathway. We recorded a significant decrease in the rate of CHOP
transcription, which is used a marker for PERK activity, in infected cells exposed to ATMi. A
recent study, using JEV, another important flavivirus, has also demonstrated the activation of
ATM kinase in infected cells [855].
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In sum, we have suggested a role of the UPR pathway, especially PERK, in modulating
global translation in response to infection. Along with other UPR pathways, PERK has been
reported to activate proteins involved in different stages of autophagy, e.g., both ATF4 and
CHOP upregulate LC3, ATG5 and P62/SQSTM1. Earlier studies linking PERK and autophagy
encouraged us to investigate the impact of inhibition of PERK on virus-mediated protection of
cells. In our model, PERK plays an important role in dengue-mediated cell protection and in this
respect, it closely mimics autophagy.

As a functional PERK pathway correlates with viral replication, we looked at the effect of
interference with this pathway on viral maturation. A complicated aspect of viral infection that
also depends on successful replication is the assembly and extracellular release of the mature
virions. In DENV infection, the virus uses replication organelles (RO) like the endoplasmic
reticulum to express the genome and produce the proteins. ER is also used as a scaffold for the
assembly of the viral genome. The Golgi apparatus is used for processing the assembled virion
(e.g. furin-mediated cleavage of prM) after which the infective virion is released by exocytosis.

A functional PERK pathway can block global protein translation. However, the virus can
exploit the feedback effect of GADD34 (target of Sal). Since functional translation machinery is
necessary for the maturation of the virus, the virus may use the ER stress pathways to produce
infective particles. In our previous study, we had linked PI3K-dependent autophagy to virus
production [652]. In this respect, deletion of the PERK pathway has the same effect as chemical
inhibition of autophagy. As discussed earlier, this highlights the importance of double membrane
vesicles in the life cycle of dengue virus. However, in dengue infected MDCK cells, expression
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of GADD34 in infected cells does not correlate with cell death. A functional PERK pathway
possibly modulates replication of the dengue genome by regulation of the host global translation.
The ability of Sal to block the activity of a pro-apoptotic GADD34 protein might also explain the
increased protection that was recorded in cells overexpressing NS4A or infected with the whole
virus [652]. The ability of the virus to protect cells from CPT has thus been linked to the
activities of both PERK and autophagy.

Finally, we have also shown the involvement of the DNA damage response (DDR) protein
ATM in mediating PERK and autophagy-dependent cell protection in infected cells. There is a
possibility that ATM might operate through the upregulation of AMPK-LKB1, as has been
shown in a recent study that looked at DENV-mediated Lipophagy [761]. However, yet another
recent study has shown that pharmacological activation of the AMPK protein reduces the
infectivity of three flaviviruses, DENV, WNV and ZIKV, highlighting an anti-viral aspect of this
protein that is conserved among several flaviviruses [791]. Thus, more mechanistic studies
should be conducted on the possible relationship between DDR, ER stress (UPR/PERK) and the
pro-survival homeostatic processes (autophagy) in DENV infection.
In this study, we have also investigated the timeline of dengue infection. Our results indicate
that ATM activation is probably one of the earliest responses mounted by the host cell, and this
activation stimulates the activation of three interconnected pathways that we have described:
PERK pathway, autophagy and cell protection. The current study shows that ATM is essential
and precedes all three. What would be an interesting follow up is to look at the mutual crosstalk
between each of these pathways. Such a study would enable us to identify a potential metabolic
target for antiviral therapy.
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Figure by
5 the amount of calreticulin produced in
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Salubrinal inhibited the production of Calreticulin even in the presence of virus. B) Actin
control. C) Fold difference in the ratio of Calreticulin produced compared to Actin.
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Figure 5: DENV infection, like tunicamycin, induces expression of calreticulin, which is
blocked by an inhibitor of PERK pathway [10].
MDCK cells were infected with DENV and treated with tunicamycin and/or salubrinal.
After 24 hours, cells were lysed and total protein was extracted. The proteins were then
quantified and run on an SDS-PAGE gel. The separated proteins were transferred to a
nitrocellulose membrane and were probed for calreticulin using specific antibodies. Infection
induced activation of calreticulin. Cotreatment with salubrinal, however, arrests this activation,
and calreticulin is sharply reduced, even dropping lower than mock-infection. Salubrinal also
suppressed the activation by tunicamycin, though not as effectively. Actin was used as a loading
control. The ratios (Cal-Actin) presented here are mean values of the ratios obtained from three
different western blot experiments. The picture shown here is a representative image of all three
blots.
[This experiment was performed in collaboration with Golnoush Golshan and Sasha Harbajan,
former students in our lab]
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Figure 6: Verification of controls [10].
MDCK cells were infected with DENV for 12 and 24 hours. Total RNA was extracted
using a kit and the transcription rate of an endogenous control β-actin (a housekeeping gene) was
measured using cDNA-specific primers (SYBR green qPCR). No significant changes (n.s.) were
recorded in mock- or DENV-infected MDCK cells after either 24 or 48 hour. In the lowest panel,
data from both the time points have been shown together. We have also included an axis (to the
right of the chart) showing the relative RNA present based on the Ct values. According to
convention, a unit change in Ct represents a two-fold change in transcription and this pattern
continues in an exponential fashion, e.g. 4-fold change in transcription for 2 unit changes in Ct,
and so on.
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Fold change (DENV2/MOCK) = 0.181

Figure 7: Transcriptional activation of ATF4 [10].
MDCK was infected with DENV for 12 or 24 hours and was tested for actively
transcribing ATF4. Total RNA was extracted using a kit and the transcription rate of ATF4 was
measured using cDNA-specific primers (SYBR green qPCR). All qPCR experiments were
calculated relative to the loading control β Actin (FIG.5). In the upper and the middle panels, we
have presented the charts showing the actual Ct values of ATF4 gene, as well as the relative Ct
values over Actin (δCtATF4 – δCtACTIN). The fold change (relative to actin) of ATF4 has been
provided in the charts showing the latter. Significant activation (>40-fold change relative to
actin) was recorded after 12 hours but not after 24 hours of infection. Thus, ATF4 activation is
an early event in infection that gradually comes down to basal level after 24 hours of infection.
In the lowermost panel we have presented the 12-hour data, without normalizing the ATF4 Ct
values relative to the Actin Ct values. As in the previous figure, we have added a scale for
relative RNA expression corresponding to threshold cycle (Ct) value. This method of evaluation
has been adopted for the all the qPCR data presented hereafter.
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DENV2

Figure 8: ATF4 activity is enhanced in infection [10].
MDCK was infected with DENV for 12 or 24 hours and tested for GADD34
transcription, which has been used as a marker of ATF4 activation. Total RNA was extracted
using a kit and GADD34 transcription was measured using cDNA-specific primers (SYBR green
qPCR). In the upper and the middle panels, we have presented the charts showing the actual Ct
values of the GADD34 gene, as well as the relative Ct values over Actin (δCtGADD34 – δCtACTIN).
The fold change (relative to actin) of GADD34 has been provided in the charts showing the
latter. Expression of GADD34 increased significantly (>200-fold change) after 12 hours of
infection and the increase persisted though diminishing until 24 hours (<10-fold change). It is
noteworthy that the downstream effect of ATF4 persists longer than ATF4 transcription. The
fold change relative to actin has been calculated as indicated in the figure. As in the previous
diagram, In the lower panel we have presented the same data, without normalizing the Ct values
relative to Actin. Here, as in the previous diagram, we have added a scale for relative RNA
corresponding to threshold cycle (Ct) value. This figure shows the internal variation in GADD34
between mock and infected cells after 12 and 24 hours.
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Figure 9: Regulation of PERK pathway is conducive to viral replication [10].
MDCK was infected with DENV, with and without salubrinal, for 24 hours. Total RNA
was extracted using a kit and NS4A transcription was measured using cDNA-specific primers
(SYBR green qPCR). For this experiment, a different set of Actin Ct values was used. In the
upper and the two middle panels, we have presented the charts showing the actual Ct values of
the loading control (Actin) and the viral gene (NS4A), as well as the relative Ct values of NS4A
over Actin (δCtNS4A – δCtACTIN). The fold change (relative to actin) has been provided in the
charts showing the relative Ct graphs. After 24 hours, Salubrinal suppressed the transcription of
dengue NS4A gene by >50% in infected MDCK cells. Treatment with SAL reduced the fold
change in NS4A expression from >600 to ~250 fold in infected cells, compared to mockinfection. As in the previous results, fold change was calculated relative to actin expression,
which SAL/Sal did not significantly affect. In the lower panel we have presented the same data,
without normalizing the NS4A Ct values relative to Actin [10]. A scale for relative RNA
corresponding to threshold cycle (Ct) value has been added to the graph in the lowest panel. This
figure shows the internal variation in NS4A between mock, infected and treated cells.
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Figure 10: PERK pathway is partially responsible for maturation and release of infective
virions [10].
PERK +/+ and -/- cells were infected with DENV for 48 hours. Supernatants were then
isolated from each cell line and were tested for their ability to form visible plaques on Baby
Hamster Kidney (BHK) cells. KO cells produced only 16% (inverse log values shown in the
chart) of the number of virions (plaques) compared to WT cells.
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Figure 11: PERK regulation is important for DENV-mediated protection [10].
MDCK cells were infected with DENV and treated with salubrinal (Sal) and/ or
camptothecin (CPT). After 24 hours of infection/ treatment, cell death was measured by Trypan
Blue exclusion assay. Salubrinal abrogated the protective effect of DENV infection in the
MDCK cells. A significant increase in cell death was recorded in infected MDCK cells that were
pretreated with salubrinal, indicating that blocking PERK pathway abrogates the cytoprotective
effect of DENV2 against CPT.
[In this figure and in others, the following convention has been used for p-value/T-test:
*P<0.05; **P<0.01, ***P<0.005 and ****P<0.001]
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Figure 12: PERK knockout modestly reduces protection from CPT in infected cells [10].
The effect of Salubrinal on CPT-treated cells was verified in PERK-knockout MEF cells.
Infected KO cells showed lower resistance against CPT-mediated cytotoxicity, compared to
infected WT cells. It should be noted, however, that in absence of the virus both WT and KO
cells responded in a similar fashion to CPT. Hence, the resistance observed in infected WT cells
was due solely to the virus.
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Figure 13: PERK might be involved in autophagosome formation in infected cells [10].
PERK WT and KO MEF cells were infected with DENV2 for 24 hours. Proteins isolated
from the cells were then probed for LC3I/II and tubulin using immunoblotting. NIH software
Image J was used for densitometry analysis of the bands. The fold change in LC3 II over LC3I
was used as quantification for autophagosome formation. In infected cells, the ratio of LC3
lipidation/ LC3-PE conjugation (measured as LC3II: I) was normalized to that of MOCK cells.
Infection in the PERK knockout cells resulted in higher LC3II lipidation, compared to mockinfected PERK KO. The rate of (lipidation) was also higher than that of infected and mock WT
cells. There was a mild increase (24%) in the LC3II/I ratio in the mock-infected PERK-/-,
compared to the mock-infected PERK+/+. Dengue-2 infection of PERK+/+ cells led to a mild
increase (36%) in the LC3II/LC3I ratio, compared to mock-infected cells. In contrast, infected
PERK -/- cells displayed a roughly two-fold increase (93%) in LC3 lipidation, compared to the
mock-infected PERK -/- cells. Also, there was a significant increase (74%) in the LC3II/I ratio in
infected PERK-/- cells compared to infected PERK+/+ cells. The values of densitometry analysis
have been provided in the table.
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Figure 14: Blocking PERK pathway in MDCK cells negatively affects net autophagy
turnover as well as expression of viral protein.
MDCK cells were grown overnight on coverslips, before being infected with DENV and/
or treated with salubrinal. After 48 hours, the cells were fixed with 4% paraformaldehyde and
were permeabilized with Triton X-100. They were then probed for viral E protein (Red
secondary/ TRITC) and the autophagy marker p62 (Green secondary/ FITC). Mock cells showed
no E protein signal. They had more p62 expression compared to infected cells, thus indicating a
lower autophagy flux compared to the latter. In presence of salubrinal, levels of E protein
decreased and p62 levels were restored to basal level. Thus, blocking the PERK pathway had a
deleterious effect on autophagy flux as well as viral protein expression. Salubrinal-treated cells
were used as a control and the same pattern of p62 expression was observed as Sal-treated
infected cells.
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Figure 15: PERK WT cells show reduction in autophagy turnover as well as E protein
translation when pretreated with Salubrinal [10].
PERK WT cells were infected with dengue for 48 hours and were probed for p62 (green)
and E (red) proteins. When cells were pretreated with salubrinal, p62 increased and E protein
translation decreased. Thus, MEF cells show the same results as in MDCK, i.e., impairment of
the PERK pathway slows autophagy turnover as well as expression of viral protein.
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Figure 16: PERK KO cells show weaker E protein expression when compared to infected
WT cells [10].
PERK KO cells, even in absence of virus, had a much slower rate of P62 degradation
compared to mock, which did not change significantly when the cells were infected with virus
(quantification presented in Fig.13). In contrast, in WT cells p62 fell significantly when the cells
were infected (Fig.11), an effect that was mostly blocked by the prior addition of salubrinal. KO
cells also expressed much less viral E protein compared to WT cells.
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Figure 17: Statistical analysis reveals a significant decrease in P62 in infected PERK WT
cells [10].
Image J was used to quantify the green p62 signals in the fluorescence images shown in
Figures 11 and 12. The images captured under the microscope were opened on Image J and each
cell was selected, mostly using the FREEFORM SELECTION TOOL. The fluorescence in each
cell was measured using the commands: ANALYZE -> SET MEASUREMENTS -> check AREA,
INTEGRATED DENSITY, and MEAN VALUE. Selecting regions outside the cells and running
the same commands also measured the background noise. Once these values had been exported
to an excel spreadsheet, the Corrected Total Cell Fluorescence was calculated using the formula:
CTCF = Integrated density – (Area of selected cell – mean fluorescence of background reading).
The values were then plotted in a chart. Here we demonstrate significant p62 degradation in
infected cells, as compared to control (MOCK) and salubrinal pretreatment (D/SAL). In contrast,
no significant difference was observed between the mock and infected PERK-/- cells.
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Figure 18: An early ATM activation is required for induction of autophagy in DENV2
infection [10].
MDCK cells were infected with Dengue virus and probed for active ATM (pATM_Ser1981) at different times (upper panel). ATM activation starts quite early in infection,
reaching its apogee between 2 hpi to 12 hpi, clearly preceding the LC3 lipidation, which
increases most dramatically after 24 hpi. Pretreatment of infected MDCK cells with 20 µM
Caffeine significantly lowered LC3 lipidation after 24 hours (lower panel).
[This experiment was performed in collaboration with Mr. Emmanuel Datan]
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Figure 19: ATM activation is essential for dengue-mediated cell protection against CPT
[10].
MDCK cells were infected with dengue, and/or pretreated with a specific ATM inhibitor,
before being treated with CPT. Cell death was quantified using trypan blue exclusion method
and was statistically analyzed using MS Excel. Similar to our previous findings, CPT
cytotoxicity was markedly lower in infected cells. This protection was however eliminated when
infected cells were pretreated and incubated with 5µM ATM inhibitor (KU55933). There was no
significant difference in cell death between ATMi-treated mock-infected and dengue-infected
cells, thus eliminating any chance of cell death due to ATMi treatment. [In this and subsequent
figures, *P<0.05; **P<0.01, ***P<0.005 and ****P<0.001 for the bracketed comparisons]
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Figure 20: ATM activation in infection positively impacts activity of PERK in MDCK cells
[10].
MDCK cells were infected with DENV and/or treated with ATMi (specific inhibitor of
ATM). After 12 hours total RNA was extracted using a kit and the transcription rate of CHOP
was measured using cDNA-specific primers (SYBR green qPCR). Infected MDCK cells that
were pretreated and incubated with KU55933 showed a significant drop in CHOP transcription
compared to DENV-infected, mock and KU55933 -treated cells. We have also included an axis
(to the right of the chart) showing the relative RNA present based on the Ct values.
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10. CHAPTER ON SUPPLEMENTARY DATA: “THE EFFECT OF ER STRESS,
APOPTOSIS AND AUTOPHAGY ON THE EXPRESSION OF ZIKA VIRUS”

10.1.

INTRODUCTION
Flaviviruses are seriously underestimated as a threat to humans. Zika, the latest flavivirus to

concern many governments, comes from the same family (Flaviviridae) and genus (Flavivirus)
as other human viruses like Dengue, West Nile and Japanese encephalitis. With Zika now a
worldwide threat, research on the mechanisms of infection is imperative. Though Zika was
identified almost 70 years ago, it attracted attention only when, in 2007, it caused an epidemic in
the Yap Islands (Micronesia) [856, 857]. Almost a decade later, it was associated with
debilitating diseases like Guillain–Barré syndrome and acute disseminated encephalomyelitis
(ADEM) in adults, and microcephaly in infants, with now over 8,000 of the latter in Brazil [858].
The virus can be passed in both directions during intercourse and is readily passed from mother
to fetus [859]. The virus has been found in amniotic fluid and in cerebrospinal fluid of micro
cephalic infants [860-863]. It can persist for a few months in semen and vaginal fluids [864,
865]. There are now over 15,000 infections in Puerto Rico, potentially creating several hundred
cases of microcephaly (though voluntary decrease in birthrates may be a limiting factor. It is now
established in Florida [866, 867]. Though a vaccine is likely in the near future, we nevertheless
need to understand how its biology makes it so destructive [868, 869].
10.1.1.

Apoptosis in ZIKV infection

ZIKV is a neurotropic virus that has been associated

with neurodegeneration both in vitro and in vivo. It has however been suggested that the virus
exerts differential cytotoxicity in different regions of the fetus brain. In a 20-week old fetus,
intermediate progenitor cells (IPC) and immature neurons were the most susceptible to infection,
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while neural progenitor cells (NPC) and mature neurons had a much lower level of infection.
Interestingly, apoptosis did not always correlate with infectivity in cells of neuronal lineage,
giving rise to speculation that a paracrine mechanism is involved in ZIKV-mediated apoptosis
[870]. The ZIKV strain responsible for the 2015 Brazil epidemic induces apoptotic cell death and
causes mitotic errors dysfunction in human neural progenitor cells (NPC). Apart from the
activation of caspases, the infected NPC also showed formation of autophagic vacuoles and
increase in LC3 lipidation, thus pointing to the possibility of crosstalk between the different
branches of programmed cell death [871]. Alternate forms of cell death have also been observed
in infected cells. In human epithelial cells (HeLa), primary fibroblasts and astrocytes, ZIKV
infection induced formation of cytoplasmic vacuoles that were derived from ER membranes.
Further analysis of these vacuoles revealed that these structures were responsible for a caspaseindependent form of cell death, and it was believed to be very similar to paraptosis. Formation of
vacuoles and cell death were particularly rampant in cells that lacked a functional Interferon
Induced Transmembrane Protein (IFITM) 3, an important antiviral factor [872].

High throughput systems virology studies have shown the close association of ZIKV with the
components of the p53-dependent apoptosis pathway, including TP53 and MDM2, in infected
human primary glioblastoma cells (U87) and female BALB/C mice [873]. Using synthetic
mimics, these authors demonstrated a direct interaction between ZIKV capsid protein (ZCP) and
MDM2, the interaction likely being important for induction of apoptotic cell death. Thus, like
DENV capsid protein, ZCP is also instrumental in the establishment of pathogenicity through the
induction of apoptotic cell death. Another important structural protein, Envelope protein (Env),
has also been implicated in the induction of intrinsic apoptosis in neuroendocrine (PC12) cells.
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Besides the activation of Bax- and Caspase-dependent intrinsic apoptosis response, lentivirusmediated expression of the truncated Env also led to mitotic catastrophe in the form of G2/M cell
cycle arrest. Like the previous study (involving ZCP), here too TP53 plays an important role in
Env-mediated apoptosis and cell cycle arrest in PC12 cells [874]. Thus TP53 lies at an important
junction of different pathways that are elicited by viral proteins.

10.1.2.

Autophagy in ZIKV infection

Autophagy plays an important role in ZIKV

infectivity and pathogenicity, as has been demonstrated by both in vivo and in vitro studies. Like
other Flaviviruses, the relation between autophagy and infectivity is not straightforward and
depends strictly on the cell type infected. ZIKV hijacks multiple forms of autophagy in various
cell lines, and pharmacological inhibition of autophagy reduces the viral load as well as the
pathogenic effects of infection [875].
ZIKV induces autophagy in human trophoblasts, and ATG16L1 was implicated in the
pathogenicity as well as vertical transmission of ZIKV to the embryo. Pharmacological
inhibition of autophagy by 3-MA, Bafilomycin, hydroxy-chloroquine was effective in limiting
the presence of ZIKV in the placenta. The same observation was recorded when ATG16L1 was
knocked out in these cells. In a separate study, chloroquine, an endocytosis-blocking agent,
blocked early stages of ZIKV replication in Vero cells, human brain microvascular endothelial
(hBMEC) cells, human neural stem cells and mouse neurospheres. Since endocytic proteins are
involved in the fusion between autophagosome and lysosome, and chloroquine and its
derivatives are commonly used to block the final step of autophagy, this finding further validates
the engagement of autophagy in ZIKV infection and transmission. Treatment with chloroquine
and Wortmannin also significantly reduced ZIKV replication/infection in human umbilical vein
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endothelial cells (HUVEC); however, induction of autophagy by rapamycin had no significant
effect on ZIKV production. ZIKV infected HUVEC manifest high autophagy flux as well as
autophagosome formation, as measured by p62 degradation and LC3 lipidation, respectively.
Beclin 1 -/- cells were shown to harbor fewer infective ZIKV compared to wild type cells [876878].

Autophagy could also be manipulated to prevent the passage of the ZIKV from placenta to the
fetus. A non-reducing disaccharide, Trehalose, is a possible antiviral agent that has the potential
to block the vertical transmission of ZIKV in the early stages of infection. Trehalose induces
autophagy through an mTORC-independent pathway and can facilitate the clearance of ZIKV
through autophagolysosomal degradation of the virus in the placenta. It also holds the potential
of activating the immune response in infected placental cells. Trehalose is harmless compared to
pharmacological inhibitors and is usually consumed as sugar additives in foods. Thus, it might be
an ideal candidate for an anti-ZIKV drug because of its low side effects. However, stringent tests
are required to test the feasibility of this sugar as an antiviral agent [603].

Although the involvement of autophagy in ZIKV has been recorded only very recently, a
significant body of work has been dedicated towards deciphering the molecular mechanism
responsible for ZIKV-induced autophagy. In human fetal neural stem cells (fNSCs) ZIKVinduced autophagy is important in impaired neurogenesis and formation of neurospheres. Not
surprisingly, the AKT-mTOR pathway, which is essential for brain formation apart from being a
negative regulator of autophagy, was inhibited by the ZIKV in fNSCs. Among all the viral
proteins, only NS4A and NS4B were demonstrated to be responsible for this inhibition of

163

autophagy. Similarly, we have previously linked DENV NS4A to induction of autophagy and
cell survival [879]. This was not the only study to point out the involvement of autophagy in
ZIKV and DENV pathogenesis: Lennemann and Coyne showed that both of these viruses were
capable of hijacking the autophagolysosomal degradation of ER membranes, a specific
autophagy known as Reticulophagy. The ER-localized reticulophagy receptor FAM134B was
identified as a restriction factor acting against both the viruses. As a countermeasure, these
viruses employ their NS3 protease to cleave FAM134B thereby disrupting the reticulophagy
process in infected cells. This might be important since it provides more double membrane
vesicles for viral replication in these cells [752].

10.1.3.

Stress in ZIKV infection As a member of the Flavivirus family, ZIKV also uses the

endoplasmic reticulum as a replication organelle inside the host cell. Although fewer studies
have been published about the role of ZIKV in ER stress, compared to other Flavivirus, ZIKV
does manipulate the stress pathways. In infected human fetuses, neural stem cells and mouse
embryos ER stress and UPR are involved in ZIKV-induced pathophysiology including
microcephaly. Treatment with a specific PERK inhibitor (GSK2656157) alleviates the
neurogenic deformities induced by ZIKV in mouse embryos, thus pointing to the direct
involvement of PERK in ZIKV pathogenicity. In this regard, we observe close parallels between
ZIKV and other flavivirus like DENV [880].

The assembly of Stress Granules (SG), aggregates of stalled translation preinitiation
complexes, is an important component of host antiviral response and is modulated by several
Flaviviruses. ZIKV also modulates SG formation in an eIF2α-dependent fashion in Vero and
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human osteosarcoma-derived U2OS cells. ZIKV blocks eIF2α phosphorylation-dependent SG
formation but not the eIF2α-independent branch. GADD34 is upregulated in ZIKV infected
cells, thus raising the possibility that the virus alters translation. An inhibitor (Sal) of GADD34mediated dephosphorylation of eIF2α decreases ZIKV replication. Since both these data match
our observations in DENV-infected MDCK and MEF cells, it is likely that these two viruses
have a similar pattern of ER stress modulation [881].

In Vero, A549 and HEK293T cells, ZIKV hijacks the SG pathway, especially the G3BP1,
TIAR, and Caprin-1, to facilitate its own replication. The viral components behind the reduction
of SG formation in infected cells were also identified in the same study - overexpression of
NS2B, NS3, NS4A and Capsid proteins inhibited SG formation [882]. These studies clearly
indicate that ZIKV depends heavily upon its ability to block global translation, usually mediated
by eIF2α phosphorylation. It also blocks one of the major pathways of host antiviral response formation of stress granules. Thus, ER stress and UPR in particular can be harnessed for putative
antiviral targets to prevent ZIKV infection.

10.2.

MATERIALS AND METHODS

10.2.1.

Cell Culture

1. SEPT4 (WT, KO) MEF

We obtained knockout MEFs for the pro-apoptotic ARTS (SEPT4)

protein from our collaborator Dr. Sarit Larisch (University of Haifa, Israel). These cells were
infected with the virus as well and provided us with information about the role of mitochondria
and apoptosis in infection. These cells were grown in DMEM+/+ media, containing 55µM βmercaptoethanol (GIBCO#21985), a reducing agent useful for scavenging oxygen radicals.
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2. P110 β (WT, KO) MEF

We collaborated with Dr. Wei-Xing Zong (Rutgers University/

Stony Brook University) and obtained MEFs deficient in one of the major catalytic subunits of
the VPS34 protein (p110 β). Since this protein is important to the induction of autophagy, we
infected these cell lines to evaluate the viral production when this pathway is blocked. These
cells were grown in DMEM+/+ media.
3. A549 This epithelial cell line (ATCC#CRM CCL 185), originally isolated from the human
lungs was used for infection with influenza, dengue and Zika viruses. These cells are also
suitable for lipofectamine-based transfection. We also used the line to look at the effects of
overexpression of viral protein. These cells were maintained in DMEM+/+ media.
4. PC12 The pheochromocytoma cell line (ATCC CRL#1721) was maintained in Ham’s F12K
medium containing 1.5 g/L L-glutamine, 10% horse serum, 2.5% fetal bovine serum and 1%
Pen-Strep. The cells were incubated in 5% CO2 at 37ºC.
5. VERO, MDCK, PERK+/+ and -/- MEF cells were grown and maintained as described above.

10.2.2.

Quantification of Cell Death

Cell death was quantified using Trypan Blue

Exclusion Assay, as has been described in the preceding sections.

10.2.3.

Treatment

Pharmacological agents were used to induce or block specific signaling

pathways. Cells were pretreated with these chemicals for 2 hours prior to infection, and were
added back after the viral adsorption. These treatments were useful to investigate the links
between viral infection and these pathways. Below is a list of the chemicals used in this study.
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CHEMICAL

EFFECT

ATM kinase inhibitor

FINAL CONCN.

Blocks ATM kinase activity

5 µM

Induces autophagy

250 nM

Blocks fusion of autophagosome

50 µM

(KU55933)
[Calbiochem#118500]
Torin 1
[Cell Signaling
Technology#14379]
Chloroquine

and lysosome
Salubrinal

Blocks eIF2 phosphorylation by 3 µM

[Santa Cruz

PERK

Biotechnology#sc202332]
Tunicamycin

Induced global ER stress by 3 µM
blocking

N-glycosylation

of

proteins

10.2.4.

(S)-(+)-Camptothecin

Inhibits type II Topoisomerase/

(Sigma#C9911)

induces apoptosis

Growing Virus

75 µM

We obtained Zika MR766 (ATCC#VR84) as a generous gift from

the lab of Dr. Adolfo Garcia Sastre (Mount Sinai Medical School, New York). We used the
general protocol followed by the Sastre lab (Mount Sinai); however, we improvised the manual
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according to the conditions and requirements in our lab. The protocol for growing and purifying
Zika was almost same as that used for DENV2 (as described earlier). However, Zika causes
cytopathic effect (CPE) much earlier than the latter; we started harvesting the virus within 2-3
days of infection. After the cells has been stored as aliquots in the -80° C, they were titered on
VERO cells.

Titering Zika virus

The protocol for titering Dengue was employed for the

quantification of Zika as well, with certain modifications. Instead of one week, the plate
containing the overlay was taken out after 3-4 days and was stained with Crystal Violet to
measure plaque formation. Apart from this classical approach, a different method was also used;
this is described below.

Instead of performing the serial dilution in naïve (-/-) media, without FBS/P-S28, we diluted
the Zika stocks in 2.5% α-MEM. Also, the Agarose overlay was replaced by 1%
carboxymethylcellulose (CMC) and 2.5% α-MEM. After 3-4 days the plates were stained with
Crystal Violet for detection of plaques. Plaques were counted and the titer of the virus was
expressed as plaque forming units (P.F.U)/ ml.

10.2.5.

RNA extraction/ qPCR

RNA was extracted from cells as described above. The

extracted RNA was then quantified and used for quantitative Polymerase Chain Reaction (qPCR)
as described above. cDNA-specific primers were used to measure the transcription of the ZIKV
NS1 gene in infected cells. Tubulin was used as a loading control. The sequence of primers used
in this experiments have been listed in the table below.
28

FBS: Fetal Bovine Serum, P-S: Penicillin/ Streptomycin
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Gene

Sequence (5’-3’)

Tubulin FWD

AGG ATT CGC AAG CTG GCT G

Tubulin REV

TAA TCC ACA GAG AGC CGC TCC

ZIKV NS1 FWD TTT GTT AGG GCG GCA AAG AC
ZIKV NS1 REV

10.2.6.

Immunofluorescence

ACG GCT GGG TCA CAT TCT AA

We looked at the expression of ZIKV Env protein in

infected cells using specific antibodies (anti-E). Immunofluorescence was performed as
described above.

10.3.

RESULTS

10.3.1.

ZIKV can efficiently replicate in different cell lines

ZIKV and DENV both are in

the genus Flavivirus. However, they possess different patterns of infectivity in cell lines. We
therefore evaluated expression of virus protein in different mammalian cell lines. We used
antibodies for ZIKV E protein (described above) to verify by immunofluorescence infection and
quantify virus protein expression. We infected three different mammalian cell lines – a human
lung cell (A549), a green monkey kidney cell (VERO), and canine kidney cell (MDCK) – with
ZIKV (moi-1) for 48 hours. After the infection period was over, we fixed the cells and stained
them with mouse anti-E primary, followed by a green (FITC) anti-mouse secondary antibody
raised in goat. Using DAPI, we performed nuclear staining. The cover slips were mounted on
glass slides and analyzed under a fluorescence microscope (as described above).
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We observed strong infection in all tested cell lines: A549 (Fig. 1A), VERO (Fig. 1B), and,
MDCK (Fig. 1C). Our images show that almost 100% of the cells are infected. We verified the
perinuclear expression of the Env protein, by presenting the merge between DAPI and FITC (Fig
1B).

10.3.2.

ZIKV does not kill MDCK cells, however, it doesn’t protect them from the toxic

effects of CPT

Having established that ZIKV replicates well in mammalian cells (after 48

hours), we investigated the effect of infection on cell survival. Since most of our DENV studies
had been conducted using MDCK, we adopted the same approach for studying ZIKV. 48 hours
after infection, we measured cell death using Trypan Blue Exclusion assay (as described above).
We did not observe any significant change in cell survival, compared to mock-infected cells
(Fig. 2). Thus, infectivity (Fig. 1C) does not correlate with death of MDCK cells. In this regard,
ZIKV was strikingly similar to DENV.

We next looked at the cytoprotective effects of ZIKV against toxins. After 24 hours of
infection, infected cells were exposed to the toxin Camptothecin (CPT), and were left at 37º C
for another 24 hours. As a control, we used MDCK cells exposed to CPT alone. Unlike DENV2,
which showed significant cytoprotective effect against CPT [652], the current study shows that
ZIKV does not protect cells against the toxic effects of CPT. Hence, DENV2 and ZIKV probably
have different mechanisms of manipulating the cell death pathways.

10.3.3.

ZIKV alone does not kill A549 cells; however, it kills cells in presence of

Camptothecin

Since most Flavivirus, including DENV and ZIKV, are known to be

170

differentially lethal to different types of cells, we looked at cell survival in other cell types. To
this end, we used a human lung epithelial cell line – A549 – that has been widely used as a
transfection and infection host. We treated these cells in a same way as MDCK (Fig. 2) and
quantified cell death using Trypan Blue Exclusion Assay.

Like MDCK, cell survival was not altered significantly after 48 hours of infection (Fig. 3),
which was earlier shown to have established a strong infection (Fig. 1A). Also, CPT at this
concentration (75µM) was much less toxic to these cells. However, the virus synergized with
CPT in killing the cells, as the number of dead cells far exceeded that of CPT treatment and
ZIKV infection alone (Fig. 3). ZIKV apparently affects cell death pathways differently in
MDCK and A549 cells.

10.3.4.

ZIKV is cytotoxic for VERO cells, and its effect becomes even more severe in

presence of Camptothecin Since VERO is used as a primary host for growing ZIKV, it is
important to study the effect of infection on the survival of these cells. VERO cells were treated
the same manner as MDCK and A549, and cell death was quantified as described above. Unlike
MDCK and A549, we observed a significant increase in VERO cell death after 48 hours of
ZIKV infection (Fig. 4). Furthermore, the presence of CPT in infected cells produced a
synergism in which cell death substantially and significantly exceeded the summed effects of the
virus and the toxin (Fig. 4). Thus, ZIKV exerts very different effect on the survival of MDCK,
A549 and VERO cells.
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10.3.5.

Dengue virus might have protective effect against ZIKA

Although ZIKA did

not significantly kill MDCK cells within 48 hours, it potentially was slower acting. We therefore
increased the span of infection to 120 hours (5 days), after which cell death was calculated using
trypan blue exclusion assay. By this time, viability of infected cells was approximately 45% of
that of control cells (Fig. 5). Therefore, ZIKV is cytotoxic, though more slowly than to other
cells.
Since DENV can protect MDCK cells from CPT and IAV, we tested whether it could
protect them from long term ZIKV infection. To this end, we infected cells with ZIKV and after
48 hours, added DENV and left the cells for a further 72 hours. Thus, we had cells infected with
ZIKV for 120 hours, and a co-infection of ZIKV/DENV for the last 72 hours. The presence of
DENV dramatically reduced death in MDCK cells (Fig. 5).

Thus, DENV protected MDCK cells from the toxicity of prolonged ZIKV exposure. In
this regard, it has the same effect as that in IAV29-infected MDCK cells, as had been reported in
our earlier study [652].

10.3.6.

ZIKV infection does not affect the survival of PC12 cells The

pheochromocytoma

PC12 cell line has been frequently used a model for studying neurodegenerative disorders. Since
ZIKV causes microcephaly, investigated the effect of infection on the survival of the neuron-like
PC12 cells. We infected these cells for 48 and 72 hours and evaluated cell death (Fig. 6). There
was no significant effect of infection on the survival pattern of these cells.

29
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10.3.7.

A functional PERK pathway is important for ZIKV transcription and translation
We had already established the importance of PERK pathway in the life cycle of DENV2

[10]. Since ZIKV is closely related to DENV, we verified the role of PERK in ZIKV infection.
To that end, we infected PERK WT and KO MEF cells with ZIKV for 48 hours. Cells were lysed
and RNA was extracted using the Qiagen kit, as described above.

We used the Power SYBR Green RT to Ct 1-step kit (Applied Bio systems30#4391178) to
measure the relative expression of the ZIKV NS1 gene, compared to a loading control tubulin.
There was no significant internal variation between tubulin expression in mock and infected WT
and KO cells (Fig. 7). We recorded a 5-fold decrease in NS1 expression in infected PERK -/cells, compared to infected PERK +/+ (Fig. 7). The relative fold change in NS1 transcription was
calculated using the formula described above. We registered a 5-fold decrease in NS1
transcription in the absence of a functional PERK pathway (Fig. 7 table).

In order to further validate the compromised ZIKV transcription, we looked at viral translation
in infected PERK WT and KO cells. These cells were infected with ZIKV for 48 hours and were
probed for the Env protein expression using specific antibodies (mouse anti- E primary/ anti-Red
secondary) in an immunofluorescence study. In our study, we demonstrate a significant reduction
in E protein expression in infected PERK KO cells, as compared to infected WT cells (Fig. 8).
Thus, as in DENV2 infection, we show that the PERK pathway is positively linked to ZIKV
replication/translation.

30
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10.3.8.

Different pathways are activated in PERK +/+ and PERK -/- following ZIKV

infection

Having established the importance of a functional PERK pathway in ZIKV

transcription/translation, we looked at related pathways that we had earlier shown to be activated
during DENV2 infection – ATM and autophagy [10]. To this end, we pretreated PERK +/+ and /- cells with the following before infecting them with ZIKV: 3µM tunicamycin (inducer of ER
stress), 3µM salubrinal (inhibitor of PERK pathway), 5µM KU55933 (inhibitor of ATM
kinase), 250nM Torin1 (inducer of autophagy) and 50µM Chloroquine (inhibitor of
autolysosome formation). After 24 hours of infection, we lysed the cells and extracted RNA.
RNA was then used as a template for a qPCR reaction where we used cDNA specific primers to
quantify NS1 expression, compared to tubulin.

In PERK +/+ cells, induction of ER stress/protein misfolding by tunicamycin increased NS1
expression by more than 10-fold relative to ZIKV infection alone (Fig. 9). Since ER stress is a
byproduct of infection and replication, apparently ER stress alone improves viral replication or
translation. Blocking GADD34-activity (PERK pathway) using salubrinal caused a smaller albeit
significant upregulation (4-fold) in NS1 transcription (Fig. 9). In this regard, ZIKV is
diametrically opposite to DENV2; our earlier study shows salubrinal reducing transcription of
DENV2 NS4A [10]. Since salubrinal blocks the feedback step in PERK pathway, it maintains
the global translation arrest initiated by PERK-induced eIF2α. While this is detrimental for both
the host and the virus, it might offer an alternate scheme of selective transcription of viral genes.
As has been described in the background section, salubrinal has also been reported to reduce
viral transcription in other cell types; hence it is important to take into account the type of cells
being infected. None of the other pathways studied here, i.e., ATM, autophagy, had any effect on
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viral transcription in PERK +/+ cells eIF2α (Fig. 9). Blocking or activating these pathways did
not alter expression of NS1. Thus, unlike our previous study evaluating how DENV functions
[10], ZIKV uses very limited crosstalk between PERK and these pathways. However, more
studies are required to reach a definite conclusion.

In contrast, neither tunicamycin nor salubrinal had any effect on NS1 transcription in infected
PERK-/- cells (Fig. 10). This points to the possibility that most of the ER stress induced by
tunicamycin was mediated mostly through the PERK pathway in ZIKV infected WT cells (Fig.
9). Thus, in absence of this pathway, tunicamycin could not upregulate viral transcription in
PERK-/- cells (Fig. 10). On the other hand, NS1 transcription was upregulated when the fusion
of autophagosome and lysosome was blocked by chloroquine (Fig. 10). Thus, blocking
autophagic degradation in PERK -/- cells increased ZIKV transcription. While this does not
indicate any direct correlation between PERK and autophagy, it nevertheless points to an indirect
link – weakening the PERK pathway and autophagy together increases viral transcription. It is
important to look at the synergistic effects of these pathways in ZIKV infection. It is even more
crucial, because, although autophagy contributes to ZIKV pathogenicity in several cell lines,
recent studies have suggested that it might be instrumental in the degradation of viral particles
especially before they transmit to the fetus from the placenta [603].

Finally, we further established the importance of PERK in ZIKV infectivity by comparing the
change of NS1 expression between infected and mock cells from each (WT, KO) background.
While infection induced a 839-fold increase of NS1 expression in WT cells, in infected KO cells
the increase was reduced to 267-fold, a 68% decrease.
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10.3.9.

An important component in the initiation step of autophagy - class IA P13K p110β

catalytic subunit - plays an important role in ZIKV protein expression Having established
the role of PERK in ZIKV infection, we turned our focus to proteins involved in autophagy.
Since many studies measured the effect of ZIKV on mTOR-dependent autophagy, we looked at a
non-mTOR branch. We examined the p110β catalytic subunit of the class IA P13K, which
interacts with the Vps34-Vps15-Beclin1-ATG14L complex during the nucleation and expansion
stages of autophagy.

We obtained p110β WT and KO MEFs from our collaborator (Dr. Wei-Xing Zong). We
infected these cells with ZIKV and looked at viral E protein expression after 24, 48, and 72
hours. In a fashion similar to our earlier studies, we used specific antibodies for the ZIKV E
protein (green FITC channel) in an immunofluorescence experiment. DAPI was used for nuclear
staining. Protein expression was severely compromised in absence of a functional p110β
catalytic subunit (Fig. 11). There was a significant drop-off in E signals in absence of the
catalytic subunit, an event that was consistent through 24 to 72 hours post infection. The early
steps of autophagy are thus important for ZIKV protein expression. However, as we have also
shown that autophagy is inhibitory in a PERK -/- background, it will be a worthy endeavor to
look at the effects of PERK inhibitor on infected p110β WT and KO cells.

10.3.10.

A pro-apoptotic protein SEPT4/ARTS possibly takes an active role in blocking

ZIKV replication/ translation

A unique member of the Septin family, Apoptosis related

protein in TGF-β pathway (ARTS) or Septin 4 (SEPT4) is a pro-apoptotic protein that
translocates from the mitochondria to the cytosol and blocks the X-linked inhibitor of apoptosis
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(XIAP) protein. As is evident from the name, this protein induces apoptosis in response to TGF-

β activation. Structural studies have shown that ARTS binds to the BIR3 domain in XIAP, at a
site different from other IAP-antagonist proteins like SMAC/Diablo. Since most studies
concerning the role of apoptosis in ZIKV have focused mainly on the TP53 and BAX/BAK, we
examined this less-studied apoptotic protein in relation to ZIKV infection.

We infected SEPT4 WT and KO MEF cells for 48 and 72 hours, then fixed and stained with
antibodies specific for the ZIKV E protein, followed by staining with anti-FITC (green)
secondary antibodies. The number of cells showing E (green) signals was quantified and
expressed as percentage of cells infected. After both times, we observed a significant, almost 4fold, increase in viral E protein in infected SEPT4 KO cells, compared to SEPT4 WT cells
(Figure 12). The genetic deletion of SEPT 4 thus positively affects viral replication and
translation.

Since most studies had shown that apoptosis was important for the pathogenicity of ZIKV, we
were then interested to see the effect of infection on the viability of these cells.

10.3.11.

In absence of SEPT4/ARTS, infection increases cell death

SEPT WT and KO

cells were infected with ZIKV for 24, 48 and 72 hours. After each time, cell death was measured
using the Trypan Blue exclusion assay. In case of the WT cells, there were more dead cells in the
cultures by 48 h but by 72 h the viability of the infected cells was similar to that of the control
(Figure 13). In case of the KO cells, infection led to more cell death compared to the WT cells,
and this reached its peak after 72 hours of infection (Figure 13). Overall, this was an interesting
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data because we registered higher cell death when a pro-apoptotic gene had been knocked out.
The higher cell death in KO cells correlate with increased viral replication (as seen in Figure
12), compared to infected WT cells. In conclusion, ZIKV potentially induces a non-SEPT4
branch of apoptosis in KO cells, which in turn facilitates viral replication. It is also possible that
SEPT4 might affect antiviral signaling, and in this regard it will be interesting to test the effect of
SEPT4 on interferon signaling.

10.4.

DISCUSSION

ZIKV is an emerging flavivirus that is potentially pandemic.

Although it belongs to the Flavivirus genera, it is unique in that it can be vertically transmitted,
i.e., placenta to fetus. This makes it different from other neurotropic members of these genera
like WNV and JEV. In the current study, we investigated the role of ZIKV infection on the
survival of different mammalian cell lines, and we have tested the roles of PERK pathway,
autophagy and apoptosis in ZIKV infectivity.

Our studies reveal a differential response to infection in A549, MDCK and VERO cells.
The fact that VERO has been widely used to grow ZIKV, and it also dies very soon once
infected, suggests that this virus derives a lot of its pathogenicity from cell death. This is in stark
contrast with DENV, which has been reported to protect cells [652]. In our study, preliminary
data suggested that DENV2 protects MDCK cells from ZIKV cytotoxicity. Unlike DENV2,
ZIKV did not protect any of these cell lines from CPT toxicity. In case of VERO and A549, it
synergized with CPT, thereby aggravating the cytotoxicity of CPT. In this regard, ZIKV induces
apoptotic cell death in the presence of CPT. However, a detailed study needs to be undertaken
before we can reach a conclusion.
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Our study also draws close parallel between ZIKV and DENV2, since in MEF cells both
these viruses need an effective PERK pathway and autophagy to carry out gene and protein
expression. However, as we performed more molecular analyses, it became clear that subtle
differences underlie this apparent similarity. Although autophagy is important for the life cycle
of both ZIKV and DENV, blocking the final step of autophagy in PERK -/- cells is favorable for
ZIKV transcription. To add to the complexity, blocking autophagy had no significant effect on
ZIKV transcription in infected WT cells. There may be some synergistic relation between PERK
and autophagy that is visible only when both these pathways are incapacitated. Salubrinal affects
ZIKV infected PERK +/+ cells, differently compared to DENV infected PERK +/+. While in the
latter case, salubrinal was reported to slow ZIKV E protein expression [10], in the former
instance we observe an increase in ZIKV NS1 transcription. This data points to a possible
difference in the mechanisms by which these viruses manipulate global translation in a host cell.
While GADD34-mediated dephosphorylation of eIF2α presents DENV2 with a possibility of
harnessing

the

benefits

of

global

host

translation,

blocking

GADD34-mediated

dephosphorylation (by salubrinal) might prove effective for ZIKV replication and infectivity.
This might also explain one of the basic differences between these two related viruses - ZIKVinfected cells might be dying faster because of limited access to the translation machinery,
compared to DENV.

While we presented data that shows that the initial steps of autophagy are important for
ZIKV infectivity, we also show that a pro-apoptotic SEPT4/ARTS protein is capable of blocking
ZIKV protein expression. We also verified that the low protein expression in SEPT4+/+ cells is
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not a consequence of cell death; infected SEPT4-/- (which show higher E protein expression) die
in greater number than the former. While this validates the role of cell death in ZIKV infectivity,
it also opens the possibility that the SEPT4 branch of apoptosis is important in blocking ZIKV
infectivity. We believe that looking deeply into this pathway might offer antiviral targets against
ZIKV infection.
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Figure 1: ZIKV can effectively infect and replicate in three different cell lines
ZIKV MR766 can efficiently replicate and produce infective virions in three different cell
lines: A549 (Fig. A), VERO (Fig. B), and MDCK (Fig. C). The cells were infected for 48 hours
and were then fixed with 4% PFA. After permeabilization with Triton X 100, the cells were
incubated in a blocking solution to prevent nonspecific binding. They were then probed for the
ZIKV E protein, using mouse anti-E and FITC-labeled anti-mouse secondary antibody. The
infected cells all show strong FITC signals, thus illustrating the high infectivity established by
the virus. DAPI was used as a nuclear stain in this experiment.
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Figure 2: ZIKV does not protect MDCK cells from the toxicity of CPT
In this experiment, MDCK cells were infected for 24 hours and were then exposed to
CPT and incubated for another 24 hours. Trypan Blue exclusion assay was used to quantify
percentage cell death. In the absence of CPT, ZIKV does not kill MDCK cells after 48 hours of
infection. In this regard, it is similar to DENV2 infection. However, unlike DENV2, ZIKV does
not protect MDCK cells against CPT, as measured after 24 hours of CPT treatment and 48 hours
of infection. ZIKV therefore probably differs from DENV2 in its effects on the cell survival
pathways.
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Figure 3: ZIKV synergizes with camptothecin to kill A549 cells
In A549 cells, ZIKV does not show any cytotoxic effect after 24 hours. However, when
CPT is added to the cell culture after 24 hours of infection, the virus shows significant cytotoxic
effect. Thus, after 48 hours of infection and 24 hours of CPT treatment, the virus possibly
establishes a synergistic cytotoxicity along with CPT.
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Figure 4: ZIKV is cytotoxic for VERO cells and synergizes in toxicity with camptothecin
Vero cells were infected with the ZIKV for 24h. The virus was significantly toxic
compared to mock inflection. When infected cells were exposed to CPT, the combination as
synergistically toxic, leading to <10% survival. In this respect A549 and VERO cells behave
similarly.
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Figure 5: Dengue virus can protect MDCK cells against ZIKV
MDCK cells were infected with ZIKV for 120 h, resulting in ~ 45% higher mortality than
controls (in which the viability ranged from 5 to 10%). The experimental cells were exposed to
ZIKV for 48 hours. DENV was then added and the cells were left for the next 72 hours. Only
10% of the cells died in the latter instance. Thus, DENV protects MDCK cells from the
cytotoxicity of ZIKV.

190

100

PC12

90

% CELL DEATH

80
70
60
50
40

p value = .61

p value = .931

30
20
10
0
MOCK 48h

ZIKV 48h

Figure 6

191

MOCK 72h

ZIKV 72h

Figure 6: Infection does not affect survival of PC-12 cells, even after 48 and 72 hours
Since neuronal cells form some of the major targets of ZIKV infection, we infected PC12
cells. These cells are derived from the adrenal gland of rats, and are frequently used as models to
study pheochromocytoma and can be differentiated into neuron-like cells. In our experiments,
there was no significant effect of ZIKV infection on the survival rate of these cells in their
undifferentiated state.
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Figure 7: A functional PERK pathway is important for ZIKV NS1 expression
PERK WT and KO cells were infected with ZIKV for 48 hours and then cells were lysed
and RNA was extracted using the Qiagen kit. The RNA was then used as a template for a 1-step
reaction where the RNA was converted to cDNA and the cDNA was used probed with specific
primers for Tubulin (loading control) and ZIKV NS1 (target gene). The relative fold change in
NS1 transcription (table) has been calculated using the formula described above. There was no
significant variation between the tubulin expression of mock and infected WT and KO cells. We
observed a similar link between PERK and ZIKV infectivity as we had shown in case of DENV
infection. Our data shows a 5-fold decrease in NS1 transcription in infected PERK KO cells,
compared to their infected counterparts.
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Figure 8: A functional PERK pathway is important for ZIKV E protein expression
PERK WT (A) and KO (B) cells were infected with ZIKV for 48 hours and were probed
for E protein expression (anti-Red secondary antibody) using immunofluorescence. E protein
signals are substantially reduced in infected PERK KO cells compared to wild type. We thus
expand our previous data for DENV and demonstrated an active link between PERK pathway
and ZIKV replication/translation.
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Figure 9: In PERK+/+ MEF cells, induction of protein misfolding and to some extent,
blocking PERK-imposed translation arrest, increases the transcription of the ZIKV NS1
gene, however neither ATM pathway nor autophagy seems to have any significant effect on
the rate of transcription
PERK +/+ MEF cells were pretreated for 2 hours with the following, before being
infected with ZIKV: 3µM tunicamycin (inducer of ER stress), 3µM salubrinal (inhibitor of
PERK pathway), 5µM KU55933 (inhibitor of ATM kinase), 250nM Torin1 (inducer of
autophagy) and 50µM Chloroquine (inhibitor of autolysosome formation). After 24 hours of
infection, RNA was extracted and quantified. Power SYBR Green RT to Ct 1-step kit
(Applied Bio systems31#4391178) was used to measure the relative transcription of the ZIKV
NS1 gene, compared to a loading control Tubulin. In case of tunicamycin and salubrinal
pretreatment, we observed 11- and 4-fold increase in NS1 expression, respectively. However,
none of the chemicals blocking ATM pathway or autophagy had any significant effect on viral
transcription; the same holds true also for inducers of autophagy.
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Figure 10: In PERK -/- MEF cells, blocking the formation of autolysosomes increases
expression of ZIKV NS1
PERK-/- MEF cells were pretreated and infected in the same manner as PERK +/+ cells.
The same procedure was used to extract RNA and measure the transcription of ZIKV NS1 and
Tubulin. In absence of a functional PERK pathway, neither tunicamycin nor salubrinal had any
significant effect on viral transcription. On the other hand, blocking the endocytosis-mediated
fusion of autophagosome and lysosome increased NS1 expression by 5-fold.
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Figure 11: An important component in the initiation step of autophagy - class IA P13K
p110β catalytic subunit - is important to expression of ZIKV E protein
We obtained p110β WT and KO MEFs from our collaborator (Dr. Wei-Xing Zong, Stony
Brook University). We infected the WT and KO cells with ZIKV and looked at viral protein
production at 24-72 hours using specific antibodies for the ZIKV E protein (green FITC
channel). Protein expression was severely compromised in absence of a functional catalytic
subunit (p110β ). DAPI staining was used to look at the cell survival, which did not vary much
between WT and KO cells. Thus, a decrease in viral expression was a result of decreased cell
viability in the KO cells, as assessed by numbers of cells in the plates. However, as determined
by E protein, the virus infected only approximately 1/5 of the cells.
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Figure 12: A pro-apoptotic protein SEPT4/ARTS blocks ZIKV replication/translation
We acquired SEPT4 WT and KO MEF cells from our collaborator Dr. Sarit Larisch
(Israel). These cells were infected with ZIKV for 48 and 72 hours, after which they were fixed
and stained with antibodies specific for the ZIKV E protein. This was followed by staining with
anti-FITC (green) secondary antibodies. The number of cells showing E (green) signals was
quantified and expressed as percentage of cells infected. After both the times, we register a
significant increase in viral E protein expression in infected SEPT4 KO cells relative to wild
type. The genetic deletion of SEPT 4 thus strongly increases viral translation.
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72h

Figure 13: In absence of SEPT4/ARTS, ZIKV infection increases cell death
SEPT WT and KO cells were infected with ZIKV for 24, 48 and 72 hours. After each
time point, cell death was measured using the Trypan Blue exclusion assay. In case of the WT
cells, we observe a slight increase in cell death after 48 hours only, which is rescued after 72
hours. In case of the KO cells, we register a higher level of cell death compared to the WT cells,
and it reaches its peak after 72 hours of infection. The higher level of cell death in KO cells
might have a correlation with increased viral replication (Figure 12), compared to infected WT
cells. Thus, ZIKV might be inducing a non-SEPT4 branch of apoptosis in KO cells, which in
turn facilitates viral replication.
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11. LIST OF ABBREVIATIONS
4EBP1
ACD
ADE
ADEM
AG129
AIDS
AIF
AKT
AMBRA1
AMPK
APAF
Apo2L
APS
ATCC
ATF4
ATF6
ATG
ATM
ATP
ATR
BAD
BAK
BALB/C
BAX
BCL-2
BECN1
BH
BHK
BID
BIM
BiP
BOK
BSA
C
CALR
CaMKII
CARD
CARM1
CASP
CBV3
CCL5
CD95
Cdc48
cDNA

Eukaryotic Initiation Factor 4E-Binding Protein 1
Accidental Cell Death
Antibody Dependent Enhancement
Acute Disseminated Encephalomyelitis
Dengue Virus Mouse Model
Acquired Immunodeficiency Disease Syndrome
Apoptosis Inducing Factor
Protein Kinase B (Serine/Threonine-Specific Protein Kinase)
Activating Molecule in BECN1-Regulated Autophagy Protein 1
Catalytic Subunit Of AMP-Activated Protein Kinase
Apoptotic Peptidase Activating Factor
Apo2 Ligand/ Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
Ammonium Persulfate
American Type Culture Collection
Activating Transcription Factor 4
Activating Transcription Factor 6
Autophagy Related Gene
Ataxia Telangiectasia Mutated Kinase
Adenosine Triphosphate
ATM And Rad53 Related (ATR) Kinase
Bcl2-Associated Agonist of Cell Death
Bcl-2 Apoptosis Killer
An Albino, Laboratory-Bred Strain Of House Mouse
Bcl-2 associated X
B-Cell Lymphoma 2
Beclin-1
Bcl-2 Homology
Baby Hamster Kidney
BH3-Interacting Domain Death Agonist
Bcl-2-Like Protein 11
Binding Immunoglobulin Protein
Bcl-2-Related Ovarian Killer Protein
Bovine Serum Albumin
Capsid Protein
Calreticulin
Calcium/Calmodulin-Dependent Protein Kinase Type II Alpha Chain
Caspase Recruitment Domain
Coactivator-Associated Arginine Methyltransferase 1
Cysteine-Dependent Aspartate-Directed Proteases
Coxsackievirus B3
C-C Motif Chemokine 5
Cluster of Differentiation 95
Cell Division Control Protein 48
Complementary DNA
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CDS
cGAS
CHK
CHME
CHO
CHOP
CMA
CNS
CPE
CPT
CREB
CRT
CTCF
CTS
CXCL10
CXCR3
CYCS
CYPD
DAMP
DAPI
DAPK1
dATP
Daxx
DC-SIGN
DCC
dCTP
DDR
DENV
DEPC
DF
dGTP
DHF
DIABLO
DISC
dLN
DMEM
DMSO
DMV
DNA
dNTP
DR3
DRP
DSB
DSS
dTTP
dUTP

Coding Sequence
Cyclic GMP-AMP Synthase
Cell Cycle Checkpoint Kinase
Cellosaurus Cell Line (Immortalized Human Microglia Cell Line)
Chinese Hamster Ovary
DNA Damage-Inducible Transcript 3 Protein (C/EBP-Homologous Protein)
Chaperone-Mediated Autophagy
Central Nervous System
Cytopathic Effect
Camptothecin
cAMP Responsive Element Binding Protein
Calreticulin
CCCTC-Binding Factor
Cathepsin
C-X-C Motif Chemokine 10
C-X-C Chemokine Receptor Type 3
Cytochrome C
Cyclophilin D
Danger Associated Molecular Pattern
4′,6-Diamidino-2-Phenylindole (Nuclear Stain)
Death Associated Protein Kinase 1
Deoxyadenosine Triphosphate
Death-associated protein 6
Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin
Netrin Receptor
Deoxycytidine Triphosphate
DNA Damage Response
Dengue Virus
Diethylpyrocarbonate
Dengue Fever
Deoxyguanosine Triphosphate
Dengue Hemorrhagic Fever
Direct IAP Binding Mitochondrial Protein with Low Pi
Death Inducing Signaling Complex
Drained Lymph Nodes
Dulbecco`s Modified Eagle Media
Dimethyl Sulfoxide
Double Membrane Vesicles
Deoxyribonucleic Acid
Deoxyribonucleotide Triphosphate
Tumor Necrosis Factor Receptor Superfamily Member 25
DAPk-related protein kinase
Double-Strand Break
Dengue Shock Syndrome
Deoxythymidine Triphosphate
Deoxyuridine Triphosphate
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E
EA. hy296
EBV
ECL
EDTA
EE
EGFR
EIF2AK3
eIF2α
ELANE
EMEM
ER
ERAD
ERICA
ERK2
ERN1
Ero1
ESCRT
EtBr
EV71
FADD
FAM134B
FBS
FDM
FGA/89
FGA/NA
FLIP
G3BP1
GA
GADD34
Gag/Pol
GE
GFAP
GFP
GRP78
GTA
H2AX
HBN
HBV
HCMV
HCV
HDAC6
HDM2
HEK
HeLa
HIV

Envelope Protein
Human Somatic Cell Hybrid
Epstein Barr Virus
Enhanced Chemiluminescence
Ethylenediaminetetraacetic acid
Early Endosomes
Epidermal Growth Factor Receptor
Eukaryotic Translation Initiation Factor 2-Alpha Kinase 3
Eukaryotic Translation Initiation Factor 2 Subunit 1
Neutrophil Elastase
Eagle’s Minimal Essential Medium
Endoplasmic Reticulum
Endoplasmic Reticulum Associated Degradation
ER-Stress Induced Chaperone Mediated Autophagy
Mitogen-Activated Protein Kinase 1
Serine/Threonine-Protein Kinase/Endoribonuclease IRE1
ERO1-Like Protein Alpha
Endosomal-Sorting Complex Required For Transport
Ethidium Bromide
Enterovirus 71
FAS-associated Death Domain
Family With Sequence Similarity 134 Member B/ Reticulophagy Regulator 1
Fetal Bovine Serum
Flavivirus Dilution Media
Dengue Virus Type 1 Strain
Dengue Virus Type 1 Strain
FLICE (FADD-Like IL-1β-Converting Enzyme)-Inhibitory Protein
G3BP Stress Granule Assembly Factor 1
Gallic Acid
Protein Phosphatase 1 Regulatory Subunit 15A
Gag Is A Lentiviral Structural Precursor Protein and Pol Is A Polymerase
General Electric
Glial Fibrillary Acidic Protein
Green Fluorescent Protein
Endoplasmic Reticulum Chaperone (BiP)
Genotoxic Stress Targeted Autophagy
Histone H2ax
CNS-derived human cell types
Hepatitis B Virus
Human Cytomegalovirus
Hepatitis C Virus
Histone Deacetylase 6
E3 Ubiquitin-Protein Ligase Mdm2
Human Embryonic Kidney
Henrietta Lacks
Human Immunodeficiency Virus
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HMC
HMCV
HMGB
hnRNPC
HPR
HPV
HR-HPV
HRK
HRPE
HSP
HSV
HT29
HTRA2
IAV
IFN
IFNAR
IL
IMM
IP3
IRE1
IRF
ISR
JAK
JEV
JNK
K562
KCl
kD/ kDA
KH2PO4
KSAV
KU55933
KU812
L-SIGN
LAMP
LAP
LDH
LE
LKB1
LMP
LUBAC1
M
MAC-ELISA
MAP1LC3B
MAPK2
MCF
MCP

Human Mast Cells
Human Cytomegalovirus
High Mobility Group Box
Heterogeneous Nucleus Ribonucleoprotein
Fenretinide
Human Papillomavirus
High-Risk Human Papillomavirus
Serine/Threonine-Protein Kinase Haspin Homolog Hrk1
CNS-Derived Human Cell Type
Heat Shock Protein
Herpes Simplex Virus
Human Colon Adenocarcinoma Cell Line
Serine Protease HTRA2, Mitochondrial
Influenza A Virus
Interferon
Interferon Alpha/Beta Receptor 1
Interleukin
Inner Mitochondrial Membrane
Inositol 1,4,5-Trisphosphate Receptor Type 1
Inositol Requiring Enzyme 1
Interferon Regulatory Factor 2-Binding Protein
Integrated Stress Response
Tyrosine-Protein Kinase
Japanese Encephalitis Virus
Mitogen-Activated Protein Kinase 8
Human Immortalized Myelogenous Leukemia Cell Line
Potassium Chloride
Kilo Daltons
Monopotassium Phosphate
Kaposi’s Sarcoma Associated Herpesvirus
Specific Inhibitor of ATM Kinase
Human Mast Cells
C-Type Lectin Domain Family 4 Member M
Lysosome-Associated Membrane Glycoprotein
LC3-associated phagocytosis
Lactate Dehydrogenase
Late Endosome
Liver Kinase B1
Lysosomal Membrane Permeabilization
Linear Ubiquitin Chain Assembly Complex
Membrane Protein
IgM Antibody Capture Enzyme-Linked Immunosorbent Assay
Microtubule-Associated Protein 1 Light Chain 3 Beta
Mitogen-Activated Protein Kinase
Michigan Cancer Foundation-7
Monocyte chemotactic protein
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MDCK
mdDC
MDM2
MEC
MEF
MEM
MHC
MIF
miR
MLKL
MOMP
MOPS
MPT
MRF
mRNA
mTORC
N-2
N18
Na2HPO4
NaCl
NADPH
NaOH
NCBI
NCCD
NDP52
NET
NFκB
NGC
NIH
NO
NOX2
NOXA
NS
NTRK3
OMM
OPTN
P-S
p70S6K
PAGE
PAMP
PANX1
PARK2
PARP
PAS
PBMC
PBS

Madine Darby Canine Kidney
Monocyte-Derived Human Dendritic Cells
Mouse Double Minute 2 Homolog/ E3 Ubiquitin Protein Ligase
Pulmonary Microvascular Endothelial Cells
Mouse Embryonic Fibroblast
Minimal Essential Media
Major Histocompatibility Complex
Macrophage Migration Inhibitory Factor
Micro RNA
Mixed Lineage Kinase Domain-Like Pseudo Kinase
Mitochondrial Outer Membrane Permeabilization
3-(N-Morpholino) Propane Sulfonic Acid
Mitochondrial Permeability Transition
Microglial Response Factor
Messenger RNA
Mammalian Target of Rapamycin
Mouse Neuroblastoma Cell Line
Mouse Neuroblastoma X Rat Glioma Hybrid
Disodium Phosphate
Sodium Chloride
Nicotinamide Adenine Dinucleotide Phosphate
Sodium Hydroxide
National Center for Biotechnology Information
Nomenclature Committee on Cell Death
Calcium-Binding and Coiled-Coil Domain-Containing Protein 2
Neutrophil Extrusion Traps
Nuclear Factor NF-Kappa-B
DENV Type 2, Strain New Guinea C
National Institutes of Health
Nitric Oxide
Cytochrome B-245 Heavy Chain
Phorbol-12-Myristate-13-Acetate-Induced Protein 1
Non-Structural
Neurotrophin-3 Growth Factor Receptor
Outer Mitochondrial Membrane
Optineurin
Phosphatidylserine
p70 ribosome S6 kinase
Polyacrylamide Gel Electrophoresis
Pathogen-Associated Molecular Pattern
Pannexin-1 (Structural Component of The Gap Junctions)
E3 Ubiquitin-Protein Ligase Parkin
Poly [ADP-Ribose] Polymerase
Pre-Autophagosome Membrane
Peripheral Blood Mononuclear Cells
Phosphate Buffer Saline
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pCAGGS
PCD
pEGFP
PERK
PEX
PFA
PHLPP1
PI3K
PI3P
PIKK
PIN1
PP2A
PPAR
PRR
PTCH1
PTEN
PTPC
PUMA
PV
qPCR
RAB7A
RAF1
RANTES
RC
RCD
RdRp
RER
RHEB
RHIM
RIDD
RIG
RIPA
RIPK1
RNA
RNase
RNS
ROCK
ROI
ROS
RPM
RPMI
rRNA
RT
RTN3
RUBICON

Mammalian Expression Vector with CMV IE Promoter
Programmed Cell Death
Mammalian Expression Vector (coding for enhanced GFP)
Protein Kinase R Like Endoplasmic Reticulum Kinase
Pexophagy
Paraformaldehyde
PH Domain Leucine-Rich Repeat-Containing Protein Phosphatase 1
Phosphatidylinositol-3-Kinase
Phosphatidyl-3-Inositol Phosphate
Phosphatidyl-3-Inositol Phosphate Like Kinase
Peptidyl-Prolyl Cis-Trans Isomerase Nima-Interacting 1
Serine/Threonine-Protein Phosphatase 2A
Peroxisome Proliferator-Activated Receptor
Transcription Factor Prr1
Protein Patched Homolog 1
Phosphatidylinositol 3,4,5-Trisphosphate 3-Phosphatase and Dual-Specificity
Protein Phosphatase
Permeabilization Transition Pore Complex
Bcl-2-Binding Component 3
Poliovirus
Quantitative Polymerase Chain Reaction
Ras-Related Protein Rab-7a
RAF Proto-Oncogene Serine/Threonine-Protein Kinase
C-C Motif Chemokine 5
Replication Complex
Regulated Cell Death
RNA-Dependent RNA Polymerase
Rough Endoplasmic Reticulum
GTPase Ras Homolog Enriched in Brain
Respective Homotypic Interaction Motif
IRE1-Dependent Decay Pathway
Retinoic Acid Inducible Gene
Radio Immuno Precipitation
Receptor Interacting Serine Threonine Protein Kinase 1
Ribonucleic Acid
Ribonuclease
Reactive Nitrogen Species
Rho-Associated Protein Kinase
Region of Interest
Reactive Oxygen Species
Revolutions Per Minute
Roswell Park Memorial Institute
Ribosomal RNA
Reverse Transcriptase
ER Membrane Protein Reticulon 3
Run Domain Beclin-1-Interacting and Cysteine-Rich Domain-Containing Protein
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Sal
sAP
SDS
SET
SIRT1
SK-N-MC
SMAC
SMPK
SMURF1
SNARE
SQSTM1
SSB
SSC
STAT
STING
STX17
SUN
SW480
SYBR
T98G
TAM
TAP
TBST
TEMED
TIM
TLR
TM
Tm
TMS
TNF RI
TNF-α
TOPBP1
TP53
TRADD
TRAF
TRAIL
TRB3
TSC2
ULK1
UNC5A
UPR
UTH1
VP
VP7
VPS34

Salubrinal
Secretory Alkaline Phosphatase
Sodium Dodecyl Sulfate
N-Lysine Methyltransferase KMT5A
NAD-Dependent Protein Deacetylase Sirtuin-1
Human Neuroblastoma Cells
Secondary Mitochondrial Activator of Caspase
C-GMP Dependent Protein Kinase
E3 Ubiquitin-Protein Ligase SMURF1
SNAP (Soluble NSF (N-Ethylmaleimide-Sensitive Factor) Attachment
Protein) Receptor
Sequestosome 1
Single-Strand Break
Oral Cancer Cells
Signal Transducer and Activator of Transcription
Stimulator of Interferon Genes Protein
Syntaxin 17
Family Of 4 Yeast Genes (SIM1, UTH1, NCA3 And SUN4)
Human Colorectal Adenocarcinoma Cell Line
Asymmetrical Cyanine Dye Used as A Nucleic Acid Stain in Molecular Biology
Homo Sapiens Brain Glioblastoma Cell Line
Protein Tyrosine Kinase Family (TYRO3, AXL and MER)
Antigen Peptide Transporter
Tris Buffer Saline (With 0.1% Tween-20 Detergent)
Tetra Methyl Ethylene Diamine
A Family of Cell Surface Phosphatidyl Receptors
Toll-Like Receptor
Tunicamycin
Primer Melting Temperature
Trans-Membrane Domains
Tumor Necrosis Factor-α Receptor I
Tumor Necrosis Factor-α
DNA Topoisomerase 2-Binding Protein 1
Tumor Protein 53
TNF-associated death domain
TNF receptor associated factor
TNF-α related apoptosis inducing ligand
Tribbles Homolog 3
Tuberous Sclerosis 2
Unc-51-Like Kinase
Netrin Receptor UNC5A
Unfolded Protein Response
Member of The Yeast SUN Family
Vesicle Packets
Rotavirus Capsid Protein
Vacuolar Protein-Sorting Protein 34
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VSV
VZV
WHO
WIPI
WNV
WNVKUN
XAF
XBP1
XIAP
YFV
ZBP
ZIKV
ZVAD-FMK

Vesicular Stomatitis Virus
Varicella Zoster Virus
World Health Organization
WD Repeat Domain, Phosphoinositide Interacting/ATG 18 Homolog
West Nile Virus
West Nile Virus Kunjin Strain
XIAP-Associated Factor 1
X-Box-Binding Protein 1
X-linked inhibitor of apoptosis protein
Yellow Fever Virus
Z-DNA binding protein
Zika Virus
Carbobenzoxy-Valyl-Alanyl-Aspartyl-[O-Methyl]- Fluoromethylketone
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216

217

218

219

220

221

222

223

224

225

226

227

228

229

12.2.
“Dengue-induced autophagy, virus replication and protection from cell death
require ER stress (PERK) pathway activation”
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